ID   3FN3_WALAE              Reviewed;          83 AA.
AC   C1IC47;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   26-MAY-2009, sequence version 1.
DT   24-JUL-2013, entry version 19.
DE   RecName: Full=Three finger toxin Wa-III;
DE   Flags: Precursor;
OS   Walterinnesia aegyptia (Desert black snake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Elapidae; Elapinae; Walterinnesia.
OX   NCBI_TaxID=64182;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 22-37, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=18405934; DOI=10.1016/j.toxicon.2008.02.012;
RA   Tsai H.-Y., Wang Y.M., Tsai I.-H.;
RT   "Cloning, characterization and phylogenetic analyses of members of
RT   three major venom families from a single specimen of Walterinnesia
RT   aegyptia.";
RL   Toxicon 51:1245-1254(2008).
RN   [2]
RP   PROTEIN SEQUENCE OF 22-83.
RC   TISSUE=Venom;
RX   PubMed=9080571; DOI=10.1016/S0041-0101(96)00138-9;
RA   Samejima Y., Aoki-Tomomatsu Y., Yanagisawa M., Mebs D.;
RT   "Amino acid sequence of two neurotoxins from the venom of the Egyptian
RT   black snake (Walterinnesia aegyptia).";
RL   Toxicon 35:151-157(1997).
RN   [3]
RP   FUNCTION, AND LETHAL DOSE.
RC   TISSUE=Venom;
RX   PubMed=960110; DOI=10.1016/0041-0101(76)90023-4;
RA   Lee C.Y., Chen Y.M., Mebs D.;
RT   "Chromatographic separation of the venom of Egyptian black snake
RT   (Walterinnesia aegyptia) and pharmacological characterization of its
RT   components.";
RL   Toxicon 14:275-281(1976).
CC   -!- FUNCTION: Three-finger toxin that reversibly binds and inhibits
CC       the muscular nicotinic acetylcholine receptor (nAChR).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=6852; Method=Electrospray; Range=22-83;
CC       Source=PubMed:18405934;
CC   -!- TOXIC DOSE: LD(50) is 0.95 mg/kg by intraperitoneal injection in
CC       mice.
CC   -!- SIMILARITY: Belongs to the snake three-finger toxin family. Type I
CC       alpha-neurotoxin subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU196555; ABX82864.1; -; mRNA.
DR   GO; GO:0035792; C:other organism postsynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0035821; P:modification of morphology or physiology of other organism; IEA:InterPro.
DR   InterPro; IPR003571; Snake_toxin.
DR   InterPro; IPR018354; Snake_toxin_BS.
DR   Pfam; PF00087; Toxin_1; 1.
DR   PROSITE; PS00272; SNAKE_TOXIN; 1.
PE   1: Evidence at protein level;
KW   Acetylcholine receptor inhibiting toxin; Direct protein sequencing;
KW   Disulfide bond; Ion channel impairing toxin; Neurotoxin;
KW   Postsynaptic neurotoxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     21
FT   CHAIN        22     83       Three finger toxin Wa-III.
FT                                /FTId=PRO_0000419224.
FT   DISULFID     24     45       By similarity.
FT   DISULFID     38     62       By similarity.
FT   DISULFID     64     75       By similarity.
FT   DISULFID     76     81       By similarity.
FT   CONFLICT     56     58       SIT -> KII (in Ref. 2; AA sequence).
SQ   SEQUENCE   83 AA;  9126 MW;  08933B007BD32AEF CRC64;
     MKTLLLTLVV VTIVCLDLGH TFVCHNQQSS QPPTTTNCSG GENKCYKKQW SDHRGSITER
     GCGCPTVKKG IKLHCCTTEK CNN
//
ID   3FN5_WALAE              Reviewed;          86 AA.
AC   C1IC49;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   26-MAY-2009, sequence version 1.
DT   24-JUL-2013, entry version 19.
DE   RecName: Full=Three finger toxin Wa-V;
DE   Flags: Precursor;
OS   Walterinnesia aegyptia (Desert black snake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Elapidae; Elapinae; Walterinnesia.
OX   NCBI_TaxID=64182;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 22-37, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=18405934; DOI=10.1016/j.toxicon.2008.02.012;
RA   Tsai H.-Y., Wang Y.M., Tsai I.-H.;
RT   "Cloning, characterization and phylogenetic analyses of members of
RT   three major venom families from a single specimen of Walterinnesia
RT   aegyptia.";
RL   Toxicon 51:1245-1254(2008).
RN   [2]
RP   FUNCTION, AND LETHAL DOSE.
RC   TISSUE=Venom;
RX   PubMed=960110; DOI=10.1016/0041-0101(76)90023-4;
RA   Lee C.Y., Chen Y.M., Mebs D.;
RT   "Chromatographic separation of the venom of Egyptian black snake
RT   (Walterinnesia aegyptia) and pharmacological characterization of its
RT   components.";
RL   Toxicon 14:275-281(1976).
CC   -!- FUNCTION: Three-finger toxin that binds and inhibits the muscular
CC       nicotinic acetylcholine receptor (nAChR). The neuromuscular block
CC       is irreversible in chick biventes cervicis, but partially
CC       reversible in the rat diaphragm preparation.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=7400; Method=Electrospray; Range=22-86;
CC       Source=PubMed:18405934;
CC   -!- TOXIC DOSE: LD(50) is 0.2 mg/kg by intraperitoneal injection in
CC       mice.
CC   -!- SIMILARITY: Belongs to the snake three-finger toxin family. Orphan
CC       group II subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU196557; ABX82866.1; -; mRNA.
DR   GO; GO:0035792; C:other organism postsynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0035821; P:modification of morphology or physiology of other organism; IEA:InterPro.
DR   InterPro; IPR003571; Snake_toxin.
DR   InterPro; IPR018354; Snake_toxin_BS.
DR   Pfam; PF00087; Toxin_1; 1.
DR   PROSITE; PS00272; SNAKE_TOXIN; 1.
PE   1: Evidence at protein level;
KW   Acetylcholine receptor inhibiting toxin; Direct protein sequencing;
KW   Disulfide bond; Ion channel impairing toxin; Neurotoxin;
KW   Postsynaptic neurotoxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     21
FT   CHAIN        22     86       Three finger toxin Wa-V.
FT                                /FTId=PRO_0000419226.
FT   DISULFID     24     45       By similarity.
FT   DISULFID     27     32       By similarity.
FT   DISULFID     38     63       By similarity.
FT   DISULFID     67     78       By similarity.
FT   DISULFID     79     84       By similarity.
SQ   SEQUENCE   86 AA;  9715 MW;  D1C2C67C3B993249 CRC64;
     MKTLLLTLVL VTIVCLDLGY TLTCLICPKK YCNQVHTCRN GENLCIKTFY EGNLLGKQFK
     RGCAATCPEA RPREIVECCS RDKCNH
//
ID   3FN4_WALAE              Reviewed;          83 AA.
AC   C1IC48;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   26-MAY-2009, sequence version 1.
DT   24-JUL-2013, entry version 19.
DE   RecName: Full=Three finger toxin Wa-IV;
DE   Flags: Precursor;
OS   Walterinnesia aegyptia (Desert black snake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Elapidae; Elapinae; Walterinnesia.
OX   NCBI_TaxID=64182;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Venom gland;
RX   PubMed=18405934; DOI=10.1016/j.toxicon.2008.02.012;
RA   Tsai H.-Y., Wang Y.M., Tsai I.-H.;
RT   "Cloning, characterization and phylogenetic analyses of members of
RT   three major venom families from a single specimen of Walterinnesia
RT   aegyptia.";
RL   Toxicon 51:1245-1254(2008).
RN   [2]
RP   PROTEIN SEQUENCE OF 22-83.
RC   TISSUE=Venom;
RX   PubMed=9080571; DOI=10.1016/S0041-0101(96)00138-9;
RA   Samejima Y., Aoki-Tomomatsu Y., Yanagisawa M., Mebs D.;
RT   "Amino acid sequence of two neurotoxins from the venom of the Egyptian
RT   black snake (Walterinnesia aegyptia).";
RL   Toxicon 35:151-157(1997).
RN   [3]
RP   FUNCTION, AND LETHAL DOSE.
RC   TISSUE=Venom;
RX   PubMed=960110; DOI=10.1016/0041-0101(76)90023-4;
RA   Lee C.Y., Chen Y.M., Mebs D.;
RT   "Chromatographic separation of the venom of Egyptian black snake
RT   (Walterinnesia aegyptia) and pharmacological characterization of its
RT   components.";
RL   Toxicon 14:275-281(1976).
CC   -!- FUNCTION: Three-finger toxin that binds and inhibits the muscular
CC       nicotinic acetylcholine receptor (nAChR). The neuromuscular block
CC       is irreversible in chick biventes cervicis, but partially
CC       reversible in the rat diaphragm preparation.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- TOXIC DOSE: LD(50) is 0.14 mg/kg by intraperitoneal injection in
CC       mice.
CC   -!- SIMILARITY: Belongs to the snake three-finger toxin family. Type I
CC       alpha-neurotoxin subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU196556; ABX82865.1; -; mRNA.
DR   GO; GO:0035792; C:other organism postsynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0035821; P:modification of morphology or physiology of other organism; IEA:InterPro.
DR   InterPro; IPR003571; Snake_toxin.
DR   InterPro; IPR018354; Snake_toxin_BS.
DR   Pfam; PF00087; Toxin_1; 1.
DR   PROSITE; PS00272; SNAKE_TOXIN; 1.
PE   1: Evidence at protein level;
KW   Acetylcholine receptor inhibiting toxin; Direct protein sequencing;
KW   Disulfide bond; Ion channel impairing toxin; Neurotoxin;
KW   Postsynaptic neurotoxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     21
FT   CHAIN        22     83       Three finger toxin Wa-IV.
FT                                /FTId=PRO_0000419225.
FT   DISULFID     24     45       By similarity.
FT   DISULFID     38     62       By similarity.
FT   DISULFID     64     75       By similarity.
FT   DISULFID     76     81       By similarity.
SQ   SEQUENCE   83 AA;  9055 MW;  B09FEE8924642C37 CRC64;
     MKTLLLTLVV VTIVCLDLGH TLLCHNQQSS TSPTTTCCSG GESKCYKKRW PTHRGTITER
     GCGCPTVKKG IELHCCTTDQ CNL
//
ID   APY_AEDAL               Reviewed;         564 AA.
AC   E0D877; Q5MIX3;
DT   25-JAN-2012, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 1.
DT   16-APR-2014, entry version 20.
DE   RecName: Full=Apyrase;
DE            EC=3.6.1.5;
DE   AltName: Full=ATP-diphosphatase;
DE            Short=ADPase;
DE   AltName: Full=ATP-diphosphohydrolase;
DE   AltName: Full=Adenosine diphosphatase;
DE   AltName: Allergen=Aed al 1;
DE   Flags: Precursor;
OS   Aedes albopictus (Asian tiger mosquito) (Stegomyia albopicta).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Endopterygota; Diptera; Nematocera; Culicoidea;
OC   Culicidae; Culicinae; Aedini; Aedes; Stegomyia.
OX   NCBI_TaxID=7160;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Salivary gland;
RX   PubMed=21842387; DOI=10.1007/s00436-011-2579-x;
RA   Dong F., Fu Y., Li X., Jiang J., Sun J., Cheng X.;
RT   "Cloning, expression, and characterization of salivary apyrase from
RT   Aedes albopictus.";
RL   Parasitol. Res. 110:931-937(2012).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 26-45, TISSUE
RP   SPECIFICITY, AND ALLERGEN.
RC   TISSUE=Salivary gland;
RX   PubMed=17244540; DOI=10.1016/j.ibmb.2006.10.007;
RA   Arca B., Lombardo F., Francischetti I.M., Pham V.M., Mestres-Simon M.,
RA   Andersen J.F., Ribeiro J.M.;
RT   "An insight into the sialome of the adult female mosquito Aedes
RT   albopictus.";
RL   Insect Biochem. Mol. Biol. 37:107-127(2007).
CC   -!- FUNCTION: Facilitates hematophagy by inhibiting ADP-dependent
CC       platelet aggregation in the host. May reduce probing time by
CC       facilitating the speed of locating blood. Platelet aggregation was
CC       inhibited by 6% when 0.4 uM recombinant apyrase was added and by
CC       9.5% when the concentration of recombinant apyrase was 0.8 uM.
CC   -!- CATALYTIC ACTIVITY: A nucleoside 5'-triphosphate + 2 H(2)O = a
CC       nucleoside 5'-phosphate + 2 phosphate.
CC   -!- COFACTOR: Divalent metal cations (By similarity).
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=11.6 uM for the recombinant enzyme;
CC         Vmax=1.02 nmol/sec/ug enzyme toward ATP;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Salivary gland specific.
CC   -!- ALLERGEN: Causes an allergic reaction in human.
CC   -!- SIMILARITY: Belongs to the 5'-nucleotidase family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB576780; BAJ14796.1; -; mRNA.
DR   EMBL; AY826087; AAV90659.1; -; mRNA.
DR   ProteinModelPortal; E0D877; -.
DR   Allergome; 1345; Aed al 1.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0009166; P:nucleotide catabolic process; IEA:InterPro.
DR   Gene3D; 3.90.780.10; -; 1.
DR   InterPro; IPR008334; 5'-Nucleotdase_C.
DR   InterPro; IPR006146; 5'-Nucleotdase_CS.
DR   InterPro; IPR006179; 5_nucleotidase/apyrase.
DR   InterPro; IPR004843; Calcineurin-like_PHP_apaH.
DR   PANTHER; PTHR11575; PTHR11575; 1.
DR   Pfam; PF02872; 5_nucleotid_C; 1.
DR   Pfam; PF00149; Metallophos; 1.
DR   PRINTS; PR01607; APYRASEFAMLY.
DR   SUPFAM; SSF55816; SSF55816; 1.
DR   PROSITE; PS00785; 5_NUCLEOTIDASE_1; 1.
DR   PROSITE; PS00786; 5_NUCLEOTIDASE_2; 1.
PE   1: Evidence at protein level;
KW   Allergen; ATP-binding; Direct protein sequencing; Glycoprotein;
KW   Hydrolase; Metal-binding; Nucleotide-binding; Secreted; Signal.
FT   SIGNAL        1     25
FT   CHAIN        26    564       Apyrase.
FT                                /FTId=PRO_5000623950.
FT   REGION      509    515       Substrate binding (By similarity).
FT   METAL        48     48       Divalent metal cation 1 (By similarity).
FT   METAL        50     50       Divalent metal cation 1 (By similarity).
FT   METAL        99     99       Divalent metal cation 1 (By similarity).
FT   METAL        99     99       Divalent metal cation 2 (By similarity).
FT   METAL       131    131       Divalent metal cation 2 (By similarity).
FT   METAL       234    234       Divalent metal cation 2 (By similarity).
FT   METAL       258    258       Divalent metal cation 2 (By similarity).
FT   BINDING     425    425       Substrate (By similarity).
FT   SITE        132    132       Transition state stabilizer (By
FT                                similarity).
FT   SITE        135    135       Transition state stabilizer (By
FT                                similarity).
FT   CARBOHYD    391    391       N-linked (GlcNAc...) (Potential).
FT   CONFLICT     14     14       L -> I (in Ref. 2; AAV90659).
FT   CONFLICT     25     26       AM -> TT (in Ref. 2; AAV90659).
FT   CONFLICT     26     26       M -> T (in Ref. 2; AA sequence).
FT   CONFLICT    438    438       N -> S (in Ref. 2; AAV90659).
FT   CONFLICT    447    447       L -> F (in Ref. 2; AAV90659).
FT   CONFLICT    472    473       SV -> KI (in Ref. 2; AAV90659).
FT   CONFLICT    498    498       R -> K (in Ref. 2; AAV90659).
FT   CONFLICT    522    522       E -> K (in Ref. 2; AAV90659).
FT   CONFLICT    551    552       LD -> WG (in Ref. 2; AAV90659).
SQ   SEQUENCE   564 AA;  62751 MW;  15B9F0F2D3BD0825 CRC64;
     MAGKPGIQLF VIFLLLSSFA AVVWAMDNMP ADKDVSKLFP LTLIHINDLH ARFDETNMKS
     NACTAKDQCI AGIARVYQKI QDLLKEYKSK NAIYLNAGDN FQGTLWYNLL RWQVTADFIT
     KLKPTAMTLG NHEFDHTPKG LAPYLAELDK AGIPTLVANL VMNDDPDLKS SKIQKSIKVT
     VGGKTIGIIG VLYDKTHEIA QTGKVTLSNA VETVKREAAA LKKDKVDIIV VLSHCSYDED
     KKIAKEAGQD IDVIVGAHSH SFLYSKESNK PYDQKDKIEG PYPTIVESNN KRKIPIVQAK
     SFGKYVGRLT LYFDNEGEVK HWEGYPEFID NKVKQDPKIL EALIPWRKKV QEIGSTKVGE
     TTIELDRDSC RDKECTLGVL YADAFADHYT NSSFRPFAII QAGNFRNPIK VGKITNGDII
     EAAPFGSTAD LIRLKGDNLW AVAEHSLALD DENRTNCLQV SGLRIVIDPS KSVGSRVVKI
     DVMDNRNPKS EDLKPLDRNA EYFIALPSYL ADGKDGFSAM KEATARWTGP LDSDVFKSYV
     EKIKKVDKLK LDRVIVCKAG SPCT
//
ID   BAGLU_SCUBA             Reviewed;         527 AA.
AC   Q9LRC8;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   19-FEB-2014, entry version 42.
DE   RecName: Full=Baicalin-beta-D-glucuronidase;
DE            EC=3.2.1.167;
DE   AltName: Full=Baicalinase.;
DE   Flags: Precursor;
GN   Name=SGUS;
OS   Scutellaria baicalensis (Baical skullcap).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; asterids; lamiids; Lamiales; Lamiaceae;
OC   Scutellarioideae; Scutellaria.
OX   NCBI_TaxID=65409;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 26-55; 273-288;
RP   410-423 AND 431-447, MUTAGENESIS OF GLU-194; GLU-212; GLU-225;
RP   GLU-272; TYR-281; GLU-329 AND TYR-376, FUNCTION, CATALYTIC ACTIVITY,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=10858442;
RA   Sasaki K., Taura F., Shoyama Y., Morimoto S.;
RT   "Molecular characterization of a novel beta-glucuronidase from
RT   Scutellaria baicalensis georgi.";
RL   J. Biol. Chem. 275:27466-27472(2000).
RN   [2]
RP   CATALYTIC ACTIVITY, AND SUBUNIT.
RX   PubMed=8593473;
RA   Ikegami F., Matsunae K., Hisamitsu M., Kurihara T., Yamamoto T.,
RA   Murakoshi I.;
RT   "Purification and properties of a plant beta-D-glucuronidase form
RT   Scutellaria root.";
RL   Biol. Pharm. Bull. 18:1531-1534(1995).
RN   [3]
RP   CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RA   Morimoto S., Harioka T., Shoyama Y.;
RT   "Purification and characterization of flavone-specific beta-
RT   glucuronidase from callus cultures of Scutellaria baicalensis
RT   Georgi.";
RL   Planta 195:535-540(1995).
CC   -!- FUNCTION: Beta-glucuronidase involved in the initiation of
CC       H(2)O(2) metabolism via the production of baicalein. Unable to use
CC       glycyrrhizin, gypsogenin-3-O-D-glucuronide, luteolin-7-O-D-
CC       glucoside and apigenin-7-O-D-glucoside as substrates.
CC   -!- CATALYTIC ACTIVITY: Baicalin + H(2)O = baicalein + D-glucuronate.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=9 uM for luteolin 3'-O-beta-D-glucuronide;
CC         KM=10 uM for baicalin;
CC         KM=30 uM for wogonin 7-O-beta-D-glucuronide;
CC         KM=40 uM for oroxlin 7-O-beta-D-glucuronide;
CC         KM=12 uM for baicalein 7-O-beta-D-glucuronide;
CC         Note=Kcat is 639 sec (-1) for baicalein 7-O-beta-D-glucuronide;
CC       pH dependence:
CC         Optimum pH is 7.0-8.0;
CC   -!- SUBUNIT: Homotetramer.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 79 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB040072; BAA97804.1; -; mRNA.
DR   ProteinModelPortal; Q9LRC8; -.
DR   CAZy; GH79; Glycoside Hydrolase Family 79.
DR   BioCyc; MetaCyc:MONOMER-15936; -.
DR   BRENDA; 3.2.1.31; 260909.
DR   GO; GO:0016020; C:membrane; IEA:InterPro.
DR   GO; GO:0052748; F:baicalin beta-D-glucuronidase activity; IDA:UniProtKB.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   Gene3D; 3.20.20.80; -; 1.
DR   InterPro; IPR005199; Glyco_hydro_79.
DR   InterPro; IPR013781; Glyco_hydro_catalytic_dom.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   PANTHER; PTHR14363; PTHR14363; 1.
DR   Pfam; PF03662; Glyco_hydro_79n; 1.
DR   SUPFAM; SSF51445; SSF51445; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Hydrolase; Signal.
FT   SIGNAL        1     25
FT   CHAIN        26    527       Baicalin-beta-D-glucuronidase.
FT                                /FTId=PRO_0000418918.
FT   ACT_SITE    212    212       Proton donor (Potential).
FT   ACT_SITE    329    329       Nucleophile (Potential).
FT   MUTAGEN     194    194       E->A: 14% reduction of activity.
FT   MUTAGEN     212    212       E->A: Loss of activity.
FT   MUTAGEN     225    225       E->A: 6% reduction of activity.
FT   MUTAGEN     272    272       E->A: 30% reduction of activity.
FT   MUTAGEN     281    281       Y->A: Loss of activity.
FT   MUTAGEN     329    329       E->A: Loss of activity.
FT   MUTAGEN     376    376       Y->A: 35% reduction of activity.
SQ   SEQUENCE   527 AA;  58772 MW;  A5DE7C423F2A1E2B CRC64;
     MGFQVWQKGL CVLCFSLIFI CGVIGEETTI VKIEENPVAQ TDENYVCATL DLWPPTKCNY
     GNCPWGKSSF LNLDLNNNII RNAVKEFAPL KLRFGGTLQD RLVYQTSRDE PCDSTFYNNT
     NLILDFSHAC LSLDRWDEIN QFILETGSEA VFGLNALRGK TVEIKGIIKD GQYLGETTTA
     VGEWDYSNSK FLIEYSLKKG YKHIRGWTLG NELGGHTLFI GVSPEDYAND AKKLHELVKE
     IYQDQGTMPL IIAPGAIFDL EWYTEFIDRT PELHVATHHM YNLGSGGDDA LKDVLLTASF
     FDEATKSMYE GLQKIVNRPG TKAVAWIGEA GGAFNSGQDG ISNTFINGFW YLNMLGYSAL
     LDTKTFCRQT LTGGNYGLLQ TGTYIPNPDY YSALLWHRLM GSKVLKTEIV GTKNVYIYAH
     CAKKSNGITM LVLNHDGESS VKISLDPSKY GSKREEYHLT PVNNNLQSRL VKLNGELLHL
     DPSGVIPALN PVEKDNSKQL EVAPYSFMFV HLPGPTMFSA CEKPAGK
//
ID   CIP2_HYPJQ              Reviewed;         460 AA.
AC   G0RV93; Q7Z9N1;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   19-OCT-2011, sequence version 1.
DT   22-JAN-2014, entry version 13.
DE   RecName: Full=4-O-methyl-glucuronoyl methylesterase;
DE            EC=3.1.1.-;
DE   AltName: Full=Glucuronoyl esterase 2;
DE            Short=GE2;
DE   Flags: Precursor;
GN   Name=cip2; ORFNames=TRIREDRAFT_123940;
OS   Hypocrea jecorina (strain QM6a) (Trichoderma reesei).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina;
OC   Sordariomycetes; Hypocreomycetidae; Hypocreales; Hypocreaceae;
OC   Trichoderma.
OX   NCBI_TaxID=431241;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INDUCTION, FUNCTION, AND DOMAIN.
RC   STRAIN=QM6a;
RX   PubMed=12788920; DOI=10.1074/jbc.M304750200;
RA   Foreman P.K., Brown D., Dankmeyer L., Dean R., Diener S.,
RA   Dunn-Coleman N.S., Goedegebuur F., Houfek T.D., England G.J.,
RA   Kelley A.S., Meerman H.J., Mitchell T., Mitchinson C., Olivares H.A.,
RA   Teunissen P.J.M., Yao J., Ward M.;
RT   "Transcriptional regulation of biomass-degrading enzymes in the
RT   filamentous fungus Trichoderma reesei.";
RL   J. Biol. Chem. 278:31988-31997(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=QM6a;
RX   PubMed=18454138; DOI=10.1038/nbt1403;
RA   Martinez D., Berka R.M., Henrissat B., Saloheimo M., Arvas M.,
RA   Baker S.E., Chapman J., Chertkov O., Coutinho P.M., Cullen D.,
RA   Danchin E.G., Grigoriev I.V., Harris P., Jackson M., Kubicek C.P.,
RA   Han C.S., Ho I., Larrondo L.F., de Leon A.L., Magnuson J.K.,
RA   Merino S., Misra M., Nelson B., Putnam N., Robbertse B., Salamov A.A.,
RA   Schmoll M., Terry A., Thayer N., Westerholm-Parvinen A., Schoch C.L.,
RA   Yao J., Barabote R., Nelson M.A., Detter C., Bruce D., Kuske C.R.,
RA   Xie G., Richardson P., Rokhsar D.S., Lucas S.M., Rubin E.M.,
RA   Dunn-Coleman N., Ward M., Brettin T.S.;
RT   "Genome sequencing and analysis of the biomass-degrading fungus
RT   Trichoderma reesei (syn. Hypocrea jecorina).";
RL   Nat. Biotechnol. 26:553-560(2008).
RN   [3]
RP   PROTEIN SEQUENCE OF 19-27, IDENTIFICATION BY MASS SPECTROMETRY,
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17678650; DOI=10.1016/j.febslet.2007.07.041;
RA   Li X.L., Spanikova S., de Vries R.P., Biely P.;
RT   "Identification of genes encoding microbial glucuronoyl esterases.";
RL   FEBS Lett. 581:4029-4035(2007).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 90-460, PUTATIVE ACTIVE
RP   SITE, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-447.
RX   PubMed=21661060; DOI=10.1002/prot.23088;
RA   Pokkuluri P.R., Duke N.E., Wood S.J., Cotta M.A., Li X.L., Biely P.,
RA   Schiffer M.;
RT   "Structure of the catalytic domain of glucuronoyl esterase Cip2 from
RT   Hypocrea jecorina.";
RL   Proteins 79:2588-2592(2011).
CC   -!- FUNCTION: Glucuronoyl esterase which may play a significant role
CC       in biomass degradation, as it is considered to disconnect
CC       hemicellulose from lignin through the hydrolysis of the ester bond
CC       between 4-O-methyl-D-glucuronic acid residues of glucuronoxylans
CC       and aromatic alcohols of lignin. Does not hydrolyze substrates of
CC       other carbohydrate esterases such as acetylxylan esterase, acetyl
CC       esterase and feruloyl esterase.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.5 mM for 4-nitrophenyl 2-O-(methyl-4-O-methyl-a-D-
CC         glucopyranosyluronate)-b-D-xylopyranoside;
CC         Vmax=5.5 umol/min/mg enzyme toward 4-nitrophenyl 2-O-(methyl-4-
CC         O-methyl-a-D-glucopyranosyluronate)-b-D-xylopyranoside;
CC       pH dependence:
CC         Optimum pH is 5.5;
CC       Temperature dependence:
CC         Optimum temperature is 40-60 degrees Celsius;
CC   -!- SUBCELLULAR LOCATION: Secreted (Probable).
CC   -!- INDUCTION: Induced in the presence of lactose or sophorose.
CC   -!- SIMILARITY: Belongs to the carbohydrate esterase 15 family.
CC   -!- SIMILARITY: Contains 1 CBM1 (fungal-type carbohydrate-binding)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY281368; AAP57749.1; -; mRNA.
DR   EMBL; GL985083; EGR44948.1; -; Genomic_DNA.
DR   PDB; 3PIC; X-ray; 1.90 A; A/B/C=90-460.
DR   PDBsum; 3PIC; -.
DR   ProteinModelPortal; G0RV93; -.
DR   SMR; G0RV93; 22-53.
DR   CAZy; CBM1; Carbohydrate-Binding Module Family 1.
DR   EnsemblFungi; EGR44948; EGR44948; TRIREDRAFT_123940.
DR   eggNOG; NOG70431; -.
DR   OrthoDB; EOG76DV35; -.
DR   EvolutionaryTrace; Q7Z9N1; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0030248; F:cellulose binding; IEA:InterPro.
DR   GO; GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0046274; P:lignin catabolic process; IEA:UniProtKB-KW.
DR   InterPro; IPR000254; Cellulose-bd_dom_fun.
DR   Pfam; PF00734; CBM_1; 1.
DR   ProDom; PD001821; CBD_fun; 1.
DR   SMART; SM00236; fCBD; 1.
DR   SUPFAM; SSF57180; SSF57180; 1.
DR   PROSITE; PS00562; CBM1_1; 1.
DR   PROSITE; PS51164; CBM1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Hydrolase; Lignin degradation; Secreted;
KW   Serine esterase; Signal.
FT   SIGNAL        1     17
FT   CHAIN        18    460       4-O-methyl-glucuronoyl methylesterase.
FT                                /FTId=PRO_0000419175.
FT   DOMAIN       18     53       CBM1.
FT   MOTIF       276    281       GXSYXG catalytic site motif.
FT   COMPBIAS     72     79       Poly-Thr.
FT   ACT_SITE    278    278       Nucleophile (Probable).
FT   ACT_SITE    411    411       Proton donor/acceptor (Probable).
FT   BINDING     282    282       Substrate (By similarity).
FT   BINDING     324    324       Substrate (By similarity).
FT   BINDING     332    332       Substrate (By similarity).
FT   BINDING     375    375       Substrate (By similarity).
FT   CARBOHYD    447    447       N-linked (GlcNAc...).
FT   DISULFID     96    131       By similarity.
FT   DISULFID    277    412
FT   DISULFID    309    384
FT   HELIX       126    143
FT   STRAND      153    160
FT   STRAND      163    170
FT   STRAND      173    182
FT   STRAND      185    187
FT   STRAND      189    197
FT   STRAND      209    213
FT   HELIX       215    218
FT   HELIX       224    226
FT   HELIX       231    236
FT   HELIX       244    261
FT   HELIX       263    265
FT   STRAND      267    277
FT   HELIX       279    290
FT   STRAND      294    301
FT   TURN        304    307
FT   HELIX       310    318
FT   HELIX       326    329
FT   TURN        330    332
FT   HELIX       338    342
FT   TURN        343    345
FT   HELIX       347    349
FT   HELIX       354    359
FT   STRAND      364    369
FT   HELIX       374    376
FT   HELIX       378    394
FT   HELIX       398    400
FT   STRAND      401    404
FT   HELIX       416    418
FT   HELIX       419    429
FT   HELIX       448    451
SQ   SEQUENCE   460 AA;  48296 MW;  D889B2C9199C0962 CRC64;
     MASRFFALLL LAIPIQAQSP VWGQCGGIGW SGPTTCVGGA TCVSYNPYYS QCIPSTQASS
     SIASTTLVTS FTTTTATRTS ASTPPASSTG AGGATCSALP GSITLRSNAK LNDLFTMFNG
     DKVTTKDKFS CRQAEMSELI QRYELGTLPG RPSTLTASFS GNTLTINCGE AGKSISFTVT
     ITYPSSGTAP YPAIIGYGGG SLPAPAGVAM INFNNDNIAA QVNTGSRGQG KFYDLYGSSH
     SAGAMTAWAW GVSRVIDALE LVPGARIDTT KIGVTGCSRN GKGAMVAGAF EKRIVLTLPQ
     ESGAGGSACW RISDYLKSQG ANIQTASEII GEDPWFSTTF NSYVNQVPVL PFDHHSLAAL
     IAPRGLFVID NNIDWLGPQS CFGCMTAAHM AWQALGVSDH MGYSQIGAHA HCAFPSNQQS
     QLTAFVQKFL LGQSTNTAIF QSDFSANQSQ WIDWTTPTLS
//
ID   EFCB_NEPCI              Reviewed;         687 AA.
AC   G9M8X1;
DT   18-APR-2012, integrated into UniProtKB/Swiss-Prot.
DT   22-FEB-2012, sequence version 1.
DT   18-SEP-2013, entry version 10.
DE   RecName: Full=Calcium-binding protein SP84;
DE   AltName: Full=84 kDa salivary protein;
DE            Short=NcSP84;
DE   Flags: Precursor;
OS   Nephotettix cincticeps (Green rice leafhopper) (Selenocephalus
OS   cincticeps).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Paraneoptera; Hemiptera; Euhemiptera;
OC   Membracoidea; Cicadellidae; Deltocephalinae; Nephotettix.
OX   NCBI_TaxID=94400;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 20-37, FUNCTION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND
RP   CALCIUM-BINDING.
RC   TISSUE=Saliva, and Salivary gland;
RX   PubMed=22019571; DOI=10.1016/j.ibmb.2011.10.001;
RA   Hattori M., Nakamura M., Komatsu S., Tsuchihara K., Tamura Y.,
RA   Hasegawa T.;
RT   "Molecular cloning of a novel calcium-binding protein in the secreted
RT   saliva of the green rice leafhopper Nephotettix cincticeps.";
RL   Insect Biochem. Mol. Biol. 42:1-9(2012).
CC   -!- FUNCTION: Binds calcium. During feeding of the phloem sap, protein
CC       is injected into sieve tubes of rice plants. This process may
CC       suppress the sieve-element clogging and facilitate continuous
CC       ingestion from sieve tubes.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed in salivary glands where expression
CC       is strongest in type III cells in the posterior lobe of the
CC       principal glands (at protein level). Not expressed in midgut,
CC       Malpighian tubules or epidermis.
CC   -!- DEVELOPMENTAL STAGE: Expressed on days 0-7 after adult emergence
CC       at roughly constant level (at protein level).
CC   -!- SIMILARITY: Contains 5 EF-hand domains.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB618633; BAL41365.1; -; mRNA.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   Gene3D; 1.10.238.10; -; 4.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   SMART; SM00054; EFh; 3.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 5.
PE   1: Evidence at protein level;
KW   Calcium; Direct protein sequencing; Metal-binding; Repeat; Secreted;
KW   Signal.
FT   SIGNAL        1     19
FT   CHAIN        20    687       Calcium-binding protein SP84.
FT                                /FTId=PRO_0000416970.
FT   DOMAIN      152    187       EF-hand 1.
FT   DOMAIN      257    292       EF-hand 2.
FT   DOMAIN      406    441       EF-hand 3.
FT   DOMAIN      476    511       EF-hand 4.
FT   DOMAIN      579    614       EF-hand 5.
FT   CA_BIND     592    603       Potential.
SQ   SEQUENCE   687 AA;  79605 MW;  6E75366A664CA6AC CRC64;
     MMRAIYLLVV VCWAAAANAS SDTVPAEVQT IVKTPGHQYD LYKKMVATIS LPANANTEIH
     KGLNIKRPDN KVTKADIELY YWHKDLKYAV TKFLHLINDD GNKEELTAEE FSNDLQKLAF
     KVALVECHYQ LSPGLRQACY ADEILTYGAL VLESDDITKF YKHLDNDKDN ELKTEEVLKI
     QHTHKNKDNK IVAEELGAYS GAKKDTVTPE EFEEYVTQES IVDDFRECRS KKATEGTTDY
     DNVCLTNELV EYVNDDLTEI DISLLYRSVD TNNDNKIIID ELKAFTGITD DVKAKRILEL
     LDMSATTPAN AKPVVDYGEW RTYLRSPTVL LQLERDCAMK HNDQLEEINC MYKLLKNLLI
     DEHDPIWLEA WDLDHVILFE IFDADKDDGK VFKDDLKKIQ KNFHFKTEAT VTRYMVEADI
     DKDSFICLEE FDEYMDIPHM VYGTGECILH SRTKPDERGD CFVEETSDVV DNFKFIENAA
     FDTWFNHYDT NHNNKIEKEA DGLLAKFNND ANVLTMFLEE TGQGGLTVEP FEFNWYVKQQ
     HLAHAYEDEK IVTALVQKFT AEQITKLHTE LIKYINDEMT ERDIEDLFDE LDHNDDHELT
     QQDFPDCWND VKDLLTHIDA LIPEGDEDTT VNYLEFWAWI NHPNPKKPQE LIKKTFETDC
     TTKHATQKEE VACYVKTFKT KDKFKTA
//
ID   GAOA_GIBZA              Reviewed;         680 AA.
AC   P0CS93; O43098; Q01745; Q4HVH6;
DT   11-JUL-2012, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2012, sequence version 1.
DT   11-DEC-2013, entry version 11.
DE   RecName: Full=Galactose oxidase;
DE            Short=GAO;
DE            Short=GO;
DE            Short=GOase;
DE            EC=1.1.3.9;
DE   Flags: Precursor;
GN   Name=GAOA;
OS   Gibberella zeae (Wheat head blight fungus) (Fusarium graminearum).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina;
OC   Sordariomycetes; Hypocreomycetidae; Hypocreales; Nectriaceae;
OC   mitosporic Nectriaceae; Fusarium.
OX   NCBI_TaxID=5518;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=ATCC 46032 / CBS 110244 / NRRL 2903;
RX   PubMed=1569070;
RA   McPherson M.J., Ogel Z.B., Stevens C.E., Yadav K.D.S., Keen J.N.,
RA   Knowles P.F.;
RT   "Galactose oxidase of Dactylium dendroides. Gene cloning and sequence
RT   analysis.";
RL   J. Biol. Chem. 267:8146-8152(1992).
RN   [2]
RP   PROTEIN SEQUENCE OF 25-33 AND 42-50, AND PROPEPTIDE CLEAVAGE.
RC   STRAIN=ATCC 46032 / CBS 110244 / NRRL 2903;
RX   DOI=10.1021/ja993385y;
RA   Rogers M.S., Baron A.J., McPherson M.J., Knowles P.F., Dooley D.M.;
RT   "Galactose oxidase pro-sequence cleavage and cofactor assembly are
RT   self-processing reactions.";
RL   J. Am. Chem. Soc. 122:990-991(2000).
RN   [3]
RP   PROTEIN SEQUENCE OF 42-47, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF ARG-371 AND PHE-505.
RX   PubMed=15239055; DOI=10.1002/cbic.200300810;
RA   Deacon S.E., Mahmoud K., Spooner R.K., Firbank S.J., Knowles P.F.,
RA   Phillips S.E., McPherson M.J.;
RT   "Enhanced fructose oxidase activity in a galactose oxidase variant.";
RL   ChemBioChem 5:972-979(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 98-142.
RC   STRAIN=DSM 4527;
RX   DOI=10.1016/S0723-2020(97)80055-0;
RA   Niessen M.L., Vogel R.F.;
RT   "Specific identification of Fusarium graminearum by PCR with gaoA
RT   targeted primers.";
RL   Syst. Appl. Microbiol. 20:111-123(1997).
RN   [5]
RP   FUNCTION.
RX   PubMed=13641238;
RA   Cooper J.A., Smith W., Bacila M., Medina H.;
RT   "Galactose oxidase from Polyporus circinatus, Fr.";
RL   J. Biol. Chem. 234:445-448(1959).
RN   [6]
RP   SUBSTRATE SPECIFICITY.
RX   PubMed=13863403;
RA   Avigad G., Amaral D., Asensio C., Horecker B.L.;
RT   "The D-galactose oxidase of Polyporus circinatus.";
RL   J. Biol. Chem. 237:2736-2743(1962).
RN   [7]
RP   TAXONOMY.
RX   DOI=10.1016/0006-291X(63)90251-1;
RA   Nobles M.K., Madhosingh C.;
RT   "Dactylium dendroides (Bull.) Fr. misnamed as Polyporus circinatus
RT   Fr.";
RL   Biochem. Biophys. Res. Commun. 12:146-147(1963).
RN   [8]
RP   ENZYME REGULATION, AND COPPER-BINDING.
RX   PubMed=14012475;
RA   Amaral D., Bernstein L., Morse D., Horecker B.L.;
RT   "Galactose oxidase of Polyporus circinatus: a copper enzyme.";
RL   J. Biol. Chem. 238:2281-2284(1963).
RN   [9]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=4441089; DOI=10.1016/0003-9861(74)90271-9;
RA   Kosman D.J., Ettinger M.J., Weiner R.E., Massaro E.J.;
RT   "The molecular properties of the copper enzyme galactose oxidase.";
RL   Arch. Biochem. Biophys. 165:456-467(1974).
RN   [10]
RP   TAXONOMY.
RX   AGRICOLA=IND20498749;
RA   Ogel Z.B., Brayford D., McPherson M.J.;
RT   "Cellulose-triggered sporulation in the galactose oxidase producing
RT   fungus Cladobotryum (Dactylium) dendroides NRRL 2903 and its re-
RT   identification as a species of Fusarium.";
RL   Mycol. Res. 98:474-480(1994).
RN   [11]
RP   REACTION MECHANISM.
RX   PubMed=11401560; DOI=10.1021/bi010303l;
RA   Whittaker M.M., Whittaker J.W.;
RT   "Catalytic reaction profile for alcohol oxidation by galactose
RT   oxidase.";
RL   Biochemistry 40:7140-7148(2001).
RN   [12]
RP   PROTEIN MATURATION.
RX   PubMed=12672814; DOI=10.1074/jbc.M300112200;
RA   Whittaker M.M., Whittaker J.W.;
RT   "Cu(I)-dependent biogenesis of the galactose oxidase redox cofactor.";
RL   J. Biol. Chem. 278:22090-22101(2003).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 42-680 IN COMPLEX WITH COPPER
RP   IONS.
RX   PubMed=2002850; DOI=10.1038/350087a0;
RA   Ito N., Phillips S.E.V., Stevens C.E., Ogel Z.B., McPherson M.J.,
RA   Keen J.N., Yadav K.D.S., Knowles P.F.;
RT   "Novel thioether bond revealed by a 1.7 A crystal structure of
RT   galactose oxidase.";
RL   Nature 350:87-90(1991).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 42-680 OF MUTANTS GLY-269 AND
RP   HIS-331 IN COMPLEX WITH COPPER IONS, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=7929198;
RA   Baron A.J., Stevens C., Wilmot C., Seneviratne K.D., Blakeley V.,
RA   Dooley D.M., Phillips S.E., Knowles P.F., McPherson M.J.;
RT   "Structure and mechanism of galactose oxidase. The free radical
RT   site.";
RL   J. Biol. Chem. 269:25095-25105(1994).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 42-680 OF MUTANT PHE-536 IN
RP   COMPLEX WITH COPPER IONS, ACTIVE SITE, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   DOI=10.1007/s007750050139;
RA   Reynolds M.P., Baron A.J., Wilmot C.M., Vinecombe E., Stevens C.,
RA   Phillips S.E.V., Knowles P.F., McPherson M.J.;
RT   "Structure and mechanism of galactose oxidase: catalytic role of
RT   tyrosine 495.";
RL   J. Biol. Inorg. Chem. 2:327-335(1997).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 25-680.
RX   PubMed=11698678; DOI=10.1073/pnas.231463798;
RA   Firbank S.J., Rogers M.S., Wilmot C.M., Dooley D.M., Halcrow M.A.,
RA   Knowles P.F., McPherson M.J., Phillips S.E.;
RT   "Crystal structure of the precursor of galactose oxidase: an unusual
RT   self-processing enzyme.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:12932-12937(2001).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 42-680 OF MUTANT SER-424 IN
RP   COMPLEX WITH COPPER IONS, MASS SPECTROMETRY, MUTAGENESIS OF CYS-424;
RP   TYR-477 AND VAL-535, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   STRAIN=ATCC 46032 / CBS 110244 / NRRL 2903;
RX   PubMed=15047910; DOI=10.1093/protein/gzh018;
RA   Wilkinson D., Akumanyi N., Hurtado-Guerrero R., Dawkes H.,
RA   Knowles P.F., Phillips S.E.V., McPherson M.J.;
RT   "Structural and kinetic studies of a series of mutants of galactose
RT   oxidase identified by directed evolution.";
RL   Protein Eng. Des. Sel. 17:141-148(2004).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 42-680 OF MUTANTS GLY-331;
RP   HIS-331 AND PHE-331 IN COMPLEX WITH COPPER IONS, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17385891; DOI=10.1021/bi062139d;
RA   Rogers M.S., Tyler E.M., Akyumani N., Kurtis C.R., Spooner R.K.,
RA   Deacon S.E., Tamber S., Firbank S.J., Mahmoud K., Knowles P.F.,
RA   Phillips S.E.V., McPherson M.J., Dooley D.M.;
RT   "The stacking tryptophan of galactose oxidase: a second-coordination
RT   sphere residue that has profound effects on tyrosyl radical behavior
RT   and enzyme catalysis.";
RL   Biochemistry 46:4606-4618(2007).
CC   -!- FUNCTION: Catalyzes the sterospecific oxidation of primary
CC       alcohols to the corresponding aldehydes. The biologically relevant
CC       substrate of the enzyme is not known as the enzyme exhibits broad
CC       substrate specificity from small alcohols through sugars to oligo-
CC       and polysaccharides.
CC   -!- CATALYTIC ACTIVITY: D-galactose + O(2) = D-galacto-hexodialdose +
CC       H(2)O(2).
CC   -!- COFACTOR: Binds 1 Cu(2+) ion per subunit.
CC   -!- ENZYME REGULATION: Inhibited by diethyldithiocarbamate.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=56 mM for 1-methyl-alpha-D-galactopyranoside;
CC         KM=57 mM for 2-methylene-1,3-propanediol;
CC         KM=68 mM for D-galactose;
CC         KM=2.5 M for D-fructose;
CC       pH dependence:
CC         Optimum pH is 7. Active from pH 5.7 to 9.4;
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- PTM: Galactose oxidase contains a protein-derived free radical
CC       cofactor. In the active state, Tyr-313, which is cross-linked to
CC       Cys-269 via a thioether bond, is oxidized to a radical and acts
CC       with Cu(2+) as a two-electron acceptor in the oxidation reaction.
CC       The cross-link is believed to modulate the redox potential of the
CC       tyrosyl radical, which is further stabilized by a stacking
CC       interaction with Trp-331 in the active site. The post-
CC       translational formation of the cross-link is closely linked to the
CC       propeptide cleavage event, and both are copper-dependent,
CC       autocatalytic processes. The propeptide may act as an
CC       intramolecular chaperone, facilitating thioester bond formation
CC       and copper binding by positioning of active-site residues,
CC       including copper ligands.
CC   -!- MASS SPECTROMETRY: Mass=68520; Method=Electrospray; Range=42-680;
CC       Source=PubMed:15047910;
CC   -!- SIMILARITY: Contains 1 F5/8 type C domain.
CC   -!- SIMILARITY: Contains 5 Kelch repeats.
CC   -!- CAUTION: Was originally thought to originate from Polyporus
CC       circinatus then later from Dactylium dendroides and is now known
CC       to be originating from Gibberella (Fusarium).
CC   -!- WEB RESOURCE: Name=Worthington enzyme manual;
CC       URL="http://www.worthington-biochem.com/GAO/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M86819; AAA16228.1; -; Unassigned_DNA.
DR   EMBL; AH005781; AAB94635.1; -; Genomic_DNA.
DR   PDB; 1GOF; X-ray; 1.70 A; A=42-680.
DR   PDB; 1GOG; X-ray; 1.90 A; A=42-680.
DR   PDB; 1GOH; X-ray; 2.20 A; A=42-680.
DR   PDB; 1K3I; X-ray; 1.40 A; A=25-680.
DR   PDB; 1T2X; X-ray; 2.30 A; A=42-680.
DR   PDB; 2EIB; X-ray; 2.10 A; A=42-680.
DR   PDB; 2EIC; X-ray; 2.80 A; A=42-680.
DR   PDB; 2EID; X-ray; 2.20 A; A=42-680.
DR   PDB; 2EIE; X-ray; 1.80 A; A=42-680.
DR   PDB; 2JKX; X-ray; 1.84 A; A=42-680.
DR   PDB; 2VZ1; X-ray; 1.91 A; A=42-680.
DR   PDB; 2VZ3; X-ray; 1.90 A; A=42-680.
DR   PDB; 2WQ8; X-ray; 2.19 A; A=42-680.
DR   PDBsum; 1GOF; -.
DR   PDBsum; 1GOG; -.
DR   PDBsum; 1GOH; -.
DR   PDBsum; 1K3I; -.
DR   PDBsum; 1T2X; -.
DR   PDBsum; 2EIB; -.
DR   PDBsum; 2EIC; -.
DR   PDBsum; 2EID; -.
DR   PDBsum; 2EIE; -.
DR   PDBsum; 2JKX; -.
DR   PDBsum; 2VZ1; -.
DR   PDBsum; 2VZ3; -.
DR   PDBsum; 2WQ8; -.
DR   ProteinModelPortal; P0CS93; -.
DR   SMR; P0CS93; 42-680.
DR   CAZy; CBM32; Carbohydrate-Binding Module Family 32.
DR   eggNOG; NOG69967; -.
DR   BioCyc; MetaCyc:MONOMER-15357; -.
DR   SABIO-RK; P0CS93; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0045480; F:galactose oxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   Gene3D; 2.130.10.80; -; 1.
DR   Gene3D; 2.60.120.260; -; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR000421; Coagulation_fac_5/8-C_type_dom.
DR   InterPro; IPR015202; DUF1929.
DR   InterPro; IPR011043; Gal_Oxase/kelch_b-propeller.
DR   InterPro; IPR015916; Gal_Oxidase_b-propeller.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR006652; Kelch_1.
DR   Pfam; PF09118; DUF1929; 1.
DR   Pfam; PF00754; F5_F8_type_C; 1.
DR   Pfam; PF01344; Kelch_1; 1.
DR   SMART; SM00231; FA58C; 1.
DR   SMART; SM00612; Kelch; 3.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF50965; SSF50965; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS50022; FA58C_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Copper; Direct protein sequencing; Disulfide bond;
KW   Kelch repeat; Metal-binding; Oxidoreductase; Repeat; Secreted; Signal;
KW   Thioether bond.
FT   SIGNAL        1     24
FT   PROPEP       25     41
FT                                /FTId=PRO_0000285407.
FT   CHAIN        42    680       Galactose oxidase.
FT                                /FTId=PRO_0000016610.
FT   DOMAIN       42    189       F5/8 type C.
FT   REPEAT      223    268       Kelch 1.
FT   REPEAT      279    321       Kelch 2.
FT   REPEAT      323    372       Kelch 3.
FT   REPEAT      436    490       Kelch 4.
FT   REPEAT      492    544       Kelch 5.
FT   ACT_SITE    536    536       Proton acceptor.
FT   METAL       313    313       Copper.
FT   METAL       536    536       Copper.
FT   METAL       537    537       Copper.
FT   METAL       622    622       Copper.
FT   DISULFID     59     68
FT   DISULFID    556    559
FT   CROSSLNK    269    313       3'-(S-cysteinyl)-tyrosine (Cys-Tyr).
FT   MUTAGEN     269    269       C->G: Reduces catalytic activity more
FT                                than 10000-fold.
FT   MUTAGEN     331    331       W->F: Reduces catalytic efficiency 50-
FT                                fold and substrate affinity 36-fold.
FT   MUTAGEN     331    331       W->G: Reduces substrate affinity 20-fold
FT                                and catalytic activity more than 6000-
FT                                fold.
FT   MUTAGEN     331    331       W->H: Reduces catalytic efficiency 1000-
FT                                fold.
FT   MUTAGEN     371    371       R->A: Reduces catalytic efficiency 250-
FT                                fold and substrate affinity 22-fold for
FT                                D-galactose, but improves catalytic
FT                                efficiency 1.8-fold towards D-fructose.
FT   MUTAGEN     371    371       R->K: Reduces catalytic efficiency 45-
FT                                fold and substrate affinity 8.7-fold for
FT                                D-galactose, but improves catalytic
FT                                efficiency 8-fold towards D-fructose.
FT   MUTAGEN     424    424       C->A: Reduces catalytic efficiency 1.5-to
FT                                2-fold towards D-galactose and 1-methyl-
FT                                alpha-D-galactopyranoside.
FT   MUTAGEN     424    424       C->S: Improves catalytic efficiency 3- to
FT                                4-fold towards D-galactose and 1-methyl-
FT                                alpha-D-galactopyranoside, mainly by
FT                                increasing the affinity for the
FT                                substrates. Improves catalytic efficiency
FT                                5.3-fold towards D-galactose; when
FT                                associated with H-477. Improves catalytic
FT                                efficiency 4.9-fold towards 1-methyl-
FT                                alpha-D-galactopyranoside; when
FT                                associated with A-535. Improves catalytic
FT                                activity 4.7-fold towards D-galactose,
FT                                but only 1.8-fold towards 1-methyl-alpha-
FT                                D-galactopyranoside; when associated with
FT                                A-477.
FT   MUTAGEN     477    477       Y->A: No effect. Improves catalytic
FT                                efficiency 2- to 3-fold towards D-
FT                                galactose and 1-methyl-alpha-D-
FT                                galactopyranoside; when associated with
FT                                A-535. Improves catalytic activity 4.7-
FT                                fold towards D-galactose, but only 1.8-
FT                                fold towards 1-methyl-alpha-D-
FT                                galactopyranoside; when associated with
FT                                S-424.
FT   MUTAGEN     477    477       Y->H: No effect. Improves catalytic
FT                                efficiency 5.3-fold towards D-galactose;
FT                                when associated with S-424.
FT   MUTAGEN     505    505       F->A: Reduces catalytic efficiency 166-
FT                                fold and substrate affinity 9-fold.
FT   MUTAGEN     535    535       V->A: Improves catalytic efficiency 1.3-
FT                                to 1.8-fold. Improves catalytic
FT                                efficiency 2- to 3-fold towards D-
FT                                galactose and 1-methyl-alpha-D-
FT                                galactopyranoside; when associated with
FT                                A-477. Improves catalytic efficiency 4.9-
FT                                fold towards 1-methyl-alpha-D-
FT                                galactopyranoside; when associated with
FT                                S-424.
FT   MUTAGEN     536    536       Y->F: Reduces catalytic efficiency 1000-
FT                                fold, but does not reduce substrate
FT                                affinity.
FT   CONFLICT    111    111       M -> I (in Ref. 4; AAB94635).
FT   HELIX        35     37
FT   STRAND       46     49
FT   STRAND       56     60
FT   HELIX        68     71
FT   STRAND       72     74
FT   HELIX        85     87
FT   STRAND       94    112
FT   STRAND      125    135
FT   STRAND      141    145
FT   STRAND      148    151
FT   STRAND      153    169
FT   STRAND      180    188
FT   STRAND      201    207
FT   STRAND      213    217
FT   TURN        219    221
FT   STRAND      224    229
FT   TURN        233    235
FT   STRAND      241    248
FT   TURN        250    252
FT   STRAND      259    262
FT   STRAND      271    274
FT   STRAND      280    283
FT   STRAND      285    287
FT   STRAND      291    295
FT   TURN        296    299
FT   STRAND      300    303
FT   STRAND      315    318
FT   STRAND      324    327
FT   STRAND      333    335
FT   STRAND      340    344
FT   TURN        345    348
FT   STRAND      349    353
FT   HELIX       359    361
FT   HELIX       368    370
FT   TURN        371    373
FT   STRAND      378    380
FT   HELIX       382    384
FT   STRAND      386    388
FT   STRAND      391    399
FT   STRAND      405    411
FT   STRAND      426    431
FT   TURN        432    435
FT   STRAND      436    440
FT   STRAND      443    450
FT   STRAND      455    459
FT   STRAND      468    471
FT   STRAND      480    482
FT   STRAND      484    487
FT   STRAND      493    496
FT   STRAND      499    501
FT   STRAND      515    518
FT   HELIX       519    521
FT   STRAND      523    526
FT   STRAND      538    542
FT   STRAND      548    552
FT   STRAND      565    570
FT   HELIX       572    574
FT   STRAND      579    581
FT   STRAND      587    591
FT   STRAND      593    596
FT   STRAND      600    607
FT   STRAND      610    616
FT   STRAND      619    621
FT   STRAND      630    632
FT   STRAND      635    639
FT   STRAND      642    646
FT   TURN        651    653
FT   STRAND      656    664
FT   STRAND      674    679
SQ   SEQUENCE   680 AA;  72823 MW;  2F97C561B63E46E9 CRC64;
     MKHLLTLALC FSSINAVAVT VPHKAVGTGI PEGSLQFLSL RASAPIGSAI SRNNWAVTCD
     SAQSGNECNK AIDGNKDTFW HTFYGANGDP KPPHTYTIDM KTTQNVNGLS MLPRQDGNQN
     GWIGRHEVYL SSDGTNWGSP VASGSWFADS TTKYSNFETR PARYVRLVAI TEANGQPWTS
     IAEINVFQAS SYTAPQPGLG RWGPTIDLPI VPAAAAIEPT SGRVLMWSSY RNDAFGGSPG
     GITLTSSWDP STGIVSDRTV TVTKHDMFCP GISMDGNGQI VVTGGNDAKK TSLYDSSSDS
     WIPGPDMQVA RGYQSSATMS DGRVFTIGGS WSGGVFEKNG EVYSPSSKTW TSLPNAKVNP
     MLTADKQGLY RSDNHAWLFG WKKGSVFQAG PSTAMNWYYT SGSGDVKSAG KRQSNRGVAP
     DAMCGNAVMY DAVKGKILTF GGSPDYQDSD ATTNAHIITL GEPGTSPNTV FASNGLYFAR
     TFHTSVVLPD GSTFITGGQR RGIPFEDSTP VFTPEIYVPE QDTFYKQNPN SIVRVYHSIS
     LLLPDGRVFN GGGGLCGDCT TNHFDAQIFT PNYLYNSNGN LATRPKITRT STQSVKVGGR
     ITISTDSSIS KASLIRYGTA THTVNTDQRR IPLTLTNNGG NSYSFQVPSD SGVALPGYWM
     LFVMNSAGVP SVASTIRVTQ
//
ID   IVB4_WALAE              Reviewed;          83 AA.
AC   C1IC53;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   26-MAY-2009, sequence version 1.
DT   16-APR-2014, entry version 22.
DE   RecName: Full=Protease inhibitor 4;
DE   AltName: Full=Kunitz inhibitor IV;
DE   Flags: Precursor;
OS   Walterinnesia aegyptia (Desert black snake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Elapidae; Elapinae; Walterinnesia.
OX   NCBI_TaxID=64182;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 25-40, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=18405934; DOI=10.1016/j.toxicon.2008.02.012;
RA   Tsai H.-Y., Wang Y.M., Tsai I.-H.;
RT   "Cloning, characterization and phylogenetic analyses of members of
RT   three major venom families from a single specimen of Walterinnesia
RT   aegyptia.";
RL   Toxicon 51:1245-1254(2008).
CC   -!- FUNCTION: Snake venom serine protease inhibitor (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=6779; Method=Electrospray; Range=25-83;
CC       Source=PubMed:18405934;
CC   -!- SIMILARITY: Contains 1 BPTI/Kunitz inhibitor domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU196561; ABX82870.1; -; mRNA.
DR   MEROPS; I02.022; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR   Gene3D; 4.10.410.10; -; 1.
DR   InterPro; IPR002223; Prot_inh_Kunz-m.
DR   InterPro; IPR020901; Prtase_inh_Kunz-CS.
DR   Pfam; PF00014; Kunitz_BPTI; 1.
DR   PRINTS; PR00759; BASICPTASE.
DR   SMART; SM00131; KU; 1.
DR   SUPFAM; SSF57362; SSF57362; 1.
DR   PROSITE; PS00280; BPTI_KUNITZ_1; 1.
DR   PROSITE; PS50279; BPTI_KUNITZ_2; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Protease inhibitor;
KW   Secreted; Serine protease inhibitor; Signal; Toxin.
FT   SIGNAL        1     24
FT   CHAIN        25     83       Protease inhibitor 4.
FT                                /FTId=PRO_0000419230.
FT   DOMAIN       31     81       BPTI/Kunitz inhibitor.
FT   DISULFID     31     81       By similarity.
FT   DISULFID     40     64       By similarity.
FT   DISULFID     56     77       By similarity.
SQ   SEQUENCE   83 AA;  9270 MW;  B3D0399DDBB94C6A CRC64;
     MSSGCLLLLL GLLTLWAELT PISGLGGPKY CHLPADPGPC SNYRPAYYYN PASRKCEEFM
     YGGCKGNKNN FKTRHECHRV CVR
//
ID   IVB1_WALAE              Reviewed;          81 AA.
AC   C1IC50;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   26-MAY-2009, sequence version 1.
DT   16-APR-2014, entry version 21.
DE   RecName: Full=Protease inhibitor 1;
DE   AltName: Full=Kunitz inhibitor KIn-I;
DE   Flags: Precursor;
OS   Walterinnesia aegyptia (Desert black snake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Elapidae; Elapinae; Walterinnesia.
OX   NCBI_TaxID=64182;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 25-40, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=18405934; DOI=10.1016/j.toxicon.2008.02.012;
RA   Tsai H.-Y., Wang Y.M., Tsai I.-H.;
RT   "Cloning, characterization and phylogenetic analyses of members of
RT   three major venom families from a single specimen of Walterinnesia
RT   aegyptia.";
RL   Toxicon 51:1245-1254(2008).
CC   -!- FUNCTION: Snake venom serine protease inhibitor (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=6347; Method=Electrospray; Range=25-81;
CC       Source=PubMed:18405934;
CC   -!- SIMILARITY: Contains 1 BPTI/Kunitz inhibitor domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU196558; ABX82867.1; -; mRNA.
DR   MEROPS; I02.055; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR   Gene3D; 4.10.410.10; -; 1.
DR   InterPro; IPR002223; Prot_inh_Kunz-m.
DR   InterPro; IPR020901; Prtase_inh_Kunz-CS.
DR   Pfam; PF00014; Kunitz_BPTI; 1.
DR   PRINTS; PR00759; BASICPTASE.
DR   SMART; SM00131; KU; 1.
DR   SUPFAM; SSF57362; SSF57362; 1.
DR   PROSITE; PS00280; BPTI_KUNITZ_1; 1.
DR   PROSITE; PS50279; BPTI_KUNITZ_2; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Protease inhibitor;
KW   Secreted; Serine protease inhibitor; Signal; Toxin.
FT   SIGNAL        1     24
FT   CHAIN        25     81       Protease inhibitor 1.
FT                                /FTId=PRO_0000419227.
FT   DOMAIN       29     79       BPTI/Kunitz inhibitor.
FT   DISULFID     29     79       By similarity.
FT   DISULFID     38     62       By similarity.
FT   DISULFID     54     75       By similarity.
SQ   SEQUENCE   81 AA;  8777 MW;  AD08828832239D01 CRC64;
     MSSGGLLLLL GLLTLWAELT PVSGRPGLCE LPAETGPCKA RIRAFYYNPH SHKCLEFTYG
     GCKGNANNFK TIDECNRTCV G
//
ID   IVB2_WALAE              Reviewed;          81 AA.
AC   C1IC52;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   26-MAY-2009, sequence version 1.
DT   16-APR-2014, entry version 21.
DE   RecName: Full=Protease inhibitor 2;
DE   AltName: Full=Kunitz inhibitor KIn-II;
DE   Flags: Precursor;
OS   Walterinnesia aegyptia (Desert black snake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Elapidae; Elapinae; Walterinnesia.
OX   NCBI_TaxID=64182;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 25-40, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=18405934; DOI=10.1016/j.toxicon.2008.02.012;
RA   Tsai H.-Y., Wang Y.M., Tsai I.-H.;
RT   "Cloning, characterization and phylogenetic analyses of members of
RT   three major venom families from a single specimen of Walterinnesia
RT   aegyptia.";
RL   Toxicon 51:1245-1254(2008).
CC   -!- FUNCTION: Snake venom serine protease inhibitor (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=6394; Method=Electrospray; Range=25-81;
CC       Source=PubMed:18405934;
CC   -!- SIMILARITY: Contains 1 BPTI/Kunitz inhibitor domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU196560; ABX82869.1; -; mRNA.
DR   MEROPS; I02.055; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR   Gene3D; 4.10.410.10; -; 1.
DR   InterPro; IPR002223; Prot_inh_Kunz-m.
DR   InterPro; IPR020901; Prtase_inh_Kunz-CS.
DR   Pfam; PF00014; Kunitz_BPTI; 1.
DR   PRINTS; PR00759; BASICPTASE.
DR   SMART; SM00131; KU; 1.
DR   SUPFAM; SSF57362; SSF57362; 1.
DR   PROSITE; PS00280; BPTI_KUNITZ_1; 1.
DR   PROSITE; PS50279; BPTI_KUNITZ_2; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Protease inhibitor;
KW   Secreted; Serine protease inhibitor; Signal; Toxin.
FT   SIGNAL        1     24
FT   CHAIN        25     81       Protease inhibitor 2.
FT                                /FTId=PRO_0000419228.
FT   DOMAIN       29     79       BPTI/Kunitz inhibitor.
FT   DISULFID     29     79       By similarity.
FT   DISULFID     38     62       By similarity.
FT   DISULFID     54     75       By similarity.
SQ   SEQUENCE   81 AA;  8870 MW;  9F611182F1B4BC74 CRC64;
     MSSGCLLLLL GLLTLWAELT PVSGRPRLCE LPAESGLCNA YIPSFYYNPH SHKCQKFMYG
     GCGGNANNFK TIDECHRTCV G
//
ID   IVBMA_MICTN             Reviewed;          84 AA.
AC   G9I929;
DT   18-APR-2012, integrated into UniProtKB/Swiss-Prot.
DT   22-FEB-2012, sequence version 1.
DT   16-APR-2014, entry version 14.
DE   RecName: Full=Neurotoxin MitTx-alpha;
DE   Flags: Precursor;
OS   Micrurus tener tener (Texas coral snake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Elapidae; Elapinae; Micrurus.
OX   NCBI_TaxID=1114302;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, FUNCTION,
RP   SUBUNIT, AND PYROGLUTAMATE FORMATION AT GLN-25.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=22094702; DOI=10.1038/nature10607;
RA   Bohlen C.J., Chesler A.T., Sharif-Naeini R., Medzihradszky K.F.,
RA   Zhou S., King D., Sanchez E.E., Burlingame A.L., Basbaum A.I.,
RA   Julius D.;
RT   "A heteromeric Texas coral snake toxin targets acid-sensing ion
RT   channels to produce pain.";
RL   Nature 479:410-414(2011).
CC   -!- FUNCTION: This heterodimeric toxin potently activates mouse acid-
CC       sensing ion channel ASIC1/ACCN2 expressed in Xenopus oocytes. Both
CC       alternatively spliced isoforms ASIC1a and ASIC1b are activated,
CC       with a higher potency for ASIC1a (EC(50)=9.4 nM) vs ASIC1b
CC       (EC(50)=23 nM). The ASIC3/ACCN3 subtype is also sensitive to the
CC       heterodimer, but with a lower potency (EC(50)=830 nM). On
CC       ASIC2a/ACCN1, the toxin shows a very weak activation, but produces
CC       a remarkable potentiation (>100-fold) of protons when the
CC       extracellular pH drops below neutrality. The toxin interacts with
CC       the extracellular region of the channel, since responses are only
CC       observed in the outside-out configuration. In vivo, the
CC       heterodimer elicits robust pain-related behavior in mice by
CC       activation of ASIC1/ACCN2 channels on capsaicin-sensitive nerve
CC       fibers.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta chains.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MISCELLANEOUS: This toxin has been studied to probe molecular
CC       mechanisms underlying pain sensation. By targeting ASIC1/ACCN2, it
CC       reveals an unexpected contribution of this channel to nociception
CC       (PubMed:22094702).
CC   -!- MISCELLANEOUS: The heterodimeric toxin does not affect
CC       ASIC2b/ACCN1, ASIC4/ACCN4, Kv2.1/KCNB1, Cav3.3/CACNA1I,
CC       ENaC/SCNN1A, TRPA1, TRPV1, TRPV3, TRPM8, P2X2/P2RX2, and 5-
CC       HT3/HTR3A channels (PubMed:22094702).
CC   -!- SIMILARITY: Belongs to the venom Kunitz-type family.
CC   -!- SIMILARITY: Contains 1 BPTI/Kunitz inhibitor domain.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=The poison in pain -
CC       Issue 140 of July 2012;
CC       URL="http://web.expasy.org/spotlight/back_issues/140";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; JN613325; AET85559.1; -; mRNA.
DR   PDB; 4NTW; X-ray; 2.07 A; B=25-84.
DR   PDB; 4NTX; X-ray; 2.27 A; B=25-84.
DR   PDB; 4NTY; X-ray; 2.65 A; B=25-84.
DR   PDBsum; 4NTW; -.
DR   PDBsum; 4NTX; -.
DR   PDBsum; 4NTY; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR   Gene3D; 4.10.410.10; -; 1.
DR   InterPro; IPR002223; Prot_inh_Kunz-m.
DR   Pfam; PF00014; Kunitz_BPTI; 1.
DR   SMART; SM00131; KU; 1.
DR   SUPFAM; SSF57362; SSF57362; 1.
DR   PROSITE; PS50279; BPTI_KUNITZ_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Disulfide bond;
KW   Ion channel impairing toxin; Neurotoxin; Protease inhibitor;
KW   Pyrrolidone carboxylic acid; Secreted; Serine protease inhibitor;
KW   Signal; Toxin.
FT   SIGNAL        1     24
FT   CHAIN        25     84       Neurotoxin MitTx-alpha.
FT                                /FTId=PRO_5000828217.
FT   DOMAIN       31     82       BPTI/Kunitz inhibitor.
FT   MOD_RES      25     25       Pyrrolidone carboxylic acid.
FT   DISULFID     31     82       By similarity.
FT   DISULFID     41     65       By similarity.
FT   DISULFID     57     78       By similarity.
SQ   SEQUENCE   84 AA;  9498 MW;  7D5C274A6ABDA89D CRC64;
     MSSGGLLLLL GLLTLCAELT PVSSQIRPAF CYEDPPFFQK CGAFVDSYYF NRSRITCVHF
     FYGQCDVNQN HFTTMSECNR VCHG
//
ID   LECG_PATPE              Reviewed;         168 AA.
AC   Q8WPD0;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   16-OCT-2013, entry version 46.
DE   RecName: Full=Alpha-N-acetylgalactosamine-specific lectin;
DE   AltName: Full=Alpha-N-acetylgalactosamine-binding lectin;
DE   AltName: Full=GalNAc-specific lectin;
DE   AltName: Full=Lectin;
DE            Short=ApL;
DE   AltName: Full=Tn antigen-specific lectin;
DE   Flags: Precursor;
OS   Patiria pectinifera (Starfish) (Asterina pectinifera).
OC   Eukaryota; Metazoa; Echinodermata; Eleutherozoa; Asterozoa;
OC   Asteroidea; Valvatacea; Valvatida; Asterinidae; Patiria.
OX   NCBI_TaxID=7594;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 19-26; 51-74; 88-107
RP   AND 157-163, FUNCTION, SUBUNIT, AND VARIANTS VAL-4; SER-15; GLN-67;
RP   ALA-84 AND VAL-153.
RX   PubMed=11886841; DOI=10.1093/glycob/12.2.85;
RA   Kakiuchi M., Okino N., Sueyoshi N., Ichinose S., Omori A.,
RA   Kawabata S., Yamaguchi K., Ito M.;
RT   "Purification, characterization, and cDNA cloning of alpha-N-
RT   acetylgalactosamine-specific lectin from starfish, Asterina
RT   pectinifera.";
RL   Glycobiology 12:85-94(2002).
CC   -!- FUNCTION: Alpha-N-acetylgalactosamine-specific lectin. The
CC       oligomeric form has Ca(2+)-dependent hemagglutination activity
CC       towards sheep erythrocytes. Its hemagglutination activity is
CC       inhibited by various monosaccharides, oligosaccharides and
CC       glycopeptides, including inhibition by GalNAc, blood group A
CC       trisaccharide, Tn antigen, mucin and asialomucin.
CC   -!- SUBUNIT: Monomer, homodimer and homooligomer.
CC   -!- SIMILARITY: Contains 1 C-type lectin domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB062765; BAB78598.1; -; mRNA.
DR   EMBL; AB079848; BAB85109.1; -; mRNA.
DR   ProteinModelPortal; Q8WPD0; -.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:InterPro.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Hemagglutinin; Lectin;
KW   Polymorphism; Signal.
FT   SIGNAL        1     18
FT   CHAIN        19    168       Alpha-N-acetylgalactosamine-specific
FT                                lectin.
FT                                /FTId=PRO_5000049722.
FT   DOMAIN       38    163       C-type lectin.
FT   DISULFID     59    162       By similarity.
FT   DISULFID    136    154       By similarity.
FT   VARIANT       4      4       F -> V.
FT   VARIANT      15     15       F -> S.
FT   VARIANT      67     67       L -> Q.
FT   VARIANT      84     84       T -> A.
FT   VARIANT     153    153       A -> V.
SQ   SEQUENCE   168 AA;  18936 MW;  6F3CACBC2CCFCFFC CRC64;
     MAFFRALCFV LLVGFAAACQ PDCSWKCPPK CPPMWTFYNG NCYRYFGTGK TYDEAESHCQ
     EFTEVGLGHL ASIASAEENN LLLTMWKSVR TTTTGGLWIG LNDQAEEGNF IWTDGSAVTF
     TDWATTQPDN YQNEDCAHMR HELDGDDRWN DIACSRAFAY VCKMSTTN
//
ID   NXL1_AUSLA              Reviewed;          96 AA.
AC   B2BRQ5;
DT   13-JUN-2012, integrated into UniProtKB/Swiss-Prot.
DT   20-MAY-2008, sequence version 1.
DT   24-JUL-2013, entry version 29.
DE   RecName: Full=Alpha-elapitoxin-Al2b;
DE            Short=Alpha-EPTX-Al2b;
DE   Flags: Precursor;
OS   Austrelaps labialis (Pygmy copperhead) (Denisonia superba).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Elapidae; Acanthophiinae;
OC   Austrelaps.
OX   NCBI_TaxID=471292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Venom gland;
RX   PubMed=18307759; DOI=10.1186/1471-2148-8-70;
RA   Doley R., Tram N.N.B., Reza M.A., Kini R.M.;
RT   "Unusual accelerated rate of deletions and insertions in toxin genes
RT   in the venom glands of the pygmy copperhead (Austrelaps labialis) from
RT   Kangaroo island.";
RL   BMC Evol. Biol. 8:70-70(2008).
RN   [2]
RP   NOMENCLATURE.
RX   PubMed=20950587; DOI=10.1016/j.bcp.2010.10.004;
RA   Blacklow B., Kornhauser R., Hains P.G., Loiacono R., Escoubas P.,
RA   Graudins A., Nicholson G.M.;
RT   "alpha-Elapitoxin-Aa2a, a long-chain snake alpha-neurotoxin with
RT   potent actions on muscle (alpha1)(2)betagammadelta nicotinic
RT   receptors, lacks the classical high affinity for neuronal alpha7
RT   nicotinic receptors.";
RL   Biochem. Pharmacol. 81:314-325(2011).
RN   [3]
RP   PROTEIN SEQUENCE OF 22-96, AND FUNCTION.
RA   Nicholson G.;
RL   Unpublished observations (APR-2012).
CC   -!- FUNCTION: Potent long-chain postsynaptic neurotoxin. Pseudo-
CC       irreversibly inhibits the nicotinic acetylcholine receptor through
CC       competitive antagonism.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- SIMILARITY: Belongs to the snake three-finger toxin family. Type
CC       II alpha-neurotoxin subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU003085; ABX58151.1; -; mRNA.
DR   ProteinModelPortal; B2BRQ5; -.
DR   SMR; B2BRQ5; 24-90.
DR   GO; GO:0035792; C:other organism postsynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0035821; P:modification of morphology or physiology of other organism; IEA:InterPro.
DR   InterPro; IPR003571; Snake_toxin.
DR   InterPro; IPR018354; Snake_toxin_BS.
DR   Pfam; PF00087; Toxin_1; 1.
DR   PROSITE; PS00272; SNAKE_TOXIN; 1.
PE   1: Evidence at protein level;
KW   Acetylcholine receptor inhibiting toxin; Direct protein sequencing;
KW   Disulfide bond; Ion channel impairing toxin; Neurotoxin;
KW   Postsynaptic neurotoxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     21
FT   CHAIN        22     96       Alpha-elapitoxin-Al2b.
FT                                /FTId=PRO_0000417624.
FT   DISULFID     24     41       By similarity.
FT   DISULFID     34     62       By similarity.
FT   DISULFID     47     51       By similarity.
FT   DISULFID     66     77       By similarity.
FT   DISULFID     78     83       By similarity.
SQ   SEQUENCE   96 AA;  10258 MW;  A5F1C98D258BD638 CRC64;
     MKTLLLTLVV VTIVCLDFGG GLICYMGPKT PRTCPPGQNL CYTKTWCDGF CGSRGKVVVL
     GCAATCPTVK PGVDITCCAT DKCNPFPKTK APWERP
//
ID   NXSM1_DENPO             Reviewed;          78 AA.
AC   P0DKR6; B3EWQ5; K0C0K0;
DT   28-NOV-2012, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2012, sequence version 1.
DT   19-FEB-2014, entry version 7.
DE   RecName: Full=Mambalgin-1;
DE            Short=Mamb-1;
DE   AltName: Full=Pi-Dp1;
DE   Flags: Precursor;
OS   Dendroaspis polylepis polylepis (Black mamba).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Elapidae; Elapinae; Dendroaspis.
OX   NCBI_TaxID=8620;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 22-78, FUNCTION,
RP   BIOASSAY, PHARMACEUTICAL, MASS SPECTROMETRY, AND 3D-STRUCTURE
RP   MODELING.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=23034652; DOI=10.1038/nature11494;
RA   Diochot S., Baron A., Salinas M., Douguet D., Scarzello S.,
RA   Dabert-Gay A.-S., Debayle D., Friend V., Alloui A., Lazdunski M.,
RA   Lingueglia E.;
RT   "Black mamba venom peptides target acid-sensing ion channels to
RT   abolish pain.";
RL   Nature 490:552-555(2012).
CC   -!- FUNCTION: This three-finger toxin shows a potent analgesic effect
CC       against acute and inflammatory pain upon central and peripheral
CC       injection. It acts through a reversible block of the heteromeric
CC       channel ASIC1a-ASIC2a (ACCN2-ACCN1) in central neurons and of
CC       ASIC1b-containing channels in nociceptors. Acts as a gating
CC       modifier toxin by binding to the closed/inactivated channel. On
CC       channels expressed in COS-7 cells, it shows IC(50) of: 55 nM on
CC       rASIC1a, 127 nM on hASIC1a, 246 nM on rASIC1a-rASIC2a, 61 nM on
CC       rASIC1a-rASIC2b, 192 nM on ASIC1b, and 72 nM on rASIC1a-rASIC1b.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=6555.7; Method=MALDI; Range=22-78;
CC       Note=Average mass; Source=PubMed:23034652;
CC   -!- PHARMACEUTICAL: Promising peptide that shows a potent analgesic
CC       effect against acute and inflammatory pain that can be as strong
CC       as morphine but resistant to naloxone, with much less tolerance
CC       and no respiratory distress.
CC   -!- MISCELLANEOUS: Has no effect on ASIC2a (ACCN1), ASIC3 (ACCN3),
CC       ASIC1a-ASIC3 (ACCN2-ACCN3) and ASIC1b-ASIC3 (ACCN2-ACCN3)
CC       channels, as well as on TRPV1, P2RX2 (P2X2), HTR3A (5-HT3A),
CC       Nav1.8 (SCN10A), Cav3.2 (CACNA1H) and Kv1.2 (KCNA2) channels. Does
CC       not produce motor dysfunction, apathy, flaccid paralysis,
CC       convulsions or death upon central injections (intrathecal or
CC       intracerebroventricular) in mice (PubMed:23034652).
CC   -!- SIMILARITY: Belongs to the snake three-finger toxin family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; JX428743; AFT65615.1; -; mRNA.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   InterPro; IPR003571; Snake_toxin.
DR   Pfam; PF00087; Toxin_1; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond;
KW   Ion channel impairing toxin; Neurotoxin; Pharmaceutical; Secreted;
KW   Signal; Toxin.
FT   SIGNAL        1     21
FT   CHAIN        22     78       Mambalgin-1.
FT                                /FTId=PRO_0000420360.
FT   DISULFID     24     40       By similarity.
FT   DISULFID     33     58       By similarity.
FT   DISULFID     62     70       By similarity.
FT   DISULFID     71     76       By similarity.
SQ   SEQUENCE   78 AA;  8853 MW;  CC140CD5D3CB14FC CRC64;
     MKTLLLTLLV VTIVCLDLGY SLKCYQHGKV VTCHRDMKFC YHNTGMPFRN LKLILQGCSS
     SCSETENNKC CSTDRCNK
//
ID   OXLA2_CROAD             Reviewed;         516 AA.
AC   F8S0Z5; J3S821;
DT   11-JUL-2012, integrated into UniProtKB/Swiss-Prot.
DT   21-SEP-2011, sequence version 1.
DT   16-APR-2014, entry version 13.
DE   RecName: Full=L-amino-acid oxidase;
DE            Short=LAAO;
DE            Short=LAO;
DE            EC=1.4.3.2;
DE   Flags: Precursor;
OS   Crotalus adamanteus (Eastern diamondback rattlesnake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae; Crotalus.
OX   NCBI_TaxID=8729;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Venom gland;
RX   PubMed=21255598; DOI=10.1016/j.toxicon.2011.01.008;
RA   Rokyta D.R., Wray K.P., Lemmon A.R., Lemmon E.M., Caudle S.B.;
RT   "A high-throughput venom-gland transcriptome for the eastern
RT   diamondback rattlesnake (Crotalus adamanteus) and evidence for
RT   pervasive positive selection across toxin classes.";
RL   Toxicon 57:657-671(2011).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Venom gland;
RA   Rokyta D.R., Lemmon A.R., Margres M.J., Aronow K.;
RT   "The venom-gland transcriptome of the eastern diamondback rattlesnake
RT   (Crotalus adamanteus).";
RL   BMC Genomics 13:312-312(2012).
RN   [3]
RP   PROTEIN SEQUENCE OF 19-27, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Venom;
RX   PubMed=24231107; DOI=10.1016/j.jprot.2013.11.001;
RA   Margres M.J., McGivern J.J., Wray K.P., Seavy M., Calvin K.,
RA   Rokyta D.R.;
RT   "Linking the transcriptome and proteome to characterize the venom of
RT   the eastern diamondback rattlesnake (Crotalus adamanteus).";
RL   J. Proteomics 96:145-158(2013).
CC   -!- FUNCTION: Catalyzes an oxidative deamination of predominantly
CC       hydrophobic and aromatic L-amino acids (L-Leu), thus producing
CC       hydrogen peroxide that may contribute to the diverse toxic effects
CC       of this enzyme. Exhibits diverse biological activities, such as
CC       hemolysis, edema, hemorrhage, apoptosis, antibacterial and
CC       antiparasitic activities, as well as regulation of platelet
CC       aggregation. Effects of snake L-amino oxidases on platelets are
CC       controversial, since they either induce aggregation or inhibit
CC       agonist-induced aggregation. These different effects are probably
CC       due to different experimental conditions (By similarity).
CC   -!- CATALYTIC ACTIVITY: An L-amino acid + H(2)O + O(2) = a 2-oxo acid
CC       + NH(3) + H(2)O(2).
CC   -!- COFACTOR: FAD (By similarity).
CC   -!- SUBUNIT: Homodimer; non-covalently linked (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- PTM: N-glycosylated. Glycosylation is needed for activity (By
CC       similarity).
CC   -!- SIMILARITY: Belongs to the flavin monoamine oxidase family. FIG1
CC       subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HQ414099; AEJ31977.1; -; mRNA.
DR   EMBL; JU173667; AFJ49193.1; -; mRNA.
DR   ProteinModelPortal; F8S0Z5; -.
DR   SMR; F8S0Z5; 21-503.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0001716; F:L-amino-acid oxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:InterPro.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR   GO; GO:0044179; P:hemolysis in other organism; IEA:UniProtKB-KW.
DR   InterPro; IPR002937; Amino_oxidase.
DR   Pfam; PF01593; Amino_oxidase; 1.
PE   1: Evidence at protein level;
KW   Antibiotic; Antimicrobial; Apoptosis; Cytolysis;
KW   Direct protein sequencing; Disulfide bond; FAD; Flavoprotein;
KW   Glycoprotein; Hemolysis; Hemostasis impairing toxin; Oxidoreductase;
KW   Secreted; Signal; Toxin.
FT   SIGNAL        1     18
FT   CHAIN        19    516       L-amino-acid oxidase.
FT                                /FTId=PRO_5000771366.
FT   NP_BIND      61     62       FAD (By similarity).
FT   NP_BIND      81     82       FAD (By similarity).
FT   NP_BIND     103    106       FAD (By similarity).
FT   NP_BIND     482    487       FAD (By similarity).
FT   NP_BIND     482    483       Substrate (By similarity).
FT   BINDING      89     89       FAD (By similarity).
FT   BINDING     106    106       Substrate (By similarity).
FT   BINDING     239    239       Substrate (By similarity).
FT   BINDING     279    279       FAD; via amide nitrogen and carbonyl
FT                                oxygen (By similarity).
FT   BINDING     390    390       Substrate (By similarity).
FT   BINDING     475    475       FAD (By similarity).
FT   CARBOHYD    379    379       N-linked (GlcNAc...) (Potential).
FT   DISULFID     28    189       By similarity.
FT   DISULFID    349    430       By similarity.
SQ   SEQUENCE   516 AA;  58767 MW;  6CB90A49A0C015E5 CRC64;
     MNVFFMFSLL FLAALGSCAH DRNPLEECFR ETDYEEFLEI AKNGLTATSN PKRVVIVGAG
     MAGLSAAYVL AGAGHQVTVL EASERVGGRV RTYRKKDWYA NLGPMRLPTK HRIVREYIKK
     FDLKLNEFSQ ENENAWYFIK NIRKRVREVK NNPGLLEYPV KPSEEGKSAA QLYVESLRKV
     VKELKRTNCK YILDKYDTYS TKEYLLKEGN LSPGAVDMIG DLLNEDSGYY VSFIESLKHD
     DIFGYEKRFD EIVGGMDQLP TSMYEAIKEK VQVHFNARVI EIQQNDREAT VTYQTSANEM
     SSVTADYVIV CTTSRAARRI KFEPPLPPKK AHALRSVHYR SGTKIFLTCK KKFWEDDGIR
     GGKSTTDLPS RFIYYPNHNF TSGVGVIIAY GIGDDANFFQ ALDFKDCADI VINDLSLIHQ
     LPKEDIQTFC RPSMIQRWSL DKYAMGGITT FTPYQFQHFS EALTAPFKRI YFAGEYTAQF
     HGWIDSTIKS GLTAARDVNR ASENPSGIHL SNDNEF
//
ID   OXLA_DABRR              Reviewed;         504 AA.
AC   G8XQX1;
DT   11-JUL-2012, integrated into UniProtKB/Swiss-Prot.
DT   22-FEB-2012, sequence version 1.
DT   16-APR-2014, entry version 14.
DE   RecName: Full=L-amino-acid oxidase;
DE            Short=DrLAO;
DE            Short=LAAO;
DE            EC=1.4.3.2;
DE   Flags: Precursor;
OS   Daboia russelii (Russel's viper) (Vipera russelii).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Viperinae; Daboia.
OX   NCBI_TaxID=31159;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 19-38, FUNCTION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF HIS-241, MASS
RP   SPECTROMETRY, IDENTIFICATION BY MASS SPECTROMETRY, AND 3D-STRUCTURE
RP   MODELING IN COMPLEX WITH SUBSTRATE.
RC   STRAIN=Eastern India; TISSUE=Venom, and Venom gland;
RX   PubMed=21802487; DOI=10.1016/j.biochi.2011.07.022;
RA   Chen H.-S., Wang Y.-M., Huang W.-T., Huang K.-F., Tsai I.-H.;
RT   "Cloning, characterization and mutagenesis of Russell's viper venom L-
RT   amino acid oxidase: insights into its catalytic mechanism.";
RL   Biochimie 94:335-344(2012).
CC   -!- FUNCTION: Catalyzes an oxidative deamination of predominantly
CC       hydrophobic and aromatic L-amino acids (L-Tyr followed by L-Phe,
CC       L-Met, L-Leu, L-Trp), thus producing hydrogen peroxide that may
CC       contribute to the diverse toxic effects of this enzyme. Inhibits
CC       ADP- and collagen-induced platelet aggregation. This inhibition is
CC       inhibited by catalase, indicating the importance of generated
CC       H(2)O(2) for the inhibitory effect. This effect on platelets among
CC       snake L-amino-acid oxidases is however controversial, since some
CC       of them induce aggregation, whereas the other inhibit agonist-
CC       induced aggregation. In vivo, this enzyme induces a rapid,
CC       substantial and reversible increase in the paw volume of mice
CC       (edema). In addition, myofibrosis, and inflammatory cell
CC       infiltration on the paw tissue are also observed.
CC   -!- CATALYTIC ACTIVITY: An L-amino acid + H(2)O + O(2) = a 2-oxo acid
CC       + NH(3) + H(2)O(2).
CC   -!- COFACTOR: FAD (By similarity).
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.081 mM for L-Tyr (at pH 7.5 and 25 degrees Celsius);
CC         KM=0.142 mM for L-Phe (at pH 7.5 and 25 degrees Celsius);
CC         KM=0.373 mM for L-Met (at pH 7.5 and 25 degrees Celsius);
CC         KM=0.318 mM for L-Trp (at pH 7.5 and 25 degrees Celsius);
CC         KM=0.490 mM for L-Leu (at pH 7.5 and 25 degrees Celsius);
CC         KM=1.40 mM for L-Ile (at pH 7.5 and 25 degrees Celsius);
CC         KM=12.20 mM for L-Arg (at pH 7.5 and 25 degrees Celsius);
CC         KM=13.92 mM for L-Val (at pH 7.5 and 25 degrees Celsius);
CC         KM=64.00 mM for L-Lys (at pH 7.5 and 25 degrees Celsius);
CC         KM=116.48 mM for L-Ala (at pH 7.5 and 25 degrees Celsius);
CC   -!- SUBUNIT: Homodimer; non-covalently linked (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=62025; Method=MALDI; Range=19-504;
CC       Source=PubMed:21802487;
CC   -!- MISCELLANEOUS: Does not induce dermal hemorrhage when
CC       subcutaneously injected into mice at the dose of 40 ug
CC       (PubMed:21802487).
CC   -!- SIMILARITY: Belongs to the flavin monoamine oxidase family. FIG1
CC       subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU663622; ACF70483.1; -; mRNA.
DR   GO; GO:0005576; C:extracellular region; NAS:UniProtKB.
DR   GO; GO:0043655; C:extracellular space of host; NAS:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; TAS:UniProtKB.
DR   GO; GO:0001716; F:L-amino-acid oxidase activity; IDA:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; TAS:UniProtKB.
DR   GO; GO:0044398; P:envenomation resulting in induction of edema in other organism; IDA:UniProtKB.
DR   GO; GO:0044477; P:envenomation resulting in negative regulation of platelet aggregation in other organism; IDA:UniProtKB.
DR   GO; GO:0044179; P:hemolysis in other organism; IEA:UniProtKB-KW.
DR   InterPro; IPR002937; Amino_oxidase.
DR   Pfam; PF01593; Amino_oxidase; 1.
PE   1: Evidence at protein level;
KW   Cytolysis; Direct protein sequencing; Disulfide bond; FAD;
KW   Flavoprotein; Glycoprotein; Hemolysis; Hemostasis impairing toxin;
KW   Oxidoreductase; Platelet aggregation inhibiting toxin; Secreted;
KW   Signal; Toxin.
FT   SIGNAL        1     18
FT   CHAIN        19    504       L-amino-acid oxidase.
FT                                /FTId=PRO_5000825648.
FT   NP_BIND      61     62       FAD (By similarity).
FT   NP_BIND      81     82       FAD (By similarity).
FT   NP_BIND     105    108       FAD (By similarity).
FT   NP_BIND     482    487       FAD (By similarity).
FT   NP_BIND     482    483       Substrate (By similarity).
FT   BINDING      89     89       FAD (By similarity).
FT   BINDING     108    108       Substrate (By similarity).
FT   BINDING     241    241       Substrate (By similarity).
FT   BINDING     279    279       FAD; via amide nitrogen and carbonyl
FT                                oxygen (By similarity).
FT   BINDING     390    390       Substrate (By similarity).
FT   BINDING     475    475       FAD (By similarity).
FT   CARBOHYD    190    190       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    379    379       N-linked (GlcNAc...) (Potential).
FT   DISULFID     28    191       By similarity.
FT   DISULFID    349    430       By similarity.
FT   MUTAGEN     241    241       H->A: Shows high reactivity toward L-Arg,
FT                                but does not induce change toward L-Leu,
FT                                L-Phe and L-Met.
FT   MUTAGEN     241    241       H->N: No change in activity.
FT   MUTAGEN     241    241       H->S: Shows middle reactivity toward L-
FT                                Arg and L-Phe, but does not induce change
FT                                toward L-Leu, and L-Met.
SQ   SEQUENCE   504 AA;  56888 MW;  938FBF23BBAA7681 CRC64;
     MNVFFMFSLL FLATLGSCAD DKNPLEECFR EDDYEEFLEI AKNGLKKTSN PKHIVIVGAG
     MSGLSAAYVL AGAGHKVTVL EASERPGGRV RTHRNVKEGW YANLGPMRVP EKHRIIREYI
     RKFGLKLNEF VQETENGWYF IKNIRKRVGE VKKDPGLLKY PVKPSEAGKS AGQLYQESLG
     KAVEELKRTN CSYILNKYDT YSTKEYLIKE GNLSPGAVDM IGDLLNEDSG YYVSFIESLK
     HDDIFAYEKR FDEIVGGMDQ LPTSMYRAIE ESVHFKARVI KIQQNAEKVT VTYQTTQKNL
     LLETADYVIV CTTSRAARRI TFKPPLPPKK AHALRSVHYR SGTKIFLTCT KKFWEDDGIQ
     GGKSTTDLPS RFIYYPNHNF TTGVGVIIAY GIGDDANFFQ ALNLNECADI VFNDLSSIHQ
     LPKKDLQTFC YPSIIQKWSL DKYAMGAITT FTPYQFQHFS EALTAPVGRI FFAGEYTANA
     HGWIDSTIKS GLTAARDVNR ASEL
//
ID   PA2A1_ECHCA             Reviewed;         136 AA.
AC   Q7T3S7;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   11-DEC-2013, entry version 63.
DE   RecName: Full=Acidic phospholipase A2 EC-I;
DE            Short=EC-I-PLA2;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Echis carinatus (Saw-scaled viper).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Viperinae; Echis.
OX   NCBI_TaxID=40353;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, X-RAY
RP   CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 17-136 IN COMPLEX WITH CALCIUM
RP   IONS, AND DISULFIDE BOND.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=14684894;
RA   Jasti J., Paramasivam M., Srinivasan A., Singh T.P.;
RT   "Structure of an acidic phospholipase A2 from Indian saw-scaled viper
RT   (Echis carinatus) at 2.6 A resolution reveals a novel intermolecular
RT   interaction.";
RL   Acta Crystallogr. D 60:66-72(2004).
RN   [2]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Venom;
RX   PubMed=10519645; DOI=10.1016/S0041-0101(99)00104-X;
RA   Kemparaju K., Krishnakanth T.P., Veerabasappa Gowda T.;
RT   "Purification and characterization of a platelet aggregation inhibitor
RT   acidic phospholipase A2 from Indian saw-scaled viper (Echis carinatus)
RT   venom.";
RL   Toxicon 37:1659-1671(1999).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits human
CC       platelet aggregation induced by ADP, collagen and epinephrin
CC       (possibly by binding the platelet receptor alpha-IIb/beta-III) and
CC       induces mild edema in the foot pads of mice. PLA2 catalyzes the
CC       calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.66 mM for phospholipids;
CC       pH dependence:
CC         Optimum pH is 7.5;
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius;
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MISCELLANEOUS: Is non-lethal to mice and devoid of neurotoxicity,
CC       myotoxicity, hemorrhage, anticoagulant activity and cytotoxicity
CC       (PubMed:10519645).
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY268946; AAP41217.1; -; mRNA.
DR   PDB; 1OZ6; X-ray; 2.60 A; A=17-136.
DR   PDBsum; 1OZ6; -.
DR   ProteinModelPortal; Q7T3S7; -.
DR   SMR; Q7T3S7; 17-136.
DR   BindingDB; Q7T3S7; -.
DR   ChEMBL; CHEMBL4195; -.
DR   HOVERGEN; HBG008137; -.
DR   EvolutionaryTrace; Q7T3S7; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Direct protein sequencing; Disulfide bond;
KW   Hemostasis impairing toxin; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Metal-binding;
KW   Platelet aggregation inhibiting toxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    136       Acidic phospholipase A2 EC-I.
FT                                /FTId=PRO_0000419211.
FT   REGION      112    133       May be responsible for inhibition of the
FT                                platelet-aggregation activity.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen.
FT   METAL        45     45       Calcium; via carbonyl oxygen.
FT   METAL        47     47       Calcium; via carbonyl oxygen.
FT   METAL        64     64       Calcium.
FT   DISULFID     42    129
FT   DISULFID     44     60
FT   DISULFID     59    111
FT   DISULFID     65    136
FT   DISULFID     66    104
FT   DISULFID     73     97
FT   DISULFID     91    102
FT   HELIX        18     29
FT   HELIX        33     37
FT   TURN         41     44
FT   STRAND       45     47
FT   HELIX        55     69
FT   TURN         75     77
FT   STRAND       82     85
FT   STRAND       88     91
FT   HELIX        96    113
FT   HELIX       116    118
FT   HELIX       121    124
SQ   SEQUENCE   136 AA;  15523 MW;  39699DA1D01271BA CRC64;
     MKTLWIVAVW LIAVEGNLYQ FGRMIWNRTG KLPILSYGSY GCYCGWGGQG PPKDATDRCC
     LVHDCCYTRV GDCSPKMTLY SYRFENGDII CDNKDPCKRA VCECDREAAI CLGENVNTYD
     KKYKSYEDCT EEVQEC
//
ID   PA2A1_DABRR             Reviewed;         138 AA.
AC   A8CG86; Q2ES54;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 1.
DT   16-OCT-2013, entry version 35.
DE   RecName: Full=Acidic phospholipase A2 Drk-a1;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   AltName: Full=Phospholipase A2 Drk-a1';
DE   AltName: Full=Phospholipase A2-I;
DE   Flags: Precursor;
OS   Daboia russelii (Russel's viper) (Vipera russelii).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Viperinae; Daboia.
OX   NCBI_TaxID=31159;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-27, FUNCTION, AND
RP   MASS SPECTROMETRY.
RC   STRAIN=Eastern India; TISSUE=Venom, and Venom gland;
RX   PubMed=17611171; DOI=10.1016/j.bbapap.2007.04.012;
RA   Tsai I.-H., Tsai H.-Y., Wang Y.-M., Pe T., Warrell D.-A.;
RT   "Venom phospholipases of Russell's vipers from Myanmar and eastern
RT   India--cloning, characterization and phylogeographic analysis.";
RL   Biochim. Biophys. Acta 1774:1020-1028(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Venom gland;
RA   Madhukumar A.V., Reza M.A., Gowda T.V., Kini R.M.;
RT   "A survey of Daboia russelii venom gland transcripts (cDNA):
RT   unraveling the venom proteins and peptides.";
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that exhibits high
CC       hydrolytic activities and shows strong preference for the anionic
CC       micelles (dPPC with deoxycholate) to the zwitterionic micelles
CC       (dPPC with Triton X-100). PLA2 catalyzes the calcium-dependent
CC       hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13573; Method=Electrospray; Range=17-138;
CC       Note=in Drk-a1; Source=PubMed:17611171;
CC   -!- MASS SPECTROMETRY: Mass=13812; Method=Electrospray; Range=17-138;
CC       Note=in Drk-a1' which has only its protein sequence AA 17-27
CC       sequenced; Source=PubMed:17611171;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ090658; AAZ53180.1; -; mRNA.
DR   EMBL; DQ365974; ABD24036.1; -; mRNA.
DR   ProteinModelPortal; A8CG86; -.
DR   SMR; A8CG86; 17-138.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Direct protein sequencing; Disulfide bond; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding; Secreted; Signal;
KW   Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Acidic phospholipase A2 Drk-a1.
FT                                /FTId=PRO_0000419215.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
FT   VARIANT      18     18       L -> F (in Drk-a1').
SQ   SEQUENCE   138 AA;  15329 MW;  324139CF8B6FC15C CRC64;
     MRTLWIVAVC LIGVEGNLFQ FAEMIVKMTG KEAVHSYAIY GCYCGWGGQG KPQDATDRCC
     FVHDCCYGTV NDCNPKMATY SYSFENGDIV CGDNNLCLKT VCECDRAAAI CLGQNVNTYD
     KNYENYAISH CTEESEQC
//
ID   PA2A2_VIPRE             Reviewed;         137 AA.
AC   F8QN53;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   21-SEP-2011, sequence version 1.
DT   16-OCT-2013, entry version 13.
DE   RecName: Full=Acidic phospholipase A2 Vur-PL2B;
DE            Short=Vur-PL2;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Vipera renardi (Steppe viper) (Vipera ursinii renardi).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Viperinae; Vipera.
OX   NCBI_TaxID=927686;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-43, FUNCTION,
RP   CATALYTIC ACTIVITY, MASS SPECTROMETRY, LETHAL DOSE, AND CIRCULAR
RP   DICHROISM.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=21185324; DOI=10.1016/j.toxicon.2010.12.012;
RA   Tsai I.-H., Wang Y.M., Cheng A.C., Starkov V., Osipov A., Nikitin I.,
RA   Makarova Y., Ziganshin R., Utkin Y.;
RT   "cDNA cloning, structural, and functional analyses of venom
RT   phospholipases A and a Kunitz-type protease inhibitor from steppe
RT   viper Vipera ursinii renardi.";
RL   Toxicon 57:332-341(2011).
CC   -!- FUNCTION: Snake venom phospholipase A2 that causes internal
CC       bleeding, shows very strong anticoagulant activities and inhibits
CC       ADP-induced platelet aggregation. Shows very low cytotoxicity.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13547.9; Method=MALDI; Range=17-137;
CC       Source=PubMed:21185324;
CC   -!- TOXIC DOSE: LD(50) is 10.7 mg/kg by intraperitoneal injection into
CC       mice.
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -!- CAUTION: Two proteins (Vur-PL2A and Vur-PL2B) with different
CC       masses and detected in two different fractions have been isolated
CC       from the venom. They both seem to have the same sequence. Vur-PL2B
CC       is possibly a more stable conformer than Vur-PL2A. Since data on
CC       both proteins are very similar, information reported here only
CC       concern Vur-PL2B.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; GQ304907; ADG86231.1; -; mRNA.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Blood coagulation cascade inhibiting toxin; Direct protein sequencing;
KW   Disulfide bond; Hemorrhagic toxin; Hemostasis impairing toxin;
KW   Hydrolase; Lipid degradation; Lipid metabolism; Metal-binding;
KW   Platelet aggregation inhibiting toxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    137       Acidic phospholipase A2 Vur-PL2B.
FT                                /FTId=PRO_0000419639.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    137       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   137 AA;  15316 MW;  282C6D9F894F708D CRC64;
     MRILWIVAVC LIGVEGNLYQ FGKMIRYKTG KSALLSYSDY GCYCGWGGQG KPKDATDRCC
     FVHDCCYGRV NGCDPKLTIY SYSFENGDIV CGGDDSCKRA VCECDRVAAI CFGENLNTYD
     KKYKNYPSSQ CTETEQC
//
ID   PA2A2_DABSI             Reviewed;         138 AA.
AC   A8CG78;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 1.
DT   16-OCT-2013, entry version 33.
DE   RecName: Full=Acidic phospholipase A2 DsM-a2/DsM-a2';
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Daboia siamensis (Eastern Russel's viper) (Daboia russelii siamensis).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Viperinae; Daboia.
OX   NCBI_TaxID=343250;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-29, FUNCTION, AND
RP   MASS SPECTROMETRY.
RC   STRAIN=Myanmar; TISSUE=Venom, and Venom gland;
RX   PubMed=17611171; DOI=10.1016/j.bbapap.2007.04.012;
RA   Tsai I.-H., Tsai H.-Y., Wang Y.-M., Pe T., Warrell D.-A.;
RT   "Venom phospholipases of Russell's vipers from Myanmar and eastern
RT   India--cloning, characterization and phylogeographic analysis.";
RL   Biochim. Biophys. Acta 1774:1020-1028(2007).
CC   -!- FUNCTION: Exhibits high hydrolytic activities and shows strong
CC       preference for the anionic micelles (dPPC with deoxycholate) to
CC       the zwitterionic micelles (dPPC with Triton X-100). PLA2 catalyzes
CC       the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13810; Method=Electrospray; Range=17-138;
CC       Note=in Dsm-a2'; Source=PubMed:17611171;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -!- CAUTION: Sequence obtained after translation (DsM-a2) and sequence
CC       directly sequenced from protein (Dsm-a2', AA 17-29) correspond
CC       exactly. However, the mass found for the protein (13810) does not
CC       correspond to the expected mass calculated after translation
CC       (13810) (PubMed:17611171).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ090654; AAZ53176.1; -; mRNA.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding; Secreted; Signal;
KW   Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Acidic phospholipase A2 DsM-a2/DsM-a2'.
FT                                /FTId=PRO_0000419219.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15586 MW;  184ABFC632EA29B6 CRC64;
     MRTLWIVAVC LIGVEGNLYQ FGEMINQKTG NFGLLSYVYY GCYCGWGGKG KPQDATDRCC
     FVHDCCYGRV KGCDPKTATY SYSFENGDIV CGGDDPCLRA VCECDRVAAI CFRENMNTYD
     KKYMLYSIFD CKEESDQC
//
ID   PA2A3_VIPRE             Reviewed;         137 AA.
AC   F8QN51;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   21-SEP-2011, sequence version 1.
DT   16-OCT-2013, entry version 13.
DE   RecName: Full=Acidic phospholipase A2 Vur-PL3;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Vipera renardi (Steppe viper) (Vipera ursinii renardi).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Viperinae; Vipera.
OX   NCBI_TaxID=927686;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=21185324; DOI=10.1016/j.toxicon.2010.12.012;
RA   Tsai I.-H., Wang Y.M., Cheng A.C., Starkov V., Osipov A., Nikitin I.,
RA   Makarova Y., Ziganshin R., Utkin Y.;
RT   "cDNA cloning, structural, and functional analyses of venom
RT   phospholipases A and a Kunitz-type protease inhibitor from steppe
RT   viper Vipera ursinii renardi.";
RL   Toxicon 57:332-341(2011).
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13560; Method=MALDI; Range=17-137;
CC       Source=PubMed:21185324;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; GQ304905; ADG86229.1; -; mRNA.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond; Hydrolase; Lipid degradation; Lipid metabolism;
KW   Metal-binding; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    137       Acidic phospholipase A2 Vur-PL3.
FT                                /FTId=PRO_0000419640.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    137       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   137 AA;  15318 MW;  ABEC29BAEF85C404 CRC64;
     MRTLWIVAVC LIGVEGNLFQ FGKMIKYKTG KSALLSYSAY GCYCGWGGQG KPQDPTDRCC
     FVHDCCYGRV NGCNPKMDTY SYSFLNGDIV CGDDDPCLRA ICECDRAAAI CFGENVNTYD
     KKYKYYSSSH CTETEQC
//
ID   PA2AA_TRIPE             Reviewed;         138 AA.
AC   Q2YHJ6; Q0VJ50;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   16-OCT-2013, entry version 46.
DE   RecName: Full=Acidic phospholipase A2 Tpu-E6a;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Trimeresurus puniceus (Flat-nosed pitviper).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=197218;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION,
RP   SUBUNIT, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=15955061; DOI=10.1111/j.1742-4658.2005.04715.x;
RA   Wang Y.-M., Peng H.-F., Tsai I.-H.;
RT   "Unusual venom phospholipases A2 of two primitive tree vipers
RT   Trimeresurus puniceus and Trimeresurus borneensis.";
RL   FEBS J. 272:3015-3025(2005).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that impairs
CC       hemostasis. It weakly inhibits ADP-induced platelet aggregation
CC       when tested on platelet rich plasma from human and rabbit blood
CC       (15-25% of inhibition at 5-10 ug of enzyme), and dose-dependently
CC       inhibits blood coagulation, possibly by inhibiting thrombin
CC       activation. Exhibits high hydrolytic activities toward L-
CC       dipalmitoyl phosphatidylcholine. PLA2 catalyzes the calcium-
CC       dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13723.2; Method=Electrospray; Range=17-
CC       138; Source=PubMed:15955061;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY355174; AAR14168.1; -; mRNA.
DR   EMBL; AY355176; AAR14170.1; -; mRNA.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Blood coagulation cascade inhibiting toxin; Calcium;
KW   Direct protein sequencing; Disulfide bond; Hemostasis impairing toxin;
KW   Hydrolase; Lipid degradation; Lipid metabolism; Metal-binding;
KW   Platelet aggregation inhibiting toxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Acidic phospholipase A2 Tpu-E6a.
FT                                /FTId=PRO_0000419058.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
FT   CONFLICT     23     23       L -> M (in Ref. 1; AAR14170).
SQ   SEQUENCE   138 AA;  15520 MW;  9D12AE323E089A15 CRC64;
     MRTLWIMAVL LLGVKGNLLQ FELMIKKMSG RSGIRWYSDY GCYCGKGGHG QPQDATDRCC
     FVHDCCYGKV SGCDPKMAFY KYSSDNNDIV CGGNNPCLKE ICECDRAAAI CFRDNLSTYD
     NKYWNVPSET CQVESEPC
//
ID   PA2AA_CROVV             Reviewed;         138 AA.
AC   Q800C4;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   16-OCT-2013, entry version 55.
DE   RecName: Full=Acidic phospholipase A2 Cvv-E6a;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Crotalus viridis viridis (Prairie rattlesnake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae; Crotalus.
OX   NCBI_TaxID=8742;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION,
RP   COFACTOR, AND MASS SPECTROMETRY.
RC   STRAIN=Colorado, New Mexico, South Dakota, Southeastern Arizona,
RC   Texas, Western Oklahoma, and Wyoming; TISSUE=Venom, and Venom gland;
RX   PubMed=12623078; DOI=10.1016/S0003-9861(02)00747-6;
RA   Tsai I.-H., Wang Y.-M., Chen Y.-H., Tu A.T.;
RT   "Geographic variations, cloning, and functional analyses of the venom
RT   acidic phospholipases A2 of Crotalus viridis viridis.";
RL   Arch. Biochem. Biophys. 411:289-296(2003).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that significantly
CC       inhibits ADP-induced platelet aggregation in platelet-rich plasma
CC       of human, rabbit and guinea pig. PLA2 catalyzes the calcium-
CC       dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Calcium.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13467; Method=Electrospray; Range=17-138;
CC       Source=PubMed:12623078;
CC   -!- MISCELLANEOUS: Has no edema-inducing activities (PubMed:12623078).
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF403134; AAO93137.1; -; mRNA.
DR   ProteinModelPortal; Q800C4; -.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Direct protein sequencing; Disulfide bond;
KW   Hemostasis impairing toxin; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Metal-binding;
KW   Platelet aggregation inhibiting toxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Acidic phospholipase A2 Cvv-E6a.
FT                                /FTId=PRO_0000418553.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium (By similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15233 MW;  6FAB76496C7246E3 CRC64;
     MRTLWIVAVL LLGVEGSLVQ FETLIMKIAG RSGLLWYSAY GCYCGWGGHG LPQDATDRCC
     FVHDCCYGKA TDCNPKTVSY TYSEENGEIV CGGDNPCGTQ ICECDKAAAI CFRDNIPSYS
     NKYWLFLPKN CRGDPEPC
//
ID   PA2AA_TRIST             Reviewed;         138 AA.
AC   Q6H3D0;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   16-OCT-2013, entry version 52.
DE   RecName: Full=Acidic phospholipase A2 Ts-A1;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Trimeresurus stejnegeri (Chinese green tree viper) (Viridovipera
OS   stejnegeri).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=39682;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION,
RP   DEVELOPMENTAL STAGE, AND MASS SPECTROMETRY.
RC   STRAIN=Taiwan; TISSUE=Venom, and Venom gland;
RX   PubMed=12959640; DOI=10.1042/BJ20030818;
RA   Tsai I.-H., Wang Y.-M., Chen Y.-H., Tsai T.-S., Tu M.-C.;
RT   "Venom phospholipases A2 of bamboo viper (Trimeresurus stejnegeri):
RT   molecular characterization, geographic variations and evidence of
RT   multiple ancestries.";
RL   Biochem. J. 377:215-223(2004).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that shows a
CC       moderate inhibition of ADP-induced human platelet aggregation when
CC       tested on platelet rich plasma. Exhibits high hydrolytic
CC       activities and prefers the anionic micelles (dPPC with
CC       deoxycholate) to the zwitterionic micelles (dPPC with Triton X-
CC       100). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-
CC       acyl groups in 3-sn-phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- DEVELOPMENTAL STAGE: Is expressed more abundantly in juvenile than
CC       in adult vipers.
CC   -!- MASS SPECTROMETRY: Mass=13734; Method=Electrospray; Range=17-138;
CC       Source=PubMed:12959640;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -!- CAUTION: According to PubMed:12959640, T.stejnegeri was formerly
CC       named T.gramineus, supposing that this protein is the same as PLA-
CC       I from T.gramineus. They have been kept separated, because
CC       T.gramineus and T.stejnegeri are considered as being two different
CC       species (see http://reptile-database.org/).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY211939; AAP48897.1; -; mRNA.
DR   ProteinModelPortal; Q6H3D0; -.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Direct protein sequencing; Disulfide bond;
KW   Hemostasis impairing toxin; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Metal-binding;
KW   Platelet aggregation inhibiting toxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Acidic phospholipase A2 Ts-A1.
FT                                /FTId=PRO_0000419065.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15534 MW;  840F0551CCA0A5E1 CRC64;
     MRTLWIMAVL QVGVEGHLMQ FETLIMKVAG RSGVWYYGSY GCFCGAGGQG RPQDASDRCC
     FVHDCCYGKV NGCDPKKDFY TYSEENGAIV CGGDDPCKKE ICECDKDAAI CFRDNKDTYD
     NKYWFFPAKN CQEESEPC
//
ID   PA2AB_CROVV             Reviewed;         138 AA.
AC   Q7ZTA6;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   16-OCT-2013, entry version 54.
DE   RecName: Full=Acidic phospholipase A2 Cvv-E6b;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Crotalus viridis viridis (Prairie rattlesnake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae; Crotalus.
OX   NCBI_TaxID=8742;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION,
RP   COFACTOR, AND MASS SPECTROMETRY.
RC   STRAIN=Colorado, and Wyoming; TISSUE=Venom, and Venom gland;
RX   PubMed=12623078; DOI=10.1016/S0003-9861(02)00747-6;
RA   Tsai I.-H., Wang Y.-M., Chen Y.-H., Tu A.T.;
RT   "Geographic variations, cloning, and functional analyses of the venom
RT   acidic phospholipases A2 of Crotalus viridis viridis.";
RL   Arch. Biochem. Biophys. 411:289-296(2003).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that shows very low
CC       inhibition of ADP-induced platelet aggregation in platelet-rich
CC       plasma of human, rabbit and guinea pig. PLA2 catalyzes the
CC       calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Calcium.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13660; Method=Electrospray; Range=17-138;
CC       Source=PubMed:12623078;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY120877; AAM80565.1; -; mRNA.
DR   ProteinModelPortal; Q7ZTA6; -.
DR   SMR; Q7ZTA6; 17-138.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Direct protein sequencing; Disulfide bond;
KW   Hemostasis impairing toxin; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Metal-binding;
KW   Platelet aggregation inhibiting toxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Acidic phospholipase A2 Cvv-E6b.
FT                                /FTId=PRO_0000418554.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium (By similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15440 MW;  44B35FB1EF6B29D1 CRC64;
     MRTLWILAVL LLGVEGNLVQ FELLIMKVAK RSGLLSYSAY GCYCGWGGYG RPQDATDRCC
     FVHDCCYGKV TDCNPKTASY TYSEENGEIV CGGDDPCKKQ VCECDRVAAI CFRDNIPSYD
     NKYIQFPAKN CQEKPEPC
//
ID   PA2AB_DABSI             Reviewed;         130 AA.
AC   Q7T3T5;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   16-OCT-2013, entry version 56.
DE   RecName: Full=Acidic phospholipase A2 daboiatoxin B chain;
DE            Short=DbTx-B;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Acidic phospholipase A2-II;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor; Fragment;
OS   Daboia siamensis (Eastern Russel's viper) (Daboia russelii siamensis).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Viperinae; Daboia.
OX   NCBI_TaxID=343250;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Jia Y.-H., Jin Y., Chen R.-Q., Li D.-S., Wang W.-Y., Xiong Y.-L.;
RT   "Biochemical and pharmacological properties of three phospholipases
RT   from Vipera russelli siamensis.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION.
RX   PubMed=7778130; DOI=10.1016/0041-0101(94)00133-S;
RA   Thwin M.M., Gopalakrishnakone P., Yuen R., Tan C.H.;
RT   "A major lethal factor of the venom of Burmese Russell's viper (Daboia
RT   russelli siamensis): isolation, N-terminal sequencing and biological
RT   activities of daboiatoxin.";
RL   Toxicon 33:63-76(1995).
RN   [3]
RP   FUNCTION.
RX   PubMed=8711753; DOI=10.1016/0041-0101(95)00134-4;
RA   Thwin M.M., Gopalakrishnakone P., Yuen R., Tan C.H.;
RT   "Synaptosomal binding of 125I-labelled daboiatoxin, a new PLA2
RT   neurotoxin from the venom of Daboia russelli siamensis.";
RL   Toxicon 34:183-199(1996).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 9-130, DISULFIDE BOND,
RP   SUBUNIT, AND TOXIC DOSE.
RC   TISSUE=Venom;
RX   PubMed=17505111; DOI=10.1107/S0907444907016204;
RA   Gopalan G., Thwin M.M., Gopalakrishnakone P., Swaminathan K.;
RT   "Structural and pharmacological comparison of daboiatoxin from Daboia
RT   russelli siamensis with viperotoxin F and vipoxin from other vipers.";
RL   Acta Crystallogr. D 63:722-729(2007).
CC   -!- FUNCTION: Monomer: Snake venom phospholipase A2 (PLA2) that shows
CC       a high PLA2 activity (2110 umol/min/mg).
CC   -!- FUNCTION: Heterodimer (A and B chains): snake venom phospholipase
CC       A2 that shows a moderate PLA2 activity (1377 umol/min/mg). Acts as
CC       a presynaptic neurotoxin. In vivo, induces edema and produces
CC       neurotoxic symptoms in mice. It exhibits indirect hemolysis and a
CC       strong myonecrotic activity and is cytotoxic. PLA2 catalyzes the
CC       calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBUNIT: Heterodimer of an acidic protein having phospholipase A2
CC       activity (B chain) and an A chain which weakly inhibits the B
CC       chain enzymatic activity but potentiates its lethal potency.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- TOXIC DOSE: DbTx-A alone is non-lethal, even at doses as high as 2
CC       ug/g. The lethal (intraperitoneal) dose of the heterodimer is
CC       estimated to be about 0.1 ug/g.
CC   -!- MISCELLANEOUS: Does not provoke hemorrhage (PubMed:7778130).
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY286006; AAP37177.1; -; mRNA.
DR   PDB; 2H4C; X-ray; 2.60 A; B/D/F/H=9-130.
DR   PDBsum; 2H4C; -.
DR   ProteinModelPortal; Q7T3T5; -.
DR   SMR; Q7T3T5; 9-130.
DR   HOVERGEN; HBG008137; -.
DR   EvolutionaryTrace; Q7T3T5; -.
DR   GO; GO:0072556; C:other organism presynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Disulfide bond; Hydrolase;
KW   Inflammatory response; Lipid degradation; Lipid metabolism;
KW   Metal-binding; Myotoxin; Neurotoxin; Presynaptic neurotoxin; Secreted;
KW   Signal; Toxin.
FT   SIGNAL       <1      8
FT   CHAIN         9    130       Acidic phospholipase A2 daboiatoxin B
FT                                chain.
FT                                /FTId=PRO_0000419223.
FT   ACT_SITE     55     55       By similarity.
FT   ACT_SITE     97     97       By similarity.
FT   METAL        35     35       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        37     37       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        39     39       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        56     56       Calcium (By similarity).
FT   DISULFID     34    123
FT   DISULFID     36     52
FT   DISULFID     51    103
FT   DISULFID     57    130
FT   DISULFID     58     96
FT   DISULFID     65     89
FT   DISULFID     83     94
FT   NON_TER       1      1
FT   HELIX        10     20
FT   TURN         23     26
FT   HELIX        27     29
FT   TURN         33     35
FT   STRAND       36     38
FT   HELIX        47     59
FT   STRAND       67     69
FT   STRAND       75     77
FT   STRAND       80     82
FT   HELIX        88    106
FT   STRAND      108    110
FT   TURN        120    122
SQ   SEQUENCE   130 AA;  14828 MW;  3C8DB0AAF3C47689 CRC64;
     MCLIGVEGNL FQFARLIDAK QEAFSFFKYI SYGCYCGWGG QGTPKDATDR CCFVHDCCYA
     RVKGCNPKLV EYSYSYRTGK IVCGGDDPCL RAVCECDRVA AICFRENMNT YDKKYMLYSI
     FDCKEESDQC
//
ID   PA2AA_DABSI             Reviewed;         138 AA.
AC   Q7T2R1;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   16-APR-2014, entry version 59.
DE   RecName: Full=Acidic phospholipase A2 daboiatoxin A chain;
DE            Short=DbTx-A;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phospholipase A2 Dsm-a1;
DE   AltName: Full=Phospholipase A2 inhibitor;
DE   AltName: Full=Phospholipase A2-III;
DE   Flags: Precursor;
OS   Daboia siamensis (Eastern Russel's viper) (Daboia russelii siamensis).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Viperinae; Daboia.
OX   NCBI_TaxID=343250;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-27, FUNCTION, AND
RP   MASS SPECTROMETRY.
RC   STRAIN=Myanmar; TISSUE=Venom, and Venom gland;
RX   PubMed=17611171; DOI=10.1016/j.bbapap.2007.04.012;
RA   Tsai I.-H., Tsai H.-Y., Wang Y.-M., Pe T., Warrell D.-A.;
RT   "Venom phospholipases of Russell's vipers from Myanmar and eastern
RT   India--cloning, characterization and phylogeographic analysis.";
RL   Biochim. Biophys. Acta 1774:1020-1028(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Jia Y.-H., Jin Y., Chen R.-Q., Li D.-S., Wang W.-Y., Xiong Y.-L.;
RT   "Biochemical and pharmacological properties of three phospholipase A2s
RT   from Vipera russelli siamensis venom.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   PROTEIN SEQUENCE OF 17-36, AND FUNCTION.
RC   TISSUE=Venom;
RX   PubMed=7778130; DOI=10.1016/0041-0101(94)00133-S;
RA   Thwin M.M., Gopalakrishnakone P., Yuen R., Tan C.H.;
RT   "A major lethal factor of the venom of Burmese Russell's viper (Daboia
RT   russelli siamensis): isolation, N-terminal sequencing and biological
RT   activities of daboiatoxin.";
RL   Toxicon 33:63-76(1995).
RN   [4]
RP   FUNCTION.
RX   PubMed=8711753; DOI=10.1016/0041-0101(95)00134-4;
RA   Thwin M.M., Gopalakrishnakone P., Yuen R., Tan C.H.;
RT   "Synaptosomal binding of 125I-labelled daboiatoxin, a new PLA2
RT   neurotoxin from the venom of Daboia russelli siamensis.";
RL   Toxicon 34:183-199(1996).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 17-138, DISULFIDE BOND,
RP   SUBUNIT, AND TOXIC DOSE.
RC   TISSUE=Venom;
RX   PubMed=17505111; DOI=10.1107/S0907444907016204;
RA   Gopalan G., Thwin M.M., Gopalakrishnakone P., Swaminathan K.;
RT   "Structural and pharmacological comparison of daboiatoxin from Daboia
RT   russelli siamensis with viperotoxin F and vipoxin from other vipers.";
RL   Acta Crystallogr. D 63:722-729(2007).
CC   -!- FUNCTION: Monomer: Snake venom phospholipase A2 (PLA2) that shows
CC       an PLA2 activity of 578 umol/min/mg.
CC   -!- FUNCTION: Heterodimer (A and B chains): snake venom phospholipase
CC       A2 that shows a PLA2 activity of 1377 umol/min/mg. Acts as a
CC       presynaptic neurotoxin. In vivo, induces edema and produces
CC       neurotoxic symptoms in mice. It exhibits indirect hemolysis and a
CC       strong myonecrotic activity and is cytotoxic. PLA2 catalyzes the
CC       calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBUNIT: Heterodimer of an acidic protein having phospholipase A2
CC       activity (B chain) and an A chain which weakly inhibits the B
CC       chain enzymatic activity but potentiates its lethal potency.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13607; Method=Electrospray; Range=17-138;
CC       Note=in Dsm-a1; Source=PubMed:17611171;
CC   -!- MASS SPECTROMETRY: Mass=13812; Method=Electrospray; Range=17-138;
CC       Note=in Dsm-a1' which has only its protein sequence AA 17-27
CC       sequenced; Source=PubMed:17611171;
CC   -!- TOXIC DOSE: The lethal (intraperitoneal) dose of DbTx-B is
CC       estimated to be 0.5 ug/g, while that of the heterodimer is about
CC       0.1 ug/g.
CC   -!- MISCELLANEOUS: Does not provoke hemorrhage (PubMed:7778130).
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY303800; AAP58959.1; -; mRNA.
DR   EMBL; DQ090655; AAZ53177.1; -; mRNA.
DR   PDB; 2H4C; X-ray; 2.60 A; A/C/E/G=17-138.
DR   PDBsum; 2H4C; -.
DR   ProteinModelPortal; Q7T2R1; -.
DR   HOVERGEN; HBG008137; -.
DR   EvolutionaryTrace; Q7T2R1; -.
DR   GO; GO:0072556; C:other organism presynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0019834; F:phospholipase A2 inhibitor activity; IEA:UniProtKB-KW.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Direct protein sequencing; Disulfide bond;
KW   Hydrolase; Lipid degradation; Lipid metabolism; Metal-binding;
KW   Myotoxin; Neurotoxin; Phospholipase A2 inhibitor;
KW   Presynaptic neurotoxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Acidic phospholipase A2 daboiatoxin A
FT                                chain.
FT                                /FTId=PRO_0000419222.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131
FT   DISULFID     44     60
FT   DISULFID     59    111
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104
FT   DISULFID     73     97
FT   DISULFID     91    102
FT   HELIX        18     25
FT   TURN         26     28
FT   TURN         34     39
FT   TURN         41     44
FT   HELIX        55     69
FT   TURN         75     77
FT   STRAND       82     84
FT   STRAND       89     91
FT   HELIX        98    111
FT   TURN        112    118
FT   STRAND      123    125
FT   TURN        129    131
SQ   SEQUENCE   138 AA;  15395 MW;  36BC84C66C7B9B5C CRC64;
     MRTLWIMAVC LIGVEGNFFQ FAEMIVKMTG KEAVHSYAIY GCYCGWGGQG KPQDATDRCC
     FVHDCCYGTV NDCNPKMATY SYSFENGDIV CGDNNLCLKT VCECDRAAAI CLGQNVNTYD
     KNYENYAISH CTEESEQC
//
ID   PA2AE_CROVV             Reviewed;         138 AA.
AC   Q7ZTA8;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   16-OCT-2013, entry version 54.
DE   RecName: Full=Acidic phospholipase A2 Cvv-E6e;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Crotalus viridis viridis (Prairie rattlesnake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae; Crotalus.
OX   NCBI_TaxID=8742;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION,
RP   COFACTOR, AND MASS SPECTROMETRY.
RC   STRAIN=New Mexico, Southeastern Arizona, Texas, and Western Oklahoma;
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=12623078; DOI=10.1016/S0003-9861(02)00747-6;
RA   Tsai I.-H., Wang Y.-M., Chen Y.-H., Tu A.T.;
RT   "Geographic variations, cloning, and functional analyses of the venom
RT   acidic phospholipases A2 of Crotalus viridis viridis.";
RL   Arch. Biochem. Biophys. 411:289-296(2003).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that significantly
CC       inhibits ADP-induced platelet aggregation in platelet-rich plasma
CC       of human, rabbit and guinea pig. PLA2 catalyzes the calcium-
CC       dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Calcium.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13633; Method=Electrospray; Range=17-138;
CC       Source=PubMed:12623078;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY120875; AAM80563.1; -; mRNA.
DR   ProteinModelPortal; Q7ZTA8; -.
DR   SMR; Q7ZTA8; 17-138.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Direct protein sequencing; Disulfide bond;
KW   Hemostasis impairing toxin; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Metal-binding;
KW   Platelet aggregation inhibiting toxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Acidic phospholipase A2 Cvv-E6e.
FT                                /FTId=PRO_0000418557.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium (By similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15414 MW;  44A35EA1FE6A39D0 CRC64;
     MRTLWILAVL LLGVEGNLVQ FELLIMKVAK RSGLLSYSAY GCYCGWGGHG RPQDATDRCC
     FVHDCCYGKV TDCNPKTASY TYSEENGEIV CGGDDPCKKQ VCECDRVAAI CFRDNIPSYD
     NKYIQFPAKN CQEKPEPC
//
ID   PA2AF_TRIST             Reviewed;         138 AA.
AC   Q6H3C8;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   16-OCT-2013, entry version 50.
DE   RecName: Full=Acidic phospholipase A2 Ts-A6;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=CTs-A6;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Trimeresurus stejnegeri (Chinese green tree viper) (Viridovipera
OS   stejnegeri).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=39682;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION, AND
RP   MASS SPECTROMETRY.
RC   STRAIN=Chinese, and Taiwan; TISSUE=Venom, and Venom gland;
RX   PubMed=12959640; DOI=10.1042/BJ20030818;
RA   Tsai I.-H., Wang Y.-M., Chen Y.-H., Tsai T.-S., Tu M.-C.;
RT   "Venom phospholipases A2 of bamboo viper (Trimeresurus stejnegeri):
RT   molecular characterization, geographic variations and evidence of
RT   multiple ancestries.";
RL   Biochem. J. 377:215-223(2004).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that shows a
CC       moderate inhibition of ADP-induced human platelet aggregation when
CC       tested on platelet rich plasma. Exhibits high hydrolytic
CC       activities and prefers the anionic micelles (dPPC with
CC       deoxycholate) to the zwitterionic micelles (dPPC with Triton X-
CC       100). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-
CC       acyl groups in 3-sn-phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13939; Method=Electrospray; Range=17-138;
CC       Source=PubMed:12959640;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -!- CAUTION: According to PubMed:12959640, T.stejnegeri was formerly
CC       named T.gramineus, supposing that this protein is the same as PLA-
CC       VI from T.gramineus. They have been kept separated, because
CC       T.gramineus and T.stejnegeri are considered as being two different
CC       species (see http://reptile-database.org/).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY211941; AAP48899.1; -; mRNA.
DR   ProteinModelPortal; Q6H3C8; -.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Direct protein sequencing; Disulfide bond;
KW   Hemostasis impairing toxin; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Metal-binding;
KW   Platelet aggregation inhibiting toxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Acidic phospholipase A2 Ts-A6.
FT                                /FTId=PRO_0000419070.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15707 MW;  45D3F960A246BDE1 CRC64;
     MRALWIMAVL LLGVEGHLMQ FENMIKKVTG RSGIWWYGSY GCYCGKGGQG LPQDASDRCC
     FVHDCCYGKV NGCDPKDDFY VYSSENRDIV CGEDNPCTKE ICECDKAAAI CFRDNMDTYQ
     NKYWFYPSSN CNEESEPC
//
ID   PA2A_BOTER              Reviewed;         138 AA.
AC   Q2HZ28;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 1.
DT   16-OCT-2013, entry version 47.
DE   RecName: Full=Acidic phospholipase A2 BE-I-PLA2;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Bothrops erythromelas (Caatinga lance head).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae; Bothrops.
OX   NCBI_TaxID=44710;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-37; 78-91; 99-109
RP   AND 122-131, FUNCTION, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=16750518; DOI=10.1016/j.bcp.2006.04.032;
RA   de Albuquerque Modesto J.C., Spencer P.J., Fritzen M., Valenca R.C.,
RA   Oliva M.L., da Silva M.B., Chudzinski-Tavassi A.M., Guarnieri M.C.;
RT   "BE-I-PLA2, a novel acidic phospholipase A2 from Bothrops erythromelas
RT   venom: isolation, cloning and characterization as potent anti-platelet
RT   and inductor of prostaglandin I2 release by endothelial cells.";
RL   Biochem. Pharmacol. 72:377-384(2006).
CC   -!- FUNCTION: Snake venom phopspholipase A2 that shows a potent
CC       inhibition of human platelet aggregation. This inhibition is
CC       concentration-dependent when aggregation is induced by collagen,
CC       and concentration-independent when aggregation is induced by
CC       arachidonic acid. In human umbilical-cord veins endothelial cells,
CC       this toxin stimulates endothelial cells to release prostaglandin
CC       I(2), suggesting an increase of its potential anti-platelet
CC       activity in vivo. PLA2 catalyzes the calcium-dependent hydrolysis
CC       of the 2-acyl groups in 3-sn-phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13649.57; Method=MALDI; Range=17-138;
CC       Source=PubMed:16750518;
CC   -!- MISCELLANEOUS: Does not inhibit platelet aggregation when
CC       aggregation is induced by ADP, and does not induce aggregation of
CC       washed platelets. Does not induce changes on the principal
CC       platelet receptors (ITGA2, ITGA2B, GPIBA, SELP). In human
CC       umbilical-cord veins endothelial cells, does not induce
CC       detachment, does not interfere on nitric oxide release, and is
CC       neither apoptotic nor proliferative (PubMed:16750518).
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ359953; ABC96692.1; -; mRNA.
DR   ProteinModelPortal; Q2HZ28; -.
DR   SMR; Q2HZ28; 17-138.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Direct protein sequencing; Disulfide bond;
KW   Hemostasis impairing toxin; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Metal-binding;
KW   Platelet aggregation inhibiting toxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Acidic phospholipase A2 BE-I-PLA2.
FT                                /FTId=PRO_5000141191.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15435 MW;  760A7A10AE6943C8 CRC64;
     MRTLWIMAVL LVGVEGSLVQ FETLIMKIAG RSGVWYYGSY GCYCGSGGQG RPQDASDRCC
     FVHDCCYGKV TDCDPKADVY TYSEENGVVV CGGDDPCKKQ ICECDRVAAT CFRDNKDTYD
     NKYWFFPAKN CQEESEPC
//
ID   PA2AD_TRIST             Reviewed;         139 AA.
AC   Q6H3C7;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   16-OCT-2013, entry version 49.
DE   RecName: Full=Acidic phospholipase A2 Ts-A4;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Trimeresurus stejnegeri (Chinese green tree viper) (Viridovipera
OS   stejnegeri).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=39682;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, AND MASS
RP   SPECTROMETRY.
RC   STRAIN=Taiwan; TISSUE=Venom, and Venom gland;
RX   PubMed=12959640; DOI=10.1042/BJ20030818;
RA   Tsai I.-H., Wang Y.-M., Chen Y.-H., Tsai T.-S., Tu M.-C.;
RT   "Venom phospholipases A2 of bamboo viper (Trimeresurus stejnegeri):
RT   molecular characterization, geographic variations and evidence of
RT   multiple ancestries.";
RL   Biochem. J. 377:215-223(2004).
CC   -!- FUNCTION: PLA2 catalyzes the calcium-dependent hydrolysis of the
CC       2-acyl groups in 3-sn-phosphoglycerides (By similarity).
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13905; Method=Electrospray; Range=17-139;
CC       Source=PubMed:12959640;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY211942; AAP48900.1; -; mRNA.
DR   ProteinModelPortal; Q6H3C7; -.
DR   SMR; Q6H3C7; 18-139.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Direct protein sequencing; Disulfide bond; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding; Secreted; Signal;
KW   Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    139       Acidic phospholipase A2 Ts-A4.
FT                                /FTId=PRO_0000419068.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    132       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    139       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   139 AA;  15671 MW;  6AA48F88022E8B42 CRC64;
     MRTLWILAVL LVGVEGHLLQ FETMIIKMTK QTGLFSYSFY GCYCGWGGHG RPQDPTDRCC
     FVHDCCYGKV TNCDPKAAAY SYTIENGGIV CGGDDPCKKQ ICECDRAAAM CFRDNLDTYN
     YAKYWKFSAK DCQEESDPC
//
ID   PA2AD_CROVV             Reviewed;         138 AA.
AC   Q7ZTA7;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   16-OCT-2013, entry version 54.
DE   RecName: Full=Acidic phospholipase A2 Cvv-E6d;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Crotalus viridis viridis (Prairie rattlesnake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae; Crotalus.
OX   NCBI_TaxID=8742;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION,
RP   COFACTOR, AND MASS SPECTROMETRY.
RC   STRAIN=Southeastern Arizona; TISSUE=Venom, and Venom gland;
RX   PubMed=12623078; DOI=10.1016/S0003-9861(02)00747-6;
RA   Tsai I.-H., Wang Y.-M., Chen Y.-H., Tu A.T.;
RT   "Geographic variations, cloning, and functional analyses of the venom
RT   acidic phospholipases A2 of Crotalus viridis viridis.";
RL   Arch. Biochem. Biophys. 411:289-296(2003).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that shows very low
CC       inhibition of ADP-induced platelet aggregation in platelet-rich
CC       plasma of human, rabbit and guinea pig. PLA2 catalyzes the
CC       calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Calcium.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13782; Method=Electrospray; Range=17-138;
CC       Source=PubMed:12623078;
CC   -!- MISCELLANEOUS: Has no edema-inducing activities (PubMed:12623078).
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY120876; AAM80564.1; -; mRNA.
DR   ProteinModelPortal; Q7ZTA7; -.
DR   SMR; Q7ZTA7; 17-138.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Direct protein sequencing; Disulfide bond;
KW   Hemostasis impairing toxin; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Metal-binding;
KW   Platelet aggregation inhibiting toxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Acidic phospholipase A2 Cvv-E6d.
FT                                /FTId=PRO_0000418556.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium (By similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15549 MW;  04FF6D7266DB0BFE CRC64;
     MRTLWIVAVL LLGVEGSLVQ FEMLIMKVAK RSGLFSYSAY GCYCGWGGHG RPQDATDHCC
     FVHDCCYGKV TDCNPKTASY TYSEENGEIV CGGDDPCKKQ VCECDRVAAI CFRDNIPTYD
     NKYWRFPPEN CQEEPEPC
//
ID   PA2A_MACLN              Reviewed;         138 AA.
AC   B5U6Z2;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   04-NOV-2008, sequence version 1.
DT   16-OCT-2013, entry version 28.
DE   RecName: Full=Acidic phospholipase A2 MVL-PLA2;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Macrovipera lebetina transmediterranea (Blunt-nosed viper) (Vipera
OS   lebetina transmediterranea).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Viperinae; Macrovipera.
OX   NCBI_TaxID=384075;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-34; 59-72; 83-93
RP   AND 100-112, FUNCTION, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=19351557; DOI=10.1016/j.matbio.2009.03.007;
RA   Bazaa A., Luis J., Srairi-Abid N., Kallech-Ziri O.,
RA   Kessentini-Zouari R., Defilles C., Lissitzky J.C., El Ayeb M.,
RA   Marrakchi N.;
RT   "MVL-PLA2, a phospholipase A2 from Macrovipera lebetina
RT   transmediterranea venom, inhibits tumor cells adhesion and
RT   migration.";
RL   Matrix Biol. 28:188-193(2009).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that displays an
CC       inhibitory effect, independent from its catalytic activity, on
CC       tumor cell adhesion and migration. This effect is mediated via
CC       specific inhibition of integrins alpha-5/beta-1 (ITGA5/ITGB1),
CC       alpha-v/beta-3 (ITGAV/ITGB3) and alpha-v/beta-6 (ITGAV/ITGB6).
CC       PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl
CC       groups in 3-sn-phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted (By similarity).
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13626.64; Method=MALDI; Range=17-138;
CC       Source=PubMed:19351557;
CC   -!- MISCELLANEOUS: Concentrations up to 2 uM during 4 days does not
CC       induce detectable cytotoxicity on human melanoma and fibrosarcoma
CC       cell lines (PubMed:19351557).
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FM202092; CAR40186.1; -; mRNA.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Cell adhesion impairing toxin; Direct protein sequencing;
KW   Disulfide bond; Hydrolase; Lipid degradation; Lipid metabolism;
KW   Metal-binding; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Acidic phospholipase A2 MVL-PLA2.
FT                                /FTId=PRO_0000419283.
FT   MOTIF        86     88       May inhibit integrin function (Atypical
FT                                cell attachment site).
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15399 MW;  8D801E95C09E9DE0 CRC64;
     MRTLWIVAVC LMGVEGHLTQ FGDMINKKTG TFGLLSYVYY GCYCGLGGKG KPQDATDRCC
     FVHDCCYGTV NGCDPKLSTY SYSFQNGDIV CGDDDPCLRA VCECDRVAAI CFGENMNTYD
     KKYMLYSLFD CMEESEKC
//
ID   PA2A_TRIGS              Reviewed;         139 AA.
AC   A8E2V8;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 1.
DT   16-APR-2014, entry version 35.
DE   RecName: Full=Acidic phospholipase A2 Tgc-E6;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Trimeresurus gracilis (Kikuchi habu).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=109781;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-46, FUNCTION,
RP   SUBUNIT, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=22115990; DOI=10.1016/j.toxicon.2011.10.016;
RA   Tsai I.-H., Tsai T.-S., Wang Y.-M., Tu M.-C., Chang H.-C.;
RT   "Cloning and characterization of Trimeresurus gracilis venom
RT   phospholipases A(2): comparison with Ovophis okinavensis venom and the
RT   systematic implications.";
RL   Toxicon 59:151-157(2012).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits the
CC       ADP-(IC(50)=272 nM) and collagen-induced (IC(50)=518 nM) human
CC       platelet aggregation in platelet rich plasma. Exhibits very high
CC       hydrolytic activities toward the synthetic lecithin, and prefers
CC       the anionic micelles (dPPC with deoxycholate) to the zwitterionic
CC       micelles (dPPC with Triton X-100). PLA2 catalyzes the calcium-
CC       dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13891; Method=MALDI; Range=17-139;
CC       Note=Oxidized forms with mass increases of 16, 32 and 48 are also
CC       detected; Source=PubMed:22115990;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY764141; AAW92121.1; -; mRNA.
DR   ProteinModelPortal; A8E2V8; -.
DR   SMR; A8E2V8; 17-139.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; TAS:UniProtKB.
DR   GO; GO:0043655; C:extracellular space of host; TAS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; NAS:UniProtKB.
DR   GO; GO:0004623; F:phospholipase A2 activity; IDA:UniProtKB.
DR   GO; GO:0044477; P:envenomation resulting in negative regulation of platelet aggregation in other organism; IDA:UniProtKB.
DR   GO; GO:0016042; P:lipid catabolic process; IDA:UniProtKB.
DR   GO; GO:0006644; P:phospholipid metabolic process; IDA:UniProtKB.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Direct protein sequencing; Disulfide bond;
KW   Hemostasis impairing toxin; Hydrolase; Metal-binding;
KW   Platelet aggregation inhibiting toxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    139       Acidic phospholipase A2 Tgc-E6.
FT                                /FTId=PRO_0000419052.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    132       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    139       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   139 AA;  15689 MW;  7E0672B83F05D0B4 CRC64;
     MRTLWIMAVL LLGVEGSLMQ FEMLIMKLAK SSGMFWYSAY GCYCGWGGQG RPQDATDRCC
     FVHDCCYGKA TGCDPKKDVY TYSEENGDIV CGGDDPCRKE VCECDKAAAI CFRDNMDTYN
     SKTYWMFPAK NCQEESEPC
//
ID   PA2A_TRIBO              Reviewed;         138 AA.
AC   Q2YHJ3;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   16-OCT-2013, entry version 48.
DE   RecName: Full=Acidic phospholipase A2 Tbo-E6;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Trimeresurus borneensis (Borneo pit viper).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=109778;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION,
RP   SUBUNIT, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=15955061; DOI=10.1111/j.1742-4658.2005.04715.x;
RA   Wang Y.-M., Peng H.-F., Tsai I.-H.;
RT   "Unusual venom phospholipases A2 of two primitive tree vipers
RT   Trimeresurus puniceus and Trimeresurus borneensis.";
RL   FEBS J. 272:3015-3025(2005).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that impairs
CC       hemostasis. It weakly inhibits ADP-induced platelet aggregation
CC       when tested on platelet rich plasma from human and rabbit blood
CC       (15-25% of inhibition at 5-10 ug of enzyme), and dose-dependently
CC       inhibits blood coagulation, possibly by inhibiting thrombin
CC       activation. Exhibits high hydrolytic activities toward L-
CC       dipalmitoyl phosphatidylcholine. PLA2 catalyzes the calcium-
CC       dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13723.0; Method=Electrospray; Range=17-
CC       138; Source=PubMed:15955061;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY355178; AAR14172.1; -; mRNA.
DR   ProteinModelPortal; Q2YHJ3; -.
DR   SMR; Q2YHJ3; 17-138.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Blood coagulation cascade inhibiting toxin; Direct protein sequencing;
KW   Disulfide bond; Hemostasis impairing toxin; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding;
KW   Platelet aggregation inhibiting toxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Acidic phospholipase A2 Tbo-E6.
FT                                /FTId=PRO_0000419056.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15504 MW;  3BC9804043E5E013 CRC64;
     MRTLWILAVL LLGVKGNLLQ FEMMINKMAG RSGIRWYSDY GCYCGKGGHG QPQDATDRCC
     FVHDCCYGKV SGCDPKMAFY KYSSDKNDIV CGGNNPCLKE ICECDRAAAI CFRDNLSTYD
     NKYWNVPSET CQVESEPC
//
ID   PA2B1_DABRR             Reviewed;         138 AA.
AC   A8CG89;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 1.
DT   16-OCT-2013, entry version 34.
DE   RecName: Full=Basic phospholipase A2 Drk-b1;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Daboia russelii (Russel's viper) (Vipera russelii).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Viperinae; Daboia.
OX   NCBI_TaxID=31159;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-27, FUNCTION, AND
RP   MASS SPECTROMETRY.
RC   STRAIN=Kolkata; TISSUE=Venom, and Venom gland;
RX   PubMed=17611171; DOI=10.1016/j.bbapap.2007.04.012;
RA   Tsai I.-H., Tsai H.-Y., Wang Y.-M., Pe T., Warrell D.-A.;
RT   "Venom phospholipases of Russell's vipers from Myanmar and eastern
RT   India--cloning, characterization and phylogeographic analysis.";
RL   Biochim. Biophys. Acta 1774:1020-1028(2007).
CC   -!- FUNCTION: Exhibits high hydrolytic activities and shows strong
CC       preference for the anionic micelles (dPPC with deoxycholate) to
CC       the zwitterionic micelles (dPPC with Triton X-100). PLA2 catalyzes
CC       the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=14077; Method=Electrospray; Range=17-138;
CC       Source=PubMed:17611171;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ090660; AAZ53182.1; -; mRNA.
DR   ProteinModelPortal; A8CG89; -.
DR   SMR; A8CG89; 17-138.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding; Secreted; Signal;
KW   Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 Drk-b1.
FT                                /FTId=PRO_0000419217.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
FT   CONFLICT     26     27       DA -> NQ (in Ref. 1; AA sequence).
SQ   SEQUENCE   138 AA;  15864 MW;  8D4CB27D00D4E28B CRC64;
     MRTLWIVAMC LIGVEGNLFQ FARMIDAKQE AFSFFKYISY GCYCGWGGQG TPKDASDRCC
     FVHDCCYARV KGCNPKLVEY SYSYRTGKIV CETYNRCKRA VCECDRVAAI CLGQNVNTYN
     KGYMFLSSYY CRQKSEQC
//
ID   PA2B1_DABSI             Reviewed;         138 AA.
AC   A8CG82;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 1.
DT   16-OCT-2013, entry version 36.
DE   RecName: Full=Basic phospholipase A2 DsM-b1/DsM-b1';
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Daboia siamensis (Eastern Russel's viper) (Daboia russelii siamensis).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Viperinae; Daboia.
OX   NCBI_TaxID=343250;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-27, FUNCTION, AND
RP   MASS SPECTROMETRY.
RC   STRAIN=Myanmar; TISSUE=Venom, and Venom gland;
RX   PubMed=17611171; DOI=10.1016/j.bbapap.2007.04.012;
RA   Tsai I.-H., Tsai H.-Y., Wang Y.-M., Pe T., Warrell D.-A.;
RT   "Venom phospholipases of Russell's vipers from Myanmar and eastern
RT   India--cloning, characterization and phylogeographic analysis.";
RL   Biochim. Biophys. Acta 1774:1020-1028(2007).
CC   -!- FUNCTION: Exhibits high hydrolytic activities and shows strong
CC       preference for the anionic micelles (dPPC with deoxycholate) to
CC       the zwitterionic micelles (dPPC with Triton X-100). PLA2 catalyzes
CC       the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=14084; Method=Electrospray; Range=1-138;
CC       Source=PubMed:17611171;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -!- CAUTION: Sequence obtained after translation (DsM-b1) and sequence
CC       directly sequenced from protein (Dsm-b1', AA 17-27) correspond
CC       exactly. However, the mass found for the protein (14084) does not
CC       correspond to the expected mass calculated after translation
CC       (14055) (PubMed:17611171).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ090656; AAZ53178.1; -; mRNA.
DR   ProteinModelPortal; A8CG82; -.
DR   SMR; A8CG82; 17-138.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding; Secreted; Signal;
KW   Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 DsM-b1/DsM-b1'.
FT                                /FTId=PRO_0000419220.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15843 MW;  E32CA3AB4D2A005E CRC64;
     MRTLWIVAMC LIGVEGNLFQ FARLIDAKQE AFSFFKYISY GCYCGWGGQG TPKDATDRCC
     FVHDCCYARV KGCNPKLVEY SYGYRTGKIV CENYNRCKRA VCECDRVAAI CLGQNVNTYN
     KGYMFLSSYY CRQKSEQC
//
ID   PA2B1_PROEL             Reviewed;         137 AA.
AC   Q2PG81; Q2PG82;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2012, sequence version 2.
DT   16-OCT-2013, entry version 47.
DE   RecName: Full=Basic phospholipase A2 PeBP(R)-I/II;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Protobothrops elegans (Elegant pitviper) (Trimeresurus elegans).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Protobothrops.
OX   NCBI_TaxID=88086;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-63, AND FUNCTION.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=16962627; DOI=10.1016/j.toxicon.2006.06.021;
RA   Chijiwa T., Tokunaga E., Ikeda R., Terada K., Ogawa T., Oda-Ueda N.,
RA   Hattori S., Nozaki M., Ohno M.;
RT   "Discovery of novel [Arg49]phospholipase A2 isozymes from
RT   Protobothrops elegans venom and regional evolution of Crotalinae snake
RT   venom phospholipase A2 isozymes in the southwestern islands of Japan
RT   and Taiwan.";
RL   Toxicon 48:672-682(2006).
CC   -!- FUNCTION: Snake venom phospholipases A2 that have myotoxic, and
CC       edema-inducing activity, as well as extremely weak lipolytic
CC       activity. PLA2 catalyzes the calcium-dependent hydrolysis of the
CC       2-acyl groups in 3-sn-phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MISCELLANEOUS: The sequence shown is that of PeBP(R)-I. PeBP(R)-II
CC       differs at two positions.
CC   -!- MISCELLANEOUS: Does not show hemorrhagic activity
CC       (PubMed:16962627).
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. R49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB219806; BAE72889.1; -; mRNA.
DR   EMBL; AB219807; BAE72890.1; -; mRNA.
DR   ProteinModelPortal; Q2PG81; -.
DR   SMR; Q2PG81; 17-137.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Hydrolase; Myotoxin;
KW   Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    137       Basic phospholipase A2 PeBP(R)-I/II.
FT                                /FTId=PRO_0000419050.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    137       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
FT   VARIANT      19     19       V -> I (in PeBP(R)-II).
SQ   SEQUENCE   137 AA;  15486 MW;  CF1E1555B9E7AA97 CRC64;
     MRTLWIMAVL LLGVEGSLVE LWKMVFQETG KEAVKNYGLY GCNCGVGKRG KPVDATDRCC
     FVHRCCYKKV TGCDPKKDRY SYSWENKAIV CGEKNPCLKQ VCECDKAVAI CLRENLGTYN
     KNHRVTVKFL CKAPESC
//
ID   PA2B2_DABRR             Reviewed;         137 AA.
AC   A8CG90;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 1.
DT   16-OCT-2013, entry version 34.
DE   RecName: Full=Basic phospholipase A2 Drk-b2;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Daboia russelii (Russel's viper) (Vipera russelii).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Viperinae; Daboia.
OX   NCBI_TaxID=31159;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-27, FUNCTION, AND
RP   MASS SPECTROMETRY.
RC   STRAIN=Kolkata; TISSUE=Venom, and Venom gland;
RX   PubMed=17611171; DOI=10.1016/j.bbapap.2007.04.012;
RA   Tsai I.-H., Tsai H.-Y., Wang Y.-M., Pe T., Warrell D.-A.;
RT   "Venom phospholipases of Russell's vipers from Myanmar and eastern
RT   India--cloning, characterization and phylogeographic analysis.";
RL   Biochim. Biophys. Acta 1774:1020-1028(2007).
CC   -!- FUNCTION: Exhibits high hydrolytic activities and shows strong
CC       preference for the anionic micelles (dPPC with deoxycholate) to
CC       the zwitterionic micelles (dPPC with Triton X-100). PLA2 catalyzes
CC       the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13704; Method=Electrospray; Range=17-137;
CC       Source=PubMed:17611171;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ090661; AAZ53183.1; -; mRNA.
DR   ProteinModelPortal; A8CG90; -.
DR   SMR; A8CG90; 17-137.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding; Secreted; Signal;
KW   Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    137       Basic phospholipase A2 Drk-b2.
FT                                /FTId=PRO_0000419218.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    137       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
FT   CONFLICT     26     27       FR -> NQ (in Ref. 1; AA sequence).
SQ   SEQUENCE   137 AA;  15461 MW;  E948F7D2B6B63DCD CRC64;
     MRTLWIVAVC LIGVEGNLLQ FGRMIFRMTA KNPLSSYSNY GCYCGWGGKG KPQDATDRCC
     FVHDCCYEKV NDCNPKTATY SYSFENGGIV CGDRDPCKRA VCECDRVAAT CFRDNLNTYD
     KKYRKYPPSQ CTGTEQC
//
ID   PA2B1_PROFL             Reviewed;         138 AA.
AC   P0DJJ8; B6F140; P20381;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2012, sequence version 1.
DT   16-OCT-2013, entry version 9.
DE   RecName: Full=Basic phospholipase A2 BP-I;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Basic protein I;
DE            Short=BPI;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Protobothrops flavoviridis (Habu) (Trimeresurus flavoviridis).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Protobothrops.
OX   NCBI_TaxID=88087;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Tokunoshima; TISSUE=Venom gland;
RX   PubMed=1528861; DOI=10.1073/pnas.89.18.8557;
RA   Ogawa T., Oda N., Nakashima K., Sasaki H., Hattori M., Sakaki Y.,
RA   Kihara H., Ohno M.;
RT   "Unusually high conservation of untranslated sequences in cDNAs for
RT   Trimeresurus flavoviridis phospholipase A2 isozymes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:8557-8561(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Tokunoshima; TISSUE=Liver;
RX   PubMed=8327468; DOI=10.1073/pnas.90.13.5964;
RA   Nakashima K., Ogawa T., Oda N., Hattori M., Sakaki Y., Kihara H.,
RA   Ohno M.;
RT   "Accelerated evolution of Trimeresurus flavoviridis venom gland
RT   phospholipase A2 isozymes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:5964-5968(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=7777556; DOI=10.1073/pnas.92.12.5605;
RA   Nakashima K., Nobuhisa I., Deshimaru M., Nakai M., Ogawa T.,
RA   Shimohigashi Y., Fukumaki Y., Hattori M., Sakaki Y., Hattori S.,
RA   Ohno M.;
RT   "Accelerated evolution in the protein-coding regions is universal in
RT   crotalinae snake venom gland phospholipase A2 isozyme genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:5605-5609(1995).
RN   [4]
RP   PROTEIN SEQUENCE OF 17-138, FUNCTION, AND COFACTOR.
RC   TISSUE=Venom;
RX   PubMed=2330604; DOI=10.1016/0041-0101(90)90005-R;
RA   Yoshizumi K., Liu S.-Y., Miyata T., Saita S., Ohno M., Iwanaga S.,
RA   Kihara H.;
RT   "Purification and amino acid sequence of basic protein I, a lysine-49-
RT   phospholipase A2 with low activity, from the venom of Trimeresurus
RT   flavoviridis (Habu snake).";
RL   Toxicon 28:43-54(1990).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that has strong
CC       myotoxic activity with a low phospholipase A2 activity. PLA2
CC       catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in
CC       3-sn-phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MISCELLANEOUS: Is abundantly expressed in Tokunoshima and Amami-
CC       Oshima P.flavoviridis venom, but is missing in Okinawa
CC       P.flavoviridis venom. It is thought that loss of BP-I in Okinawa
CC       P.flavoviridis is due to lack of necessity for a strong toxicity
CC       exerted by BP-I in the venom as far as they feed mostly on frogs.
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. K49 sub-subfamily.
CC   -!- CAUTION: Binds calcium very weakly as one of the calcium-binding
CC       ligands is lost (Asp->Lys in position 64, which corresponds to
CC       'Lys-49' in the current nomenclature).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D10718; BAA01561.1; -; mRNA.
DR   EMBL; D13383; BAA02651.1; -; Genomic_DNA.
DR   PIR; D48188; D48188.
DR   ProteinModelPortal; P0DJJ8; -.
DR   SMR; P0DJJ8; 17-138.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding; Myotoxin;
KW   Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 BP-I.
FT                                /FTId=PRO_0000022953.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    106    106       By similarity.
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   DISULFID     42    132       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    112       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    105       By similarity.
FT   DISULFID     73     98       By similarity.
FT   DISULFID     91    103       By similarity.
SQ   SEQUENCE   138 AA;  15537 MW;  D91791C6D13B7D06 CRC64;
     MRTLWIMAVL LLGVDGSLVQ LWKMIFQETG KEAAKNYGLY GCNCGVGRRG KPKDATDSCC
     YVHKCCYKKV TGCDPKMDSY SYSWKNKAIV CGEKNPPCLK QVCECDKAVA ICLRENLGTY
     NKKYTIYPKP FCKKADTC
//
ID   PA2B2_PROFL             Reviewed;         138 AA.
AC   P0DJJ9; B6F140; P20381;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2012, sequence version 1.
DT   16-OCT-2013, entry version 9.
DE   RecName: Full=Basic phospholipase A2 BP-II;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Basic protein II;
DE            Short=BPII;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Protobothrops flavoviridis (Habu) (Trimeresurus flavoviridis).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Protobothrops.
OX   NCBI_TaxID=88087;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Tokunoshima; TISSUE=Venom gland;
RX   PubMed=1528861; DOI=10.1073/pnas.89.18.8557;
RA   Ogawa T., Oda N., Nakashima K., Sasaki H., Hattori M., Sakaki Y.,
RA   Kihara H., Ohno M.;
RT   "Unusually high conservation of untranslated sequences in cDNAs for
RT   Trimeresurus flavoviridis phospholipase A2 isozymes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:8557-8561(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Tokunoshima; TISSUE=Liver;
RX   PubMed=8327468; DOI=10.1073/pnas.90.13.5964;
RA   Nakashima K., Ogawa T., Oda N., Hattori M., Sakaki Y., Kihara H.,
RA   Ohno M.;
RT   "Accelerated evolution of Trimeresurus flavoviridis venom gland
RT   phospholipase A2 isozymes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:5964-5968(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=7777556; DOI=10.1073/pnas.92.12.5605;
RA   Nakashima K., Nobuhisa I., Deshimaru M., Nakai M., Ogawa T.,
RA   Shimohigashi Y., Fukumaki Y., Hattori M., Sakaki Y., Hattori S.,
RA   Ohno M.;
RT   "Accelerated evolution in the protein-coding regions is universal in
RT   crotalinae snake venom gland phospholipase A2 isozyme genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:5605-5609(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Amami-Oshima; TISSUE=Liver;
RX   PubMed=20406671; DOI=10.1016/j.gene.2010.04.001;
RA   Ikeda N., Chijiwa T., Matsubara K., Oda-Ueda N., Hattori S.,
RA   Matsuda Y., Ohno M.;
RT   "Unique structural characteristics and evolution of a cluster of venom
RT   phospholipase A2 isozyme genes of Protobothrops flavoviridis snake.";
RL   Gene 461:15-25(2010).
RN   [5]
RP   PROTEIN SEQUENCE OF 17-138, FUNCTION, AND COFACTOR.
RC   TISSUE=Venom;
RX   PubMed=2341374;
RA   Liu S.-Y., Yoshizumi K., Oda N., Ohno M., Tokunaga F., Iwanaga S.,
RA   Kihara H.;
RT   "Purification and amino acid sequence of basic protein II, a lysine-
RT   49-phospholipase A2 with low activity, from Trimeresurus flavoviridis
RT   venom.";
RL   J. Biochem. 107:400-408(1990).
RN   [6]
RP   FUNCTION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Amami-Oshima, and Tokunoshima; TISSUE=Venom;
RX   PubMed=19463843; DOI=10.1016/j.toxicon.2009.05.003;
RA   Murakami T., Kariu T., Takazaki S., Hattori S., Chijiwa T., Ohno M.,
RA   Oda-Ueda N.;
RT   "Island specific expression of a novel [Lys(49)]phospholipase A(2)
RT   (BPIII) in Protobothrops flavoviridis venom in Amami-Oshima, Japan.";
RL   Toxicon 54:399-407(2009).
RN   [7]
RP   ERRATUM.
RA   Murakami T., Kariu T., Takazaki S., Hattori S., Chijiwa T., Ohno M.,
RA   Oda-Ueda N.;
RL   Toxicon 55:171-172(2010).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that shows
CC       anticoagulant activities, strong myolytic activity, infiltration
CC       of polymorphonuclear cells, and edema in stromal tissues. Induces
CC       cell death of Jurkat cells in a concentration dependent manner.
CC       Shows a low phospholipase A2 activity. PLA2 catalyzes the calcium-
CC       dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MISCELLANEOUS: Is abundantly expressed in Tokunoshima and Amami-
CC       Oshima P.flavoviridis venom, but is missing in Okinawa
CC       P.flavoviridis venom. It is thought that loss of BP-II in Okinawa
CC       P.flavoviridis is due to lack of necessity for a strong toxicity
CC       exerted by BP-II in the venom as far as they feed mostly on frogs.
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. K49 sub-subfamily.
CC   -!- CAUTION: Binds calcium very weakly as one of the calcium-binding
CC       ligands is lost (Asp->Lys in position 64, which corresponds to
CC       'Lys-49' in the current nomenclature).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D10719; BAA01562.1; -; mRNA.
DR   EMBL; D13384; BAA02652.1; -; Genomic_DNA.
DR   EMBL; AB440236; BAG82668.1; -; Genomic_DNA.
DR   PIR; E48188; E48188.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Blood coagulation cascade inhibiting toxin; Direct protein sequencing;
KW   Disulfide bond; Hemostasis impairing toxin; Hydrolase; Metal-binding;
KW   Myotoxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 BP-II.
FT                                /FTId=PRO_0000419282.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    106    106       By similarity.
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   DISULFID     42    132       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    112       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    105       By similarity.
FT   DISULFID     73     98       By similarity.
FT   DISULFID     91    103       By similarity.
SQ   SEQUENCE   138 AA;  15522 MW;  C21971C82A3B72E6 CRC64;
     MRTLWIMAVL LVGVDGSLVQ LWKMIFQETG KEAAKNYGLY GCNCGVGRRG KPKDATDSCC
     YVHKCCYKKV TGCNPKMDSY SYSWKNKAIV CGEKNPPCLK QVCECDKAVA ICLRENLGTY
     NKKYTIYPKP FCKKADTC
//
ID   PA2BB_SISCT             Reviewed;         138 AA.
AC   Q6EER2;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 1.
DT   16-OCT-2013, entry version 50.
DE   RecName: Full=Basic phospholipase A2 sistruxin B;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Sistrurus catenatus tergeminus (Western massasauga) (Crotalus
OS   tergeminus).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae; Sistrurus.
OX   NCBI_TaxID=8757;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=15032748;
RA   Chen Y.-H., Wang Y.-M., Hseu M.-J., Tsai I.-H.;
RT   "Molecular evolution and structure-function relationships of crotoxin-
RT   like and asparagine-6-containing phospholipases A2 in pit viper
RT   venoms.";
RL   Biochem. J. 381:25-34(2004).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that shows
CC       presynaptic neurotoxicity. PLA2 catalyzes the calcium-dependent
CC       hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Vmax=385 umol/min/mg enzyme with DPPC + deoxycholate as
CC         substrate (at pH 7.4 and 37 degrees Celsius);
CC         Vmax=192 umol/min/mg enzyme with DPPC + Triton X-100 as
CC         substrate (at pH 7.4 and 37 degrees Celsius);
CC         Note=When tested as a monomer;
CC   -!- SUBUNIT: Heterodimer of an acidic subunit and a basic chain. The
CC       acidic subunit is non-toxic, without enzymatic activity and
CC       comprises 3 peptides that are cross-linked by 7 disulfide bridges.
CC       The basic subunit is toxic, has phospholipase A2 activity and is
CC       composed of a single chain.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=14122; Method=Electrospray; Range=17-138;
CC       Source=PubMed:15032748;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY355170; AAR14164.1; -; mRNA.
DR   ProteinModelPortal; Q6EER2; -.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0072556; C:other organism presynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Direct protein sequencing; Disulfide bond; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding; Neurotoxin;
KW   Presynaptic neurotoxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 sistruxin B.
FT                                /FTId=PRO_0000418572.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
FT   CONFLICT     31     31       K -> A (in Ref. 1; AA sequence).
SQ   SEQUENCE   138 AA;  15844 MW;  2F482EB371CBFED4 CRC64;
     MRALWIVAVL LVGVEGNLLQ FNKMIKFETN KNAIPFYAFY GCYCGWGGRG RPKDATDRCC
     FVHDCCYGKL PNCDTKWDIY SYSLKSGFIT CGKGTWCEEQ ICECDRVAAE CLRRSLSTYK
     YGYMFYLDSR CKGPSEQC
//
ID   PA2BN_CROVV             Reviewed;         138 AA.
AC   Q71QE8;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   16-OCT-2013, entry version 54.
DE   RecName: Full=Basic phospholipase A2 Cvv-N6;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Cvv myotoxin;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Crotalus viridis viridis (Prairie rattlesnake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae; Crotalus.
OX   NCBI_TaxID=8742;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=15032748;
RA   Chen Y.-H., Wang Y.-M., Hseu M.-J., Tsai I.-H.;
RT   "Molecular evolution and structure-function relationships of crotoxin-
RT   like and asparagine-6-containing phospholipases A2 in pit viper
RT   venoms.";
RL   Biochem. J. 381:25-34(2004).
RN   [2]
RP   PROTEIN SEQUENCE OF 17-49, FUNCTION, SUBUNIT, AND CRYSTALLIZATION.
RC   TISSUE=Venom;
RX   PubMed=9028014; DOI=10.1016/S0041-0101(96)00054-2;
RA   Ownby C.L., Colberg T.R., White S.P.;
RT   "Isolation, characterization and crystallization of a phospholipase A2
RT   myotoxin from the venom of the prairie rattlesnake (Crotalus viridis
RT   viridis).";
RL   Toxicon 35:111-124(1997).
RN   [3]
RP   PROTEIN SEQUENCE OF 17-39, FUNCTION, COFACTOR, AND MASS SPECTROMETRY.
RC   STRAIN=Colorado, New Mexico, South Dakota, Southeastern Arizona,
RC   Texas, Western Oklahoma, and Wyoming; TISSUE=Venom, and Venom gland;
RX   PubMed=12623078; DOI=10.1016/S0003-9861(02)00747-6;
RA   Tsai I.-H., Wang Y.-M., Chen Y.-H., Tu A.T.;
RT   "Geographic variations, cloning, and functional analyses of the venom
RT   acidic phospholipases A2 of Crotalus viridis viridis.";
RL   Arch. Biochem. Biophys. 411:289-296(2003).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that induces
CC       myonecrosis in mice activities and moderate edema-inducing
CC       activity in rat paws. PLA2 catalyzes the calcium-dependent
CC       hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Vmax=280 umol/min/mg enzyme with DPPC + deoxycholate as
CC         substrate (at pH 7.4 and 37 degrees Celsius);
CC         Vmax=88 umol/min/mg enzyme with DPPC + Triton X-100 as substrate
CC         (at pH 7.4 and 37 degrees Celsius);
CC         Note=When tested as a monomer;
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=14200; Method=Electrospray; Range=17-138;
CC       Source=PubMed:15032748, PubMed:12623078;
CC   -!- MISCELLANEOUS: Does not show neurotoxic activities
CC       (PubMed:15032748 and PubMed:9028014).
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF403138; AAQ13337.1; -; mRNA.
DR   ProteinModelPortal; Q71QE8; -.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Direct protein sequencing; Disulfide bond; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding; Myotoxin;
KW   Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 Cvv-N6.
FT                                /FTId=PRO_0000418574.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
FT   CONFLICT     28     28       M -> E (in Ref. 1; AA sequence).
FT   CONFLICT     38     38       T -> A (in Ref. 1; AA sequence).
FT   CONFLICT     47     47       G -> W (in Ref. 2; AA sequence).
SQ   SEQUENCE   138 AA;  16000 MW;  7B5E4097E66A5B7A CRC64;
     MRTFWIVALL LVGVEGNLLQ FNKMIKMMTK KNAFPFYTSY GCYCGWGGRG RPKDATDRCC
     FVHDCCYEKL TNCSPKTDIY SYSWKRGVII CGKGTPCEKQ ICECDRAAAV CFRENLPTYK
     KRYMFYLDFL CTDPSEKC
//
ID   PA2B_BOTSC              Reviewed;         138 AA.
AC   Q6EER4;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 1.
DT   16-OCT-2013, entry version 49.
DE   RecName: Full=Basic phospholipase A2 Bs-N6;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Bothriechis schlegelii (Eyelash palm pitviper).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Bothriechis.
OX   NCBI_TaxID=44725;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=15032748;
RA   Chen Y.-H., Wang Y.-M., Hseu M.-J., Tsai I.-H.;
RT   "Molecular evolution and structure-function relationships of crotoxin-
RT   like and asparagine-6-containing phospholipases A2 in pit viper
RT   venoms.";
RL   Biochem. J. 381:25-34(2004).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that shows myotoxic
CC       activities. PLA2 catalyzes the calcium-dependent hydrolysis of the
CC       2-acyl groups in 3-sn-phosphoglycerides (By similarity).
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Vmax=208 umol/min/mg enzyme with DPPC + deoxycholate as
CC         substrate (at pH 7.4 and 37 degrees Celsius);
CC         Vmax=116 umol/min/mg enzyme with DPPC + Triton X-100 as
CC         substrate (at pH 7.4 and 37 degrees Celsius);
CC         Note=When tested as a monomer;
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- PTM: Contains 7 disulfide bonds (By similarity).
CC   -!- MASS SPECTROMETRY: Mass=13785; Method=Electrospray; Range=17-138;
CC       Source=PubMed:15032748;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY355168; AAR14162.1; -; mRNA.
DR   ProteinModelPortal; Q6EER4; -.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Direct protein sequencing; Disulfide bond; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding; Myotoxin;
KW   Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 Bs-N6.
FT                                /FTId=PRO_0000418579.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15537 MW;  C2BCB584C98BC8E3 CRC64;
     MRTLWIVAVL LVGVEGNLLQ FNKMIKIMTR KNGIPYYSSY GCYCGWGGQG QPLDATDRCC
     FVHDCCYEKL TDCSPKTDIY SYSWKSGVII CGEGTPCEKQ ICECDRVAAV CFGANLGTYK
     KSYMFYPDFL CTEPSEKC
//
ID   PA2B_BUNFA              Reviewed;         145 AA.
AC   A6MEY4;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 1.
DT   16-APR-2014, entry version 36.
DE   RecName: Full=Basic phospholipase A2 BFPA;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Antimicrobial phospholipase A2;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Bungarus fasciatus (Banded krait).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Elapidae; Bungarinae; Bungarus.
OX   NCBI_TaxID=8613;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 28-47; 83-89 AND
RP   92-100, FUNCTION, SUBUNIT, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=17383773; DOI=10.1016/j.peptides.2007.02.008;
RA   Xu C., Ma D., Yu H., Li Z., Liang J., Lin G., Zhang Y., Lai R.;
RT   "A bactericidal homodimeric phospholipases A(2) from Bungarus
RT   fasciatus venom.";
RL   Peptides 28:969-973(2007).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits blood
CC       coagulation and shows bactericidal activities against both Gram-
CC       negative and -positive bacteria (E.coli, MIC=0.4 uM and S.aureus,
CC       MIC=0.1 uM). PLA2 catalyzes the calcium-dependent hydrolysis of
CC       the 2-acyl groups in 3-sn-phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion per subunit (By similarity).
CC   -!- SUBUNIT: Homodimer; disulfide-linked.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group I
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ868667; ABI64153.1; -; mRNA.
DR   ProteinModelPortal; A6MEY4; -.
DR   SMR; A6MEY4; 28-145.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Antibiotic; Antimicrobial; Blood coagulation cascade inhibiting toxin;
KW   Calcium; Direct protein sequencing; Disulfide bond;
KW   Hemostasis impairing toxin; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Metal-binding; Secreted; Signal; Toxin.
FT   SIGNAL        1     27
FT   CHAIN        28    145       Basic phospholipase A2 BFPA.
FT                                /FTId=PRO_0000419214.
FT   ACT_SITE     73     73       By similarity.
FT   ACT_SITE    119    119       By similarity.
FT   METAL        53     53       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        55     55       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        57     57       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        74     74       Calcium (By similarity).
FT   DISULFID     38     97       By similarity.
FT   DISULFID     44     44       Interchain (Probable).
FT   DISULFID     52    144       By similarity.
FT   DISULFID     54     70       By similarity.
FT   DISULFID     69    125       By similarity.
FT   DISULFID     76    118       By similarity.
FT   DISULFID     86    111       By similarity.
FT   DISULFID    104    116       By similarity.
SQ   SEQUENCE   145 AA;  15796 MW;  AB8625CC94EA8C78 CRC64;
     MNPAHLLVLL AVCVSLLGAA NIPPQSLNLY QFKNMIQCAG TQLCVAYVKY GCYCGPGGTG
     TPLDQLDRCC QTHDHCYDNA KKFGNCIPYF KTYEYTCNKP DLTCTDAKGS CARNVCDCDR
     AAAICFAAAP YNLANFGINK ETHCQ
//
ID   PA2B_TRIBO              Reviewed;         138 AA.
AC   Q2YHJ2;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   16-OCT-2013, entry version 49.
DE   RecName: Full=Basic phospholipase A2 Tbo-G6D49;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Trimeresurus borneensis (Borneo pit viper).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=109778;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION,
RP   SUBUNIT, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=15955061; DOI=10.1111/j.1742-4658.2005.04715.x;
RA   Wang Y.-M., Peng H.-F., Tsai I.-H.;
RT   "Unusual venom phospholipases A2 of two primitive tree vipers
RT   Trimeresurus puniceus and Trimeresurus borneensis.";
RL   FEBS J. 272:3015-3025(2005).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that impairs
CC       hemostasis. It weakly inhibits ADP-induced platelet aggregation
CC       when tested on platelet rich plasma from human and rabbit blood
CC       (15-25% of inhibition at 5-10 ug of enzyme), and dose-dependently
CC       inhibits blood coagulation, possibly by inhibiting thrombin
CC       activation. Exhibits strong hydrolytic activities toward L-
CC       dipalmitoyl phosphatidylcholine. PLA2 catalyzes the calcium-
CC       dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13959.6; Method=Electrospray; Range=17-
CC       138; Source=PubMed:15955061;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY355179; AAR14173.1; -; mRNA.
DR   ProteinModelPortal; Q2YHJ2; -.
DR   SMR; Q2YHJ2; 18-138.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Blood coagulation cascade inhibiting toxin; Calcium;
KW   Direct protein sequencing; Disulfide bond; Hemostasis impairing toxin;
KW   Hydrolase; Lipid degradation; Lipid metabolism; Metal-binding;
KW   Platelet aggregation inhibiting toxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 Tbo-G6D49.
FT                                /FTId=PRO_0000419055.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15742 MW;  6F2F90E4748828F5 CRC64;
     MRTLWIMAVL LVGVEGSLLE FGRMIKEETG KNPLFSYISY GCYCGWGGQG QPKDATDRCC
     FVHDCCYGKL WSCSPKTDIY FYYRKNGAIV CARGTWCEKQ ICECDKAAAI CFRENLGTYK
     DEYQSYGKSR CTEKSLKC
//
ID   PA2B_VIPRE              Reviewed;         138 AA.
AC   F8QN54;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   21-SEP-2011, sequence version 1.
DT   16-OCT-2013, entry version 13.
DE   RecName: Full=Basic phospholipase A2 vurtoxin;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Vipera renardi (Steppe viper) (Vipera ursinii renardi).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Viperinae; Vipera.
OX   NCBI_TaxID=927686;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=21185324; DOI=10.1016/j.toxicon.2010.12.012;
RA   Tsai I.-H., Wang Y.M., Cheng A.C., Starkov V., Osipov A., Nikitin I.,
RA   Makarova Y., Ziganshin R., Utkin Y.;
RT   "cDNA cloning, structural, and functional analyses of venom
RT   phospholipases A and a Kunitz-type protease inhibitor from steppe
RT   viper Vipera ursinii renardi.";
RL   Toxicon 57:332-341(2011).
CC   -!- FUNCTION: Snake venom phospholipase A2 that may have a strong
CC       anticoagulant activity.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13878; Method=MALDI; Range=17-138;
CC       Source=PubMed:21185324;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; GQ304908; ADG86232.1; -; mRNA.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Blood coagulation cascade inhibiting toxin; Disulfide bond;
KW   Hemostasis impairing toxin; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Metal-binding; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 vurtoxin.
FT                                /FTId=PRO_0000419637.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15636 MW;  39D3F5DD3E780A6D CRC64;
     MRTLWIVAVC LIGVEGSLLE FGMMILEETG KNPLTSYSFY GCYCGVGGKG TPKDATDRCC
     FVHDCCYGNL PDCNPKIDRY KYHRKNGAIV CGKGTSCENR ICECDRAAAI CFRKNLKTYN
     HIYKYYPDFL CKKESEKC
//
ID   PA2B_TRIPE              Reviewed;         138 AA.
AC   Q2YHJ7;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   16-OCT-2013, entry version 50.
DE   RecName: Full=Basic phospholipase A2 Tpu-G6D49;
DE            Short=svPLA2;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase;
DE   Flags: Precursor;
OS   Trimeresurus puniceus (Flat-nosed pitviper).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=197218;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION,
RP   SUBUNIT, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=15955061; DOI=10.1111/j.1742-4658.2005.04715.x;
RA   Wang Y.-M., Peng H.-F., Tsai I.-H.;
RT   "Unusual venom phospholipases A2 of two primitive tree vipers
RT   Trimeresurus puniceus and Trimeresurus borneensis.";
RL   FEBS J. 272:3015-3025(2005).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that impairs
CC       hemostasis. It weakly inhibits ADP-induced platelet aggregation
CC       when tested on platelet rich plasma from human and rabbit blood
CC       (15-25% of inhibition at 5-10 ug of enzyme), and dose-dependently
CC       inhibits blood coagulation, possibly by inhibiting thrombin
CC       activation. Also induces local edema a few hours after injection
CC       in the hind foot. Exhibits high hydrolytic activities toward L-
CC       dipalmitoyl phosphatidylcholine. PLA2 catalyzes the calcium-
CC       dependent hydrolysis of the 2-acyl groups in 3-sn-
CC       phosphoglycerides.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- COFACTOR: Binds 1 calcium ion (By similarity).
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13912.8; Method=Electrospray; Range=17-
CC       138; Source=PubMed:15955061;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. D49 sub-subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY355173; AAR14167.1; -; mRNA.
DR   ProteinModelPortal; Q2YHJ7; -.
DR   SMR; Q2YHJ7; 18-138.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Blood coagulation cascade inhibiting toxin; Direct protein sequencing;
KW   Disulfide bond; Hemostasis impairing toxin; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding;
KW   Platelet aggregation inhibiting toxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 Tpu-G6D49.
FT                                /FTId=PRO_0000419061.
FT   ACT_SITE     63     63       By similarity.
FT   ACT_SITE    105    105       By similarity.
FT   METAL        43     43       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        45     45       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        47     47       Calcium; via carbonyl oxygen (By
FT                                similarity).
FT   METAL        64     64       Calcium (By similarity).
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15699 MW;  6F292654748839B1 CRC64;
     MRTLWIMAVL LVGVEGSLLE FGRMIKEETG KNPLFSYISY GCYCGWGGQG QPKDATDRCC
     FVHDCCYGKL WSCSPKTDIY FYYRKNGAIV CARGTWCEKQ ICECDKAAAI CFRENLGTYK
     AEYESYGKSR CTEKSLKC
//
ID   PA2HB_PROMU             Reviewed;         138 AA.
AC   Q3HLQ4;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   08-NOV-2005, sequence version 1.
DT   16-OCT-2013, entry version 43.
DE   RecName: Full=Basic phospholipase A2 homolog TM-N49;
DE            Short=svPLA2 homolog;
DE   Flags: Precursor;
OS   Protobothrops mucrosquamatus (Taiwan habu) (Trimeresurus
OS   mucrosquamatus).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Protobothrops.
OX   NCBI_TaxID=103944;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-40, FUNCTION, AND
RP   MASS SPECTROMETRY.
RC   STRAIN=Hunan; TISSUE=Venom, and Venom gland;
RX   PubMed=16413680; DOI=10.1016/j.bbagen.2005.11.022;
RA   Wei J.-F., Wei X.-L., Chen Q.-Y., Huang T., Qiao L.-Y., Wang W.-Y.,
RA   Xiong Y.-L., He S.-H.;
RT   "N49 phospholipase A2, a unique subgroup of snake venom group II
RT   phospholipase A2.";
RL   Biochim. Biophys. Acta 1760:462-471(2006).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that exhibits potent
CC       myotoxic activity causing inflammatory cell infiltration, severe
CC       myoedema, myonecrosis and myolysis in the gastrocnemius muscles of
CC       BALB/c mice.
CC   -!- SUBUNIT: Homodimer; non-covalently linked (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13875; Method=MALDI; Range=17-138;
CC       Source=PubMed:16413680;
CC   -!- MISCELLANEOUS: Does not possess enzymatic, hemolytic and
CC       hemorrhagic activities. Fails to induce platelet aggregation by
CC       itself, and does not inhibit ADP-induced platelet aggregation
CC       (PubMed:16413680).
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. N49 sub-subfamily.
CC   -!- CAUTION: Does not bind calcium as one of the calcium-binding
CC       ligands is lost (Asp->Asn in position 64, which corresponds to
CC       'Asn-49' in the current nomenclature).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ212913; ABA60780.1; -; mRNA.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Myotoxin; Secreted; Signal;
KW   Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 homolog TM-N49.
FT                                /FTId=PRO_0000419212.
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15660 MW;  62F37D5F47866B0E CRC64;
     MRTLWIMAVL LLGVEGNLLQ FRKMIKKMTG KEPILSYATY GCNCGMAGVG QPVDGTDRCC
     FVHNCCYEKV TSCSPKWDQY IYSWENGNIV CGEKNPCKKQ ICECDKAAAM CFRDNVKTYK
     KRNIFYPKSS CTEPTDTC
//
ID   PA2HA_TRIPE             Reviewed;         138 AA.
AC   Q2YHJ9;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   16-OCT-2013, entry version 50.
DE   RecName: Full=Basic phospholipase A2 homolog Tpu-K49a;
DE            Short=svPLA2 homolog;
DE   Flags: Precursor;
OS   Trimeresurus puniceus (Flat-nosed pitviper).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=197218;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION,
RP   SUBUNIT, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=15955061; DOI=10.1111/j.1742-4658.2005.04715.x;
RA   Wang Y.-M., Peng H.-F., Tsai I.-H.;
RT   "Unusual venom phospholipases A2 of two primitive tree vipers
RT   Trimeresurus puniceus and Trimeresurus borneensis.";
RL   FEBS J. 272:3015-3025(2005).
CC   -!- FUNCTION: Snake venom phospholipase A2 homolog that lacks
CC       catalytic activity. Induces local edema a few hours after
CC       injection in the hind foot.
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=14221.5; Method=Electrospray; Range=17-
CC       138; Source=PubMed:15955061;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. K49 sub-subfamily.
CC   -!- CAUTION: Does not bind calcium as one of the calcium-binding
CC       ligands is lost (Asp->Lys in position 64, which corresponds to
CC       'Lys-49' in the current nomenclature).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY355171; AAR14165.1; -; mRNA.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Hemostasis impairing toxin;
KW   Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 homolog Tpu-K49a.
FT                                /FTId=PRO_0000419062.
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  16008 MW;  2F13F2633A621E0E CRC64;
     MRTLWIMAVL LVGVEGSVIQ LGKMILQETG KNPVKYYGAY GCNCGPLGRR KPLDATDRCC
     YMHKCCYKKL TDSNPIKDRY SYSWENKAIV CKEKNPRLKE MCECDKAVAI CFRENMRTYN
     KKERINTKIF CKKTPEPC
//
ID   PA2HB_TRIPE             Reviewed;         138 AA.
AC   Q2YHJ8;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   16-OCT-2013, entry version 49.
DE   RecName: Full=Basic phospholipase A2 homolog Tpu-K49b;
DE            Short=svPLA2 homolog;
DE   Flags: Precursor;
OS   Trimeresurus puniceus (Flat-nosed pitviper).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=197218;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION,
RP   SUBUNIT, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=15955061; DOI=10.1111/j.1742-4658.2005.04715.x;
RA   Wang Y.-M., Peng H.-F., Tsai I.-H.;
RT   "Unusual venom phospholipases A2 of two primitive tree vipers
RT   Trimeresurus puniceus and Trimeresurus borneensis.";
RL   FEBS J. 272:3015-3025(2005).
CC   -!- FUNCTION: Snake venom phospholipase A2 homolog that lacks
CC       catalytic activity. Induces mild local edema a few hours after
CC       injection in the hind foot.
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=14112.8; Method=Electrospray; Range=17-
CC       138; Source=PubMed:15955061;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. K49 sub-subfamily.
CC   -!- CAUTION: Does not bind calcium as one of the calcium-binding
CC       ligands is lost (Asp->Lys in position 64, which corresponds to
CC       'Lys-49' in the current nomenclature).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY355172; AAR14166.1; -; mRNA.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Hemostasis impairing toxin;
KW   Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 homolog Tpu-K49b.
FT                                /FTId=PRO_0000419063.
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15898 MW;  2F13F2623B7B732F CRC64;
     MRTLWIMAVL LVGVEGSVIQ LGKMILQETG KNPVKYYGAY GCNCGPLGRR KPLDATDRCC
     YMHKCCYKKL TDSNPIKDSY SYSWENKAIV CKEKNPRLKE MCECDKAVAI CFRENMDTYN
     KKERINTKIF CKKTPEPC
//
ID   PA2HF_TRIST             Reviewed;         138 AA.
AC   Q6H3D2;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   19-FEB-2014, entry version 52.
DE   RecName: Full=Basic phospholipase A2 homolog Ts-K49b;
DE            Short=svPLA2 homolog;
DE   Flags: Precursor;
OS   Trimeresurus stejnegeri (Chinese green tree viper) (Viridovipera
OS   stejnegeri).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=39682;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION, AND
RP   MASS SPECTROMETRY.
RC   STRAIN=Taiwan; TISSUE=Venom, and Venom gland;
RX   PubMed=12959640; DOI=10.1042/BJ20030818;
RA   Tsai I.-H., Wang Y.-M., Chen Y.-H., Tsai T.-S., Tu M.-C.;
RT   "Venom phospholipases A2 of bamboo viper (Trimeresurus stejnegeri):
RT   molecular characterization, geographic variations and evidence of
RT   multiple ancestries.";
RL   Biochem. J. 377:215-223(2004).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that shows weak
CC       anticoagulant and myotoxic activities.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13931; Method=Electrospray; Range=17-138;
CC       Source=PubMed:12959640;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. K49 sub-subfamily.
CC   -!- CAUTION: Does not bind calcium as one of the calcium-binding
CC       ligands is lost (Asp->Lys in position 64, which corresponds to
CC       'Lys-49' in the current nomenclature).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY211937; AAP48895.1; -; mRNA.
DR   ProteinModelPortal; Q6H3D2; -.
DR   SMR; Q6H3D2; 18-138.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Blood coagulation cascade inhibiting toxin; Direct protein sequencing;
KW   Disulfide bond; Hemostasis impairing toxin; Myotoxin; Secreted;
KW   Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 homolog Ts-K49b.
FT                                /FTId=PRO_0000419079.
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15713 MW;  3A89C2293A4E9CBF CRC64;
     MRTLWIMAVL LVGVEGGVIE LTKMFVQEMG KNALTSYSLY GCNCGPGGRR KPMDATDSCC
     HVHKCCYKKL TDCDPIKDRY SYSWVNKAIV CGEDNPCLKE MCECDKAVAI RFRENLDTYD
     KKKKINLKLF CKKTSEQC
//
ID   PA2HE_TRIST             Reviewed;         138 AA.
AC   Q6H3D4;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   16-OCT-2013, entry version 51.
DE   RecName: Full=Basic phospholipase A2 homolog Ts-K49a;
DE            Short=svPLA2 homolog;
DE   Flags: Precursor;
OS   Trimeresurus stejnegeri (Chinese green tree viper) (Viridovipera
OS   stejnegeri).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=39682;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION, AND
RP   MASS SPECTROMETRY.
RC   STRAIN=Taiwan; TISSUE=Venom, and Venom gland;
RX   PubMed=12959640; DOI=10.1042/BJ20030818;
RA   Tsai I.-H., Wang Y.-M., Chen Y.-H., Tsai T.-S., Tu M.-C.;
RT   "Venom phospholipases A2 of bamboo viper (Trimeresurus stejnegeri):
RT   molecular characterization, geographic variations and evidence of
RT   multiple ancestries.";
RL   Biochem. J. 377:215-223(2004).
CC   -!- FUNCTION: Snake venom phospholipase A2 homolog that induces local
CC       edema a few hours after injection (5-10 ug) in the hind paw, and
CC       shows weak anticoagulant and myotoxic activities.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13892; Method=Electrospray; Range=17-138;
CC       Source=PubMed:12959640;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. K49 sub-subfamily.
CC   -!- CAUTION: Does not bind calcium as one of the calcium-binding
CC       ligands is lost (Asp->Lys in position 64, which corresponds to
CC       'Lys-49' in the current nomenclature).
CC   -!- CAUTION: According to PubMed:12959640, T.stejnegeri was formerly
CC       named T.gramineus, supposing that this protein is the same as PLA-
CC       V from T.gramineus. They have been kept separated, because
CC       T.gramineus and T.stejnegeri are considered as being two different
CC       species (see http://reptile-database.org/).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY211935; AAP48893.1; -; mRNA.
DR   ProteinModelPortal; Q6H3D4; -.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Blood coagulation cascade inhibiting toxin; Direct protein sequencing;
KW   Disulfide bond; Hemostasis impairing toxin; Myotoxin; Secreted;
KW   Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 homolog Ts-K49a.
FT                                /FTId=PRO_0000419078.
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15690 MW;  238F3A2FF131113F CRC64;
     MRTLWIMAVL LLGVEGSVIE LGKMIFQETG KNPATSYGLY GCNCGPGGRR KPKDATDRCC
     YVHKCCYKKL TDCDPIKDRY SYSWVNKAIV CGEDNPCLKE MCECDKAVAI CFRENLDTYD
     KKKKINLKLF CKKTSEQC
//
ID   PA2HB_TRIBO             Reviewed;         138 AA.
AC   Q2YHJ4;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   16-OCT-2013, entry version 49.
DE   RecName: Full=Basic phospholipase A2 homolog Tbo-K49;
DE            Short=svPLA2 homolog;
DE   Flags: Precursor;
OS   Trimeresurus borneensis (Borneo pit viper).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=109778;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION,
RP   SUBUNIT, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=15955061; DOI=10.1111/j.1742-4658.2005.04715.x;
RA   Wang Y.-M., Peng H.-F., Tsai I.-H.;
RT   "Unusual venom phospholipases A2 of two primitive tree vipers
RT   Trimeresurus puniceus and Trimeresurus borneensis.";
RL   FEBS J. 272:3015-3025(2005).
CC   -!- FUNCTION: Snake venom phospholipase A2 homolog that lacks
CC       catalytic activity. It induces local edema a few hours after
CC       injection in the hind foot.
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=14034.0; Method=Electrospray; Range=17-
CC       138; Source=PubMed:15955061;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. K49 sub-subfamily.
CC   -!- CAUTION: Does not bind calcium as one of the calcium-binding
CC       ligands is lost (Asp->Lys in position 64, which corresponds to
CC       'Lys-49' in the current nomenclature).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY355177; AAR14171.1; -; mRNA.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 homolog Tbo-K49.
FT                                /FTId=PRO_0000419057.
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15818 MW;  89F727166951E57F CRC64;
     MRTLWIMAVL LVGVEGSVIE LGKMILQETG KNPVTYYSAY GCNCGPLGRR KPLDATDRCC
     FMHKCCYKKL TDSNPIKDSY SYSWENKAIV CKEKNPRLKE MCECDKAVAI CFRENMGTYN
     KKERINTKIF CKKTSEPC
//
ID   PA2HP_PROMU             Reviewed;         138 AA.
AC   Q2PWA3;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 1.
DT   16-OCT-2013, entry version 47.
DE   RecName: Full=Basic phospholipase A2 homolog promutoxin;
DE            Short=svPLA2 homolog;
DE   Flags: Precursor;
OS   Protobothrops mucrosquamatus (Taiwan habu) (Trimeresurus
OS   mucrosquamatus).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Protobothrops.
OX   NCBI_TaxID=103944;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-46, FUNCTION,
RP   SUBUNIT, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=16793192; DOI=10.1016/j.biochi.2006.05.003;
RA   Wei J.-F., Li T., Wei X.-L., Sun Q.-Y., Yang F.-M., Chen Q.-Y.,
RA   Wang W.-Y., Xiong Y.-L., He S.-H.;
RT   "Purification, characterization and cytokine release function of a
RT   novel Arg-49 phospholipase A(2) from the venom of Protobothrops
RT   mucrosquamatus.";
RL   Biochimie 88:1331-1342(2006).
CC   -!- FUNCTION: Snake venom phospholipase A2 homolog that exhibits
CC       potent myotoxicity causing myonecrosis and myoedema in the
CC       gastrocnemius muscle of mice. Is also able to stimulate the
CC       release of IL12 (IL12A-IL12B), TNF-alpha (TNF), IL6 and IL1-beta
CC       (IL1B) from human monocytes, and induce IL2, TNFalpha and IL6
CC       release from T-cells.
CC   -!- SUBUNIT: Homodimer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13656; Method=MALDI; Range=17-138;
CC       Source=PubMed:16793192;
CC   -!- MISCELLANEOUS: Fails to induce platelet aggregation, and has
CC       little effect on the ADP-induced platelet aggregation. Does not
CC       show hemorrhagic activity (PubMed:16793192).
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. R49 sub-subfamily.
CC   -!- CAUTION: Does not bind calcium as one of the calcium-binding
CC       ligands is lost (Asp->Arg in position 64, which corresponds to
CC       'Arg-49' in the current nomenclature).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ299948; ABC02868.1; -; mRNA.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Myotoxin; Secreted; Signal;
KW   Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 homolog
FT                                promutoxin.
FT                                /FTId=PRO_0000419213.
FT   DISULFID     42    132       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    112       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    105       By similarity.
FT   DISULFID     73     98       By similarity.
FT   DISULFID     91    103       By similarity.
SQ   SEQUENCE   138 AA;  15443 MW;  C218367908B7F140 CRC64;
     MRTLWIMAVL LLGVEGSVIE LGKMVFQETG KNPVKNYGLY GCNCGVGKRG KPVDATDSCC
     FVHRCCYKKV TGCDPKKDRY SYSWENKAIV CGEKNPPCLK QVCECDKAVA ICLRENLGTY
     DKKHRVTMKF LCKAPESC
//
ID   PA2HI_TRIST             Reviewed;         138 AA.
AC   Q6H3D5; P82894;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   16-OCT-2013, entry version 50.
DE   RecName: Full=Basic phospholipase A2 homolog CTs-K49a;
DE            Short=svPLA2 homolog;
DE   AltName: Full=PLA2-III;
DE   Flags: Precursor;
OS   Trimeresurus stejnegeri (Chinese green tree viper) (Viridovipera
OS   stejnegeri).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=39682;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION, AND
RP   MASS SPECTROMETRY.
RC   STRAIN=Chinese; TISSUE=Venom, and Venom gland;
RX   PubMed=12959640; DOI=10.1042/BJ20030818;
RA   Tsai I.-H., Wang Y.-M., Chen Y.-H., Tsai T.-S., Tu M.-C.;
RT   "Venom phospholipases A2 of bamboo viper (Trimeresurus stejnegeri):
RT   molecular characterization, geographic variations and evidence of
RT   multiple ancestries.";
RL   Biochem. J. 377:215-223(2004).
RN   [2]
RP   PROTEIN SEQUENCE OF 17-44.
RC   TISSUE=Venom;
RA   Li S.-Y., Guo Z.-X., Yang Y.-Y., Wang W.-Y., Xiong Y.-L.;
RT   "Isolation and sequencing of five variants of phospholipase A2 from
RT   venom of snake Trimeresurus stejnegeri.";
RL   J. Hubei Univ. 25:63-68(2003).
CC   -!- FUNCTION: Snake venom phospholipase A2 homolog that shows weak
CC       anticoagulant and myotoxic activities.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13817; Method=Electrospray; Range=17-138;
CC       Source=PubMed:12959640;
CC   -!- MISCELLANEOUS: Hemolytic and neurotoxic activities are not
CC       detected (Ref.2).
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. K49 sub-subfamily.
CC   -!- CAUTION: Does not bind calcium as one of the calcium-binding
CC       ligands is lost (Asp->Lys in position 64, which corresponds to
CC       'Lys-49' in the current nomenclature).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY211934; AAP48892.1; -; mRNA.
DR   ProteinModelPortal; Q6H3D5; -.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Blood coagulation cascade inhibiting toxin; Direct protein sequencing;
KW   Disulfide bond; Hemostasis impairing toxin; Myotoxin; Secreted;
KW   Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 homolog CTs-K49a.
FT                                /FTId=PRO_0000419082.
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15641 MW;  88E9850BE293C92E CRC64;
     MRTLWIMAVL LVVVEGSLVQ LGKMIFQETG KNPATSYGLY GCNCGPGGRR KPKDATDRCC
     FLHKCCYKKL TDCDPIKDSY SYSWVNKAIV CGGDDPHLKE MCECDKAMAI CFRENLDTYD
     KKKKINLKLF CKKTSEQC
//
ID   PA2HH_TRIST             Reviewed;         137 AA.
AC   Q6H3D7;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   16-OCT-2013, entry version 54.
DE   RecName: Full=Basic phospholipase A2 homolog CTs-R6;
DE            Short=svPLA2 homolog;
DE   Flags: Precursor;
OS   Trimeresurus stejnegeri (Chinese green tree viper) (Viridovipera
OS   stejnegeri).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=39682;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION, AND
RP   MASS SPECTROMETRY.
RC   STRAIN=Chinese; TISSUE=Venom, and Venom gland;
RX   PubMed=12959640; DOI=10.1042/BJ20030818;
RA   Tsai I.-H., Wang Y.-M., Chen Y.-H., Tsai T.-S., Tu M.-C.;
RT   "Venom phospholipases A2 of bamboo viper (Trimeresurus stejnegeri):
RT   molecular characterization, geographic variations and evidence of
RT   multiple ancestries.";
RL   Biochem. J. 377:215-223(2004).
CC   -!- FUNCTION: Snake venom phospholipase A2 homolog that induces local
CC       edema a few hours after injection (5-10 ug) in the hind paw, and
CC       shows weak anticoagulant and myotoxic activities.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13576; Method=Electrospray; Range=17-137;
CC       Source=PubMed:12959640;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. N49 sub-subfamily.
CC   -!- CAUTION: Does not bind calcium as one of the calcium-binding
CC       ligands is lost (Asp->Asn in position 64, which corresponds to
CC       'Asn-49' in the current nomenclature).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY211932; AAP48890.1; -; mRNA.
DR   PDB; 4H0S; X-ray; 1.55 A; A/B/C=1-137.
DR   PDBsum; 4H0S; -.
DR   ProteinModelPortal; Q6H3D7; -.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Blood coagulation cascade inhibiting toxin;
KW   Direct protein sequencing; Disulfide bond; Hemostasis impairing toxin;
KW   Myotoxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    137       Basic phospholipase A2 homolog CTs-R6.
FT                                /FTId=PRO_0000419081.
FT   DISULFID     42    130       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    110       By similarity.
FT   DISULFID     65    137       By similarity.
FT   DISULFID     66    103       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    101       By similarity.
FT   HELIX        18     29
FT   HELIX        33     37
FT   TURN         41     43
FT   HELIX        55     68
FT   TURN         75     77
FT   STRAND       82     85
FT   STRAND       88     91
FT   HELIX        98    113
FT   TURN        114    117
FT   HELIX       120    124
FT   HELIX       127    129
SQ   SEQUENCE   137 AA;  15301 MW;  27C25A9C679332E3 CRC64;
     MRTLLIMAVL LLGVEGSLLQ LRKMIKKMTN KEPILSYSKY GCNCGMAGRG KPVDATDTCC
     SIHNCCYGKV TSCSTKWDSY SYSWENGDIV CDEKHPCKDV CECDKAVATC FRDNLDTYKK
     RNIFHPTSSC VKVSTPC
//
ID   PA2HD_TRIST             Reviewed;         137 AA.
AC   Q6H3D6; P82892;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   16-OCT-2013, entry version 51.
DE   RecName: Full=Basic phospholipase A2 homolog Ts-R6;
DE            Short=svPLA2 homolog;
DE   AltName: Full=CTs-R6;
DE   AltName: Full=PLA2-I;
DE   Flags: Precursor;
OS   Trimeresurus stejnegeri (Chinese green tree viper) (Viridovipera
OS   stejnegeri).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=39682;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION,
RP   DEVELOPMENTAL STAGE, AND MASS SPECTROMETRY.
RC   STRAIN=Chinese, and Taiwan; TISSUE=Venom, and Venom gland;
RX   PubMed=12959640; DOI=10.1042/BJ20030818;
RA   Tsai I.-H., Wang Y.-M., Chen Y.-H., Tsai T.-S., Tu M.-C.;
RT   "Venom phospholipases A2 of bamboo viper (Trimeresurus stejnegeri):
RT   molecular characterization, geographic variations and evidence of
RT   multiple ancestries.";
RL   Biochem. J. 377:215-223(2004).
RN   [2]
RP   PROTEIN SEQUENCE OF 17-32.
RC   TISSUE=Venom;
RA   Li S.-Y., Guo Z.-X., Yang Y.-Y., Wang W.-Y., Xiong Y.-L.;
RT   "Isolation and sequencing of five variants of phospholipase A2 from
RT   venom of snake Trimeresurus stejnegeri.";
RL   J. Hubei Univ. 25:63-68(2003).
CC   -!- FUNCTION: Snake venom phospholipase A2 homolog that induces local
CC       edema a few hours after injection (5-10 ug) in the hind paw and
CC       shows weak anticoagulant and myotoxic activities.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- DEVELOPMENTAL STAGE: Is expressed more abundantly in adult than in
CC       juvenile vipers.
CC   -!- MASS SPECTROMETRY: Mass=13689; Method=Electrospray; Range=17-137;
CC       Source=PubMed:12959640;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. N49 sub-subfamily.
CC   -!- CAUTION: Does not bind calcium as one of the calcium-binding
CC       ligands is lost (Asp->Asn in position 64, which corresponds to
CC       'Asn-49' in the current nomenclature).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY211933; AAP48891.1; -; mRNA.
DR   ProteinModelPortal; Q6H3D6; -.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Blood coagulation cascade inhibiting toxin; Direct protein sequencing;
KW   Disulfide bond; Hemostasis impairing toxin; Myotoxin; Secreted;
KW   Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    137       Basic phospholipase A2 homolog Ts-R6.
FT                                /FTId=PRO_0000419077.
FT   DISULFID     42    130       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    110       By similarity.
FT   DISULFID     65    137       By similarity.
FT   DISULFID     66    103       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    101       By similarity.
SQ   SEQUENCE   137 AA;  15488 MW;  87F7DE772F7065E5 CRC64;
     MRTLWIMAVL LLGVEGHLLQ LRKMIKKMTN KEPILSYGKY GCNCGMAGRG QPVDGTDRCC
     SIHNCCYGKV NGCSPKWDYY TYSEENGDIV CEEKHPCKDV CECDKAVATC FRDNLDTYKK
     RNIFHPKSSC VKVSTPC
//
ID   PA2HG_TRIST             Reviewed;         138 AA.
AC   Q6H3D3;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   16-OCT-2013, entry version 52.
DE   RecName: Full=Basic phospholipase A2 homolog Ts-K49c;
DE            Short=svPLA2 homolog;
DE   Flags: Precursor;
OS   Trimeresurus stejnegeri (Chinese green tree viper) (Viridovipera
OS   stejnegeri).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
OC   Trimeresurus.
OX   NCBI_TaxID=39682;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-39, FUNCTION, AND
RP   MASS SPECTROMETRY.
RC   STRAIN=Taiwan; TISSUE=Venom, and Venom gland;
RX   PubMed=12959640; DOI=10.1042/BJ20030818;
RA   Tsai I.-H., Wang Y.-M., Chen Y.-H., Tsai T.-S., Tu M.-C.;
RT   "Venom phospholipases A2 of bamboo viper (Trimeresurus stejnegeri):
RT   molecular characterization, geographic variations and evidence of
RT   multiple ancestries.";
RL   Biochem. J. 377:215-223(2004).
CC   -!- FUNCTION: Snake venom phospholipase A2 (PLA2) that induces local
CC       edema a few hours after injection (5-10 ug) in the hind paw, and
CC       shows weak anticoagulant and myotoxic activities.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=13876; Method=Electrospray; Range=17-138;
CC       Source=PubMed:12959640;
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II
CC       subfamily. K49 sub-subfamily.
CC   -!- CAUTION: Does not bind calcium as one of the calcium-binding
CC       ligands is lost (Asp->Lys in position 64, which corresponds to
CC       'Lys-49' in the current nomenclature).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY211936; AAP48894.1; -; mRNA.
DR   ProteinModelPortal; Q6H3D3; -.
DR   SMR; Q6H3D3; 17-138.
DR   HOVERGEN; HBG008137; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Blood coagulation cascade inhibiting toxin; Direct protein sequencing;
KW   Disulfide bond; Hemostasis impairing toxin; Myotoxin; Secreted;
KW   Signal; Toxin.
FT   SIGNAL        1     16
FT   CHAIN        17    138       Basic phospholipase A2 homolog Ts-K49c.
FT                                /FTId=PRO_0000419080.
FT   DISULFID     42    131       By similarity.
FT   DISULFID     44     60       By similarity.
FT   DISULFID     59    111       By similarity.
FT   DISULFID     65    138       By similarity.
FT   DISULFID     66    104       By similarity.
FT   DISULFID     73     97       By similarity.
FT   DISULFID     91    102       By similarity.
SQ   SEQUENCE   138 AA;  15674 MW;  39545783F131113F CRC64;
     MRTLWIMAVL LLGVEGSVIE LGKMIFQETG KNPATSYGLY GCNCGPGGRR KPKDATDRCC
     YVHKCCYKKL TDCDPIKDRY SYSWVNKAIV CGEDNPCPKE MCECDKAVAI CFRENLDTYD
     KKKKINLKLF CKKTSEQC
//
ID   PA2HB_MICTN             Reviewed;         149 AA.
AC   G9I930;
DT   18-APR-2012, integrated into UniProtKB/Swiss-Prot.
DT   22-FEB-2012, sequence version 1.
DT   16-APR-2014, entry version 16.
DE   RecName: Full=Basic phospholipase A2 homolog Tx-beta;
DE            Short=svPLA2 homolog;
DE   AltName: Full=MitTx-beta;
DE   Flags: Precursor;
OS   Micrurus tener tener (Texas coral snake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Elapidae; Elapinae; Micrurus.
OX   NCBI_TaxID=1114302;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF N-TERMINUS, FUNCTION,
RP   AND SUBUNIT.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=22094702; DOI=10.1038/nature10607;
RA   Bohlen C.J., Chesler A.T., Sharif-Naeini R., Medzihradszky K.F.,
RA   Zhou S., King D., Sanchez E.E., Burlingame A.L., Basbaum A.I.,
RA   Julius D.;
RT   "A heteromeric Texas coral snake toxin targets acid-sensing ion
RT   channels to produce pain.";
RL   Nature 479:410-414(2011).
CC   -!- FUNCTION: Heterodimer: snake venom phospholipase that potently
CC       activates mouse H(+)-gated sodium channel ASIC1/ACCN2 (acid-
CC       sensitive ion channel 1) expressed in Xenopus oocytes. Both
CC       alternatively spliced isoforms ASIC1a and ASIC1b are activated,
CC       with a higher potency for ASIC1a (EC(50)=9.4 nM) vs ASIC1b
CC       (EC(50)=23 nM). The ASIC3/ACCN3 subtype is also sensitive to the
CC       heterodimer, but with a lower potency (EC(50)=830 nM). On
CC       ASIC2a/ACCN1, the toxin shows a very weak activation, but produces
CC       a remarkable potentiation (>100-fold) of protons when the
CC       extracellular pH drops below neutrality. The toxin interacts with
CC       the extracellular region of the channel, since responses are only
CC       observed in the outside-out configuration. In vivo, the
CC       heterodimer elicits robust pain-related behavior in mice by
CC       activation of ASIC1/ACCN2 channels on capsaicin-sensitive nerve
CC       fibers.
CC   -!- FUNCTION: Monomer: does not have phospholipase A2 activity but may
CC       maintain some lipid-binding character from its PLA2 lineage, which
CC       could aid in effecting neuronal depolarization.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta chains.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MISCELLANEOUS: This toxin has been studied to probe molecular
CC       mechanisms underlying pain sensation. By targeting ASIC1/ACCN2, it
CC       reveals an unexpected contribution of this channel to nociception.
CC   -!- MISCELLANEOUS: The heterodimeric toxin does not affect
CC       ASIC2b/ACCN1, ASIC4/ACCN4, Kv2.1/KCNB1, Cav3.3/CACNA1I,
CC       ENaC/SCNN1A, TRPA1, TRPV1, TRPV3, TRPM8, P2X2/P2RX2, and 5-
CC       HT3/HTR3A channels (PubMed:22094702).
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group I
CC       subfamily. K49 sub-subfamily.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=The poison in pain -
CC       Issue 140 of July 2012;
CC       URL="http://web.expasy.org/spotlight/back_issues/140";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; JN613326; AET85560.1; -; mRNA.
DR   PDB; 4NTW; X-ray; 2.07 A; C=31-149.
DR   PDB; 4NTX; X-ray; 2.27 A; C=31-149.
DR   PDB; 4NTY; X-ray; 2.65 A; C=31-149.
DR   PDBsum; 4NTW; -.
DR   PDBsum; 4NTX; -.
DR   PDBsum; 4NTY; -.
DR   ProteinModelPortal; G9I930; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR013090; PLipase_A2_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Disulfide bond;
KW   Ion channel impairing toxin; Neurotoxin; Secreted; Signal; Toxin.
FT   SIGNAL        1     30
FT   CHAIN        31    149       Basic phospholipase A2 homolog Tx-beta.
FT                                /FTId=PRO_5000828218.
FT   DISULFID     41    100       By similarity.
FT   DISULFID     55    148       By similarity.
FT   DISULFID     57     73       By similarity.
FT   DISULFID     72    130       By similarity.
FT   DISULFID     79    123       By similarity.
FT   DISULFID     89    116       By similarity.
FT   DISULFID    109    121       By similarity.
SQ   SEQUENCE   149 AA;  16793 MW;  4CF027CBCA751BE4 CRC64;
     MDKMNPAHLL VLAAVCVSLL GASSIPPQAL NLNQFRLMIK CTNDRVWADF VDYGCYCVAR
     DSNTPVDDLD RCCQAQKQCY DEAVKVHGCK PLVMFYSFEC RYLASDLDCS GNNTKCRNFV
     CNCDRTATLC ILTATYNRNN HKIDPSRCQ
//
ID   PEPA5_HUMAN             Reviewed;         388 AA.
AC   P0DJD9; A8K749; B7ZW62; B7ZW75; P00790; Q7M4R0; Q8N1E3;
DT   22-FEB-2012, integrated into UniProtKB/Swiss-Prot.
DT   22-FEB-2012, sequence version 1.
DT   16-APR-2014, entry version 22.
DE   RecName: Full=Pepsin A-5;
DE            EC=3.4.23.1;
DE   AltName: Full=Pepsinogen-5;
DE   Flags: Precursor;
GN   Name=PGA5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=2714789; DOI=10.1016/0888-7543(89)90325-X;
RA   Evers M.P.J., Zelle B., Bebelman J.-P., van Beusechem V., Kraakman L.,
RA   Hoffer M.J.V., Pronk J.C., Mager W.H., Planta R.J., Eriksson A.W.,
RA   Frants R.R.;
RT   "Nucleotide sequence comparison of five human pepsinogen A (PGA)
RT   genes: evolution of the PGA multigene family.";
RL   Genomics 4:232-239(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Colon, Kidney, and Stomach;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PARTIAL PROTEIN SEQUENCE OF 1-28.
RX   PubMed=2415509;
RA   Ichihara Y., Sogawa K., Takahashi K.;
RT   "Isolation of human, swine, and rat prepepsinogens and calf
RT   preprochymosin, and determination of the primary structures of their
RT   NH2-terminal signal sequences.";
RL   J. Biochem. 98:483-492(1985).
RN   [6]
RP   PROTEIN SEQUENCE OF 16-100.
RX   PubMed=2515193;
RA   Athauda S.B.P., Tanji M., Kageyama T., Takahashi K.;
RT   "A comparative study on the NH2-terminal amino acid sequences and some
RT   other properties of six isozymic forms of human pepsinogens and
RT   pepsins.";
RL   J. Biochem. 106:920-927(1989).
RN   [7]
RP   PROTEIN SEQUENCE OF 16-68.
RX   PubMed=3197840; DOI=10.1016/0014-5793(88)81033-0;
RA   Foltmann B.;
RT   "Activation of human pepsinogens.";
RL   FEBS Lett. 241:69-72(1988).
RN   [8]
RP   PROTEIN SEQUENCE OF 362-388.
RX   PubMed=4909888;
RA   Huang W.-Y., Tang J.;
RT   "Carboxyl-terminal sequence of human gastricsin and pepsin.";
RL   J. Biol. Chem. 245:2189-2193(1970).
RN   [9]
RP   IDENTIFICATION.
RX   PubMed=6300126;
RA   Sogawa K., Fujii-Kuriyama Y., Mizukami Y., Ichihara Y., Takahashi K.;
RT   "Primary structure of human pepsinogen gene.";
RL   J. Biol. Chem. 258:5306-5311(1983).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 63-388, ACTIVE SITES, AND
RP   DISULFIDE BONDS.
RX   PubMed=7663352;
RA   Fujinaga M., Chernaia M.M., Tarasova N.I., Mosimann S.C.,
RA   James M.N.G.;
RT   "Crystal structure of human pepsin and its complex with pepstatin.";
RL   Protein Sci. 4:960-972(1995).
CC   -!- FUNCTION: Shows particularly broad specificity; although bonds
CC       involving phenylalanine and leucine are preferred, many others are
CC       also cleaved to some extent.
CC   -!- CATALYTIC ACTIVITY: Preferential cleavage: hydrophobic, preferably
CC       aromatic, residues in P1 and P1' positions. Cleaves 1-Phe-|-Val-2,
CC       4-Gln-|-His-5, 13-Glu-|-Ala-14, 14-Ala-|-Leu-15, 15-Leu-|-Tyr-16,
CC       16-Tyr-|-Leu-17, 23-Gly-|-Phe-24, 24-Phe-|-Phe-25 and 25-Phe-|-
CC       Tyr-26 bonds in the B chain of insulin.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- SIMILARITY: Belongs to the peptidase A1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M26032; AAA60061.1; -; Genomic_DNA.
DR   EMBL; M26025; AAA60061.1; JOINED; Genomic_DNA.
DR   EMBL; M26026; AAA60061.1; JOINED; Genomic_DNA.
DR   EMBL; M26027; AAA60061.1; JOINED; Genomic_DNA.
DR   EMBL; M26028; AAA60061.1; JOINED; Genomic_DNA.
DR   EMBL; M26029; AAA60061.1; JOINED; Genomic_DNA.
DR   EMBL; M26030; AAA60061.1; JOINED; Genomic_DNA.
DR   EMBL; M26031; AAA60061.1; JOINED; Genomic_DNA.
DR   EMBL; AP003037; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW73928.1; -; Genomic_DNA.
DR   EMBL; BC029055; AAH29055.1; -; mRNA.
DR   EMBL; BC146999; AAI47000.1; -; mRNA.
DR   EMBL; BC171889; AAI71889.1; -; mRNA.
DR   PIR; A00980; PEHU.
DR   PIR; A30142; A30142.
DR   PIR; A92058; A92058.
DR   PIR; B30142; B30142.
DR   RefSeq; NP_055039.1; NM_014224.2.
DR   UniGene; Hs.432854; -.
DR   ProteinModelPortal; P0DJD9; -.
DR   SMR; P0DJD9; 17-388.
DR   ChEMBL; CHEMBL3295; -.
DR   MEROPS; A01.071; -.
DR   PhosphoSite; P0DJD9; -.
DR   DMDM; 378522017; -.
DR   PRIDE; P0DJD9; -.
DR   Ensembl; ENST00000312403; ENSP00000309542; ENSG00000256713.
DR   GeneID; 5222; -.
DR   KEGG; hsa:5222; -.
DR   UCSC; uc001nqz.3; human.
DR   CTD; 5222; -.
DR   GeneCards; GC11P061008; -.
DR   HGNC; HGNC:8887; PGA5.
DR   HPA; CAB026358; -.
DR   HPA; HPA046875; -.
DR   MIM; 169700; gene.
DR   MIM; 169730; gene.
DR   neXtProt; NX_P0DJD9; -.
DR   PharmGKB; PA33224; -.
DR   KO; K06002; -.
DR   OMA; GMNLPTA; -.
DR   OrthoDB; EOG7HQN88; -.
DR   PhylomeDB; P0DJD9; -.
DR   TreeFam; TF314990; -.
DR   GeneWiki; PGA5; -.
DR   GenomeRNAi; 5222; -.
DR   NextBio; 20188; -.
DR   PRO; PR:P0DJD9; -.
DR   Bgee; P0DJD9; -.
DR   CleanEx; HS_PGA5; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0007586; P:digestion; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   Gene3D; 2.40.70.10; -; 2.
DR   InterPro; IPR001461; Aspartic_peptidase.
DR   InterPro; IPR001969; Aspartic_peptidase_AS.
DR   InterPro; IPR012848; Aspartic_peptidase_N.
DR   InterPro; IPR021109; Peptidase_aspartic_dom.
DR   PANTHER; PTHR13683; PTHR13683; 1.
DR   Pfam; PF07966; A1_Propeptide; 1.
DR   Pfam; PF00026; Asp; 1.
DR   PRINTS; PR00792; PEPSIN.
DR   SUPFAM; SSF50630; SSF50630; 1.
DR   PROSITE; PS00141; ASP_PROTEASE; 2.
PE   1: Evidence at protein level;
KW   Aspartyl protease; Complete proteome; Digestion;
KW   Direct protein sequencing; Disulfide bond; Hydrolase; Phosphoprotein;
KW   Protease; Reference proteome; Secreted; Signal; Zymogen.
FT   SIGNAL        1     15
FT   PROPEP       16     62       Activation peptide.
FT                                /FTId=PRO_0000415759.
FT   CHAIN        63    388       Pepsin A-5.
FT                                /FTId=PRO_0000415760.
FT   ACT_SITE     94     94
FT   ACT_SITE    277    277
FT   MOD_RES     130    130       Phosphoserine (By similarity).
FT   DISULFID    107    112
FT   DISULFID    268    272
FT   DISULFID    311    344
FT   CONFLICT     28     28       L -> F (in Ref. 1; AAA60061).
FT   CONFLICT     58     58       E -> K (in Ref. 1; AAA60061).
FT   CONFLICT     92     92       V -> L (in Ref. 1; AAA60061).
FT   CONFLICT    222    222       K -> Q (in Ref. 1; AAA60061).
FT   CONFLICT    265    265       T -> A (in Ref. 1; AAA60061).
FT   CONFLICT    353    353       V -> L (in Ref. 1; AAA60061).
FT   CONFLICT    371    372       YF -> FY (in Ref. 8; AA sequence).
FT   CONFLICT    376    376       D -> E (in Ref. 1; AAA60061).
SQ   SEQUENCE   388 AA;  41993 MW;  2C456A75DA96CDDA CRC64;
     MKWLLLLGLV ALSECIMYKV PLIRKKSLRR TLSERGLLKD FLKKHNLNPA RKYFPQWEAP
     TLVDEQPLEN YLDMEYFGTI GIGTPAQDFT VVFDTGSSNL WVPSVYCSSL ACTNHNRFNP
     EDSSTYQSTS ETVSITYGTG SMTGILGYDT VQVGGISDTN QIFGLSETEP GSFLYYAPFD
     GILGLAYPSI SSSGATPVFD NIWNQGLVSQ DLFSVYLSAD DKSGSVVIFG GIDSSYYTGS
     LNWVPVTVEG YWQITVDSIT MNGETIACAE GCQAIVDTGT SLLTGPTSPI ANIQSDIGAS
     ENSDGDMVVS CSAISSLPDI VFTINGVQYP VPPSAYILQS EGSCISGFQG MNVPTESGEL
     WILGDVFIRQ YFTVFDRANN QVGLAPVA
//
ID   PEPA4_HUMAN             Reviewed;         388 AA.
AC   P0DJD7; A8K749; B7ZW75; P00790; Q7M4R0; Q8N1E3;
DT   22-FEB-2012, integrated into UniProtKB/Swiss-Prot.
DT   22-FEB-2012, sequence version 1.
DT   16-APR-2014, entry version 21.
DE   RecName: Full=Pepsin A-4;
DE            EC=3.4.23.1;
DE   AltName: Full=Pepsinogen-4;
DE   Flags: Precursor;
GN   Name=PGA4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6300126;
RA   Sogawa K., Fujii-Kuriyama Y., Mizukami Y., Ichihara Y., Takahashi K.;
RT   "Primary structure of human pepsinogen gene.";
RL   J. Biol. Chem. 258:5306-5311(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PARTIAL PROTEIN SEQUENCE OF 1-28.
RX   PubMed=2415509;
RA   Ichihara Y., Sogawa K., Takahashi K.;
RT   "Isolation of human, swine, and rat prepepsinogens and calf
RT   preprochymosin, and determination of the primary structures of their
RT   NH2-terminal signal sequences.";
RL   J. Biochem. 98:483-492(1985).
RN   [6]
RP   PROTEIN SEQUENCE OF 16-100.
RX   PubMed=2515193;
RA   Athauda S.B.P., Tanji M., Kageyama T., Takahashi K.;
RT   "A comparative study on the NH2-terminal amino acid sequences and some
RT   other properties of six isozymic forms of human pepsinogens and
RT   pepsins.";
RL   J. Biochem. 106:920-927(1989).
RN   [7]
RP   PROTEIN SEQUENCE OF 16-68.
RX   PubMed=3197840; DOI=10.1016/0014-5793(88)81033-0;
RA   Foltmann B.;
RT   "Activation of human pepsinogens.";
RL   FEBS Lett. 241:69-72(1988).
RN   [8]
RP   PROTEIN SEQUENCE OF 362-388.
RX   PubMed=4909888;
RA   Huang W.-Y., Tang J.;
RT   "Carboxyl-terminal sequence of human gastricsin and pepsin.";
RL   J. Biol. Chem. 245:2189-2193(1970).
RN   [9]
RP   IDENTIFICATION.
RC   TISSUE=Placenta;
RX   PubMed=2714789; DOI=10.1016/0888-7543(89)90325-X;
RA   Evers M.P.J., Zelle B., Bebelman J.-P., van Beusechem V., Kraakman L.,
RA   Hoffer M.J.V., Pronk J.C., Mager W.H., Planta R.J., Eriksson A.W.,
RA   Frants R.R.;
RT   "Nucleotide sequence comparison of five human pepsinogen A (PGA)
RT   genes: evolution of the PGA multigene family.";
RL   Genomics 4:232-239(1989).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 63-388, ACTIVE SITES, AND
RP   DISULFIDE BONDS.
RX   PubMed=7663352;
RA   Fujinaga M., Chernaia M.M., Tarasova N.I., Mosimann S.C.,
RA   James M.N.G.;
RT   "Crystal structure of human pepsin and its complex with pepstatin.";
RL   Protein Sci. 4:960-972(1995).
CC   -!- FUNCTION: Shows particularly broad specificity; although bonds
CC       involving phenylalanine and leucine are preferred, many others are
CC       also cleaved to some extent.
CC   -!- CATALYTIC ACTIVITY: Preferential cleavage: hydrophobic, preferably
CC       aromatic, residues in P1 and P1' positions. Cleaves 1-Phe-|-Val-2,
CC       4-Gln-|-His-5, 13-Glu-|-Ala-14, 14-Ala-|-Leu-15, 15-Leu-|-Tyr-16,
CC       16-Tyr-|-Leu-17, 23-Gly-|-Phe-24, 24-Phe-|-Phe-25 and 25-Phe-|-
CC       Tyr-26 bonds in the B chain of insulin.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- SIMILARITY: Belongs to the peptidase A1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J00287; AAA98529.1; -; Genomic_DNA.
DR   EMBL; J00279; AAA98529.1; JOINED; Genomic_DNA.
DR   EMBL; J00280; AAA98529.1; JOINED; Genomic_DNA.
DR   EMBL; J00281; AAA98529.1; JOINED; Genomic_DNA.
DR   EMBL; J00282; AAA98529.1; JOINED; Genomic_DNA.
DR   EMBL; J00283; AAA98529.1; JOINED; Genomic_DNA.
DR   EMBL; J00284; AAA98529.1; JOINED; Genomic_DNA.
DR   EMBL; J00285; AAA98529.1; JOINED; Genomic_DNA.
DR   EMBL; J00286; AAA98529.1; JOINED; Genomic_DNA.
DR   EMBL; AK291864; BAF84553.1; -; mRNA.
DR   EMBL; AP000437; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003037; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC150659; AAI50660.1; -; mRNA.
DR   EMBL; BC171910; AAI71910.1; -; mRNA.
DR   EMBL; BC171920; AAI71920.1; -; mRNA.
DR   PIR; A00980; PEHU.
DR   PIR; A30142; A30142.
DR   PIR; A92058; A92058.
DR   PIR; B30142; B30142.
DR   RefSeq; NP_001073276.1; NM_001079808.1.
DR   UniGene; Hs.432854; -.
DR   UniGene; Hs.661883; -.
DR   PDB; 1FLH; X-ray; 2.45 A; A=63-388.
DR   PDB; 1PSN; X-ray; 2.20 A; A=63-388.
DR   PDB; 1PSO; X-ray; 2.00 A; E=63-388.
DR   PDB; 1QRP; X-ray; 1.96 A; E=63-388.
DR   PDB; 3UTL; X-ray; 2.61 A; A=63-388.
DR   PDBsum; 1FLH; -.
DR   PDBsum; 1PSN; -.
DR   PDBsum; 1PSO; -.
DR   PDBsum; 1QRP; -.
DR   PDBsum; 3UTL; -.
DR   ProteinModelPortal; P0DJD7; -.
DR   SMR; P0DJD7; 17-388.
DR   BindingDB; P0DJD7; -.
DR   MEROPS; A01.070; -.
DR   PhosphoSite; P0DJD7; -.
DR   DMDM; 378521995; -.
DR   PRIDE; P0DJD7; -.
DR   Ensembl; ENST00000378149; ENSP00000367391; ENSG00000229183.
DR   GeneID; 643847; -.
DR   KEGG; hsa:643847; -.
DR   UCSC; uc001nqy.3; human.
DR   CTD; 643847; -.
DR   GeneCards; GC11P060989; -.
DR   HGNC; HGNC:8886; PGA4.
DR   HPA; CAB026358; -.
DR   HPA; HPA046875; -.
DR   MIM; 169700; gene.
DR   MIM; 169720; gene.
DR   neXtProt; NX_P0DJD7; -.
DR   KO; K06002; -.
DR   OMA; CSTSECT; -.
DR   OrthoDB; EOG7HQN88; -.
DR   PhylomeDB; P0DJD7; -.
DR   TreeFam; TF314990; -.
DR   GenomeRNAi; 643847; -.
DR   NextBio; 115463; -.
DR   PRO; PR:P0DJD7; -.
DR   Bgee; P0DJD7; -.
DR   CleanEx; HS_PGA4; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0007586; P:digestion; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   Gene3D; 2.40.70.10; -; 2.
DR   InterPro; IPR001461; Aspartic_peptidase.
DR   InterPro; IPR001969; Aspartic_peptidase_AS.
DR   InterPro; IPR012848; Aspartic_peptidase_N.
DR   InterPro; IPR021109; Peptidase_aspartic_dom.
DR   PANTHER; PTHR13683; PTHR13683; 1.
DR   Pfam; PF07966; A1_Propeptide; 1.
DR   Pfam; PF00026; Asp; 1.
DR   PRINTS; PR00792; PEPSIN.
DR   SUPFAM; SSF50630; SSF50630; 1.
DR   PROSITE; PS00141; ASP_PROTEASE; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Aspartyl protease; Complete proteome; Digestion;
KW   Direct protein sequencing; Disulfide bond; Hydrolase; Protease;
KW   Reference proteome; Secreted; Signal; Zymogen.
FT   SIGNAL        1     15
FT   PROPEP       16     62       Activation peptide.
FT                                /FTId=PRO_0000415757.
FT   CHAIN        63    388       Pepsin A-4.
FT                                /FTId=PRO_0000415758.
FT   ACT_SITE     94     94
FT   ACT_SITE    277    277
FT   DISULFID    107    112
FT   DISULFID    268    272
FT   DISULFID    311    344
FT   CONFLICT    291    291       A -> T (in Ref. 2; BAF84553).
FT   CONFLICT    371    372       YF -> FY (in Ref. 8; AA sequence).
FT   STRAND       65     67
FT   STRAND       69     71
FT   TURN         72     74
FT   STRAND       75     82
FT   TURN         83     86
FT   STRAND       87     94
FT   STRAND      100    102
FT   HELIX       110    113
FT   HELIX       120    122
FT   STRAND      127    136
FT   STRAND      141    153
FT   STRAND      156    168
FT   HELIX       172    176
FT   STRAND      180    184
FT   HELIX       188    190
FT   HELIX       192    194
FT   HELIX       198    204
FT   STRAND      209    216
FT   STRAND      226    229
FT   HELIX       234    236
FT   STRAND      237    239
FT   STRAND      242    245
FT   TURN        249    252
FT   STRAND      253    256
FT   STRAND      258    261
FT   STRAND      264    267
FT   STRAND      272    276
FT   STRAND      282    285
FT   HELIX       287    296
FT   STRAND      307    309
FT   HELIX       311    316
FT   STRAND      320    324
FT   STRAND      327    331
FT   HELIX       333    336
FT   STRAND      337    340
FT   STRAND      343    350
FT   STRAND      361    363
FT   HELIX       365    370
FT   STRAND      371    376
FT   TURN        377    380
FT   STRAND      381    387
SQ   SEQUENCE   388 AA;  41977 MW;  C9CB89BA08F4D78B CRC64;
     MKWLLLLGLV ALSECIMYKV PLIRKKSLRR TLSERGLLKD FLKKHNLNPA RKYFPQWEAP
     TLVDEQPLEN YLDMEYFGTI GIGTPAQDFT VVFDTGSSNL WVPSVYCSSL ACTNHNRFNP
     EDSSTYQSTS ETVSITYGTG SMTGILGYDT VQVGGISDTN QIFGLSETEP GSFLYYAPFD
     GILGLAYPSI SSSGATPVFD NIWNQGLVSQ DLFSVYLSAD DQSGSVVIFG GIDSSYYTGS
     LNWVPVTVEG YWQITVDSIT MNGEAIACAE GCQAIVDTGT SLLTGPTSPI ANIQSDIGAS
     ENSDGDMVVS CSAISSLPDI VFTINGVQYP VPPSAYILQS EGSCISGFQG MNLPTESGEL
     WILGDVFIRQ YFTVFDRANN QVGLAPVA
//
ID   PEPA3_HUMAN             Reviewed;         388 AA.
AC   P0DJD8; A8K749; B2R7D6; B7ZW75; P00790; Q7M4R0; Q8N1E3;
DT   22-FEB-2012, integrated into UniProtKB/Swiss-Prot.
DT   22-FEB-2012, sequence version 1.
DT   16-APR-2014, entry version 19.
DE   RecName: Full=Pepsin A-3;
DE            EC=3.4.23.1;
DE   AltName: Full=Pepsinogen-3;
DE   Flags: Precursor;
GN   Name=PGA3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Stomach;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PARTIAL PROTEIN SEQUENCE OF 1-28.
RX   PubMed=2415509;
RA   Ichihara Y., Sogawa K., Takahashi K.;
RT   "Isolation of human, swine, and rat prepepsinogens and calf
RT   preprochymosin, and determination of the primary structures of their
RT   NH2-terminal signal sequences.";
RL   J. Biochem. 98:483-492(1985).
RN   [5]
RP   PROTEIN SEQUENCE OF 16-100.
RX   PubMed=2515193;
RA   Athauda S.B.P., Tanji M., Kageyama T., Takahashi K.;
RT   "A comparative study on the NH2-terminal amino acid sequences and some
RT   other properties of six isozymic forms of human pepsinogens and
RT   pepsins.";
RL   J. Biochem. 106:920-927(1989).
RN   [6]
RP   PROTEIN SEQUENCE OF 16-68.
RX   PubMed=3197840; DOI=10.1016/0014-5793(88)81033-0;
RA   Foltmann B.;
RT   "Activation of human pepsinogens.";
RL   FEBS Lett. 241:69-72(1988).
RN   [7]
RP   PROTEIN SEQUENCE OF 362-388.
RX   PubMed=4909888;
RA   Huang W.-Y., Tang J.;
RT   "Carboxyl-terminal sequence of human gastricsin and pepsin.";
RL   J. Biol. Chem. 245:2189-2193(1970).
RN   [8]
RP   IDENTIFICATION.
RX   PubMed=6300126;
RA   Sogawa K., Fujii-Kuriyama Y., Mizukami Y., Ichihara Y., Takahashi K.;
RT   "Primary structure of human pepsinogen gene.";
RL   J. Biol. Chem. 258:5306-5311(1983).
RN   [9]
RP   IDENTIFICATION.
RC   TISSUE=Placenta;
RX   PubMed=2714789; DOI=10.1016/0888-7543(89)90325-X;
RA   Evers M.P.J., Zelle B., Bebelman J.-P., van Beusechem V., Kraakman L.,
RA   Hoffer M.J.V., Pronk J.C., Mager W.H., Planta R.J., Eriksson A.W.,
RA   Frants R.R.;
RT   "Nucleotide sequence comparison of five human pepsinogen A (PGA)
RT   genes: evolution of the PGA multigene family.";
RL   Genomics 4:232-239(1989).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 63-388, ACTIVE SITES, AND
RP   DISULFIDE BONDS.
RX   PubMed=7663352;
RA   Fujinaga M., Chernaia M.M., Tarasova N.I., Mosimann S.C.,
RA   James M.N.G.;
RT   "Crystal structure of human pepsin and its complex with pepstatin.";
RL   Protein Sci. 4:960-972(1995).
CC   -!- FUNCTION: Shows particularly broad specificity; although bonds
CC       involving phenylalanine and leucine are preferred, many others are
CC       also cleaved to some extent.
CC   -!- CATALYTIC ACTIVITY: Preferential cleavage: hydrophobic, preferably
CC       aromatic, residues in P1 and P1' positions. Cleaves 1-Phe-|-Val-2,
CC       4-Gln-|-His-5, 13-Glu-|-Ala-14, 14-Ala-|-Leu-15, 15-Leu-|-Tyr-16,
CC       16-Tyr-|-Leu-17, 23-Gly-|-Phe-24, 24-Phe-|-Phe-25 and 25-Phe-|-
CC       Tyr-26 bonds in the B chain of insulin.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- SIMILARITY: Belongs to the peptidase A1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK312941; BAG35783.1; -; mRNA.
DR   EMBL; AK125628; BAG54225.1; -; mRNA.
DR   EMBL; AP000437; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC171815; AAI71815.1; -; mRNA.
DR   PIR; A00980; PEHU.
DR   PIR; A30142; A30142.
DR   PIR; A92058; A92058.
DR   PIR; B30142; B30142.
DR   RefSeq; NP_001073275.1; NM_001079807.1.
DR   RefSeq; XP_005276461.1; XM_005276404.1.
DR   UniGene; Hs.601055; -.
DR   UniGene; Hs.661883; -.
DR   ProteinModelPortal; P0DJD8; -.
DR   SMR; P0DJD8; 17-388.
DR   PhosphoSite; P0DJD8; -.
DR   DMDM; 378521956; -.
DR   PRIDE; P0DJD8; -.
DR   Ensembl; ENST00000325558; ENSP00000322192; ENSG00000229859.
DR   GeneID; 101929842; -.
DR   GeneID; 643834; -.
DR   KEGG; hsa:101929842; -.
DR   KEGG; hsa:643834; -.
DR   UCSC; uc001nqx.3; human.
DR   CTD; 643834; -.
DR   GeneCards; GC11P060970; -.
DR   HGNC; HGNC:8885; PGA3.
DR   HPA; CAB026358; -.
DR   HPA; HPA046875; -.
DR   MIM; 169700; gene.
DR   MIM; 169710; gene.
DR   neXtProt; NX_P0DJD8; -.
DR   eggNOG; NOG248684; -.
DR   HOGENOM; HOG000197681; -.
DR   HOVERGEN; HBG000482; -.
DR   KO; K06002; -.
DR   OMA; XNDESGS; -.
DR   OrthoDB; EOG7HQN88; -.
DR   PhylomeDB; P0DJD8; -.
DR   TreeFam; TF314990; -.
DR   ChiTaRS; PGA3; human.
DR   NextBio; 115445; -.
DR   PRO; PR:P0DJD8; -.
DR   Bgee; P0DJD8; -.
DR   CleanEx; HS_PGA3; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0007586; P:digestion; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   Gene3D; 2.40.70.10; -; 2.
DR   InterPro; IPR001461; Aspartic_peptidase.
DR   InterPro; IPR001969; Aspartic_peptidase_AS.
DR   InterPro; IPR012848; Aspartic_peptidase_N.
DR   InterPro; IPR021109; Peptidase_aspartic_dom.
DR   PANTHER; PTHR13683; PTHR13683; 1.
DR   Pfam; PF07966; A1_Propeptide; 1.
DR   Pfam; PF00026; Asp; 1.
DR   PRINTS; PR00792; PEPSIN.
DR   SUPFAM; SSF50630; SSF50630; 1.
DR   PROSITE; PS00141; ASP_PROTEASE; 2.
PE   1: Evidence at protein level;
KW   Aspartyl protease; Complete proteome; Digestion;
KW   Direct protein sequencing; Disulfide bond; Hydrolase; Protease;
KW   Reference proteome; Secreted; Signal; Zymogen.
FT   SIGNAL        1     15
FT   PROPEP       16     62       Activation peptide.
FT                                /FTId=PRO_0000026013.
FT   CHAIN        63    388       Pepsin A-3.
FT                                /FTId=PRO_0000026014.
FT   ACT_SITE     94     94
FT   ACT_SITE    277    277
FT   DISULFID    107    112
FT   DISULFID    268    272
FT   DISULFID    311    344
FT   CONFLICT     92     92       V -> L (in Ref. 1; BAG35783/BAG54225 and
FT                                3; AAI71815).
FT   CONFLICT    371    372       YF -> FY (in Ref. 7; AA sequence).
SQ   SEQUENCE   388 AA;  41976 MW;  5DA16E41FE198582 CRC64;
     MKWLLLLGLV ALSECIMYKV PLIRKKSLRR TLSERGLLKD FLKKHNLNPA RKYFPQWKAP
     TLVDEQPLEN YLDMEYFGTI GIGTPAQDFT VVFDTGSSNL WVPSVYCSSL ACTNHNRFNP
     EDSSTYQSTS ETVSITYGTG SMTGILGYDT VQVGGISDTN QIFGLSETEP GSFLYYAPFD
     GILGLAYPSI SSSGATPVFD NIWNQGLVSQ DLFSVYLSAD DQSGSVVIFG GIDSSYYTGS
     LNWVPVTVEG YWQITVDSIT MNGEAIACAE GCQAIVDTGT SLLTGPTSPI ANIQSDIGAS
     ENSDGDMVVS CSAISSLPDI VFTINGVQYP VPPSAYILQS EGSCISGFQG MNLPTESGEL
     WILGDVFIRQ YFTVFDRANN QVGLAPVA
//
ID   PEPP_ALLCE              Reviewed;         481 AA.
AC   Q93WP4;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   16-APR-2014, entry version 51.
DE   RecName: Full=Phosphoenolpyruvate phosphatase;
DE            Short=PEP phosphatase;
DE            EC=3.1.3.60;
DE   Flags: Precursor;
GN   Name=ACPEPP;
OS   Allium cepa (Onion).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; Liliopsida; Asparagales; Amaryllidaceae;
OC   Allioideae; Allieae; Allium.
OX   NCBI_TaxID=4679;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, FUNCTION, AND SUBCELLULAR LOCATION.
RX   DOI=10.1016/S0168-9452(01)00480-0;
RA   Shinano T., Yonetani R., Ushihara N., Adachi H., Wasaki J., Matsui H.,
RA   Osaki M.;
RT   "Characteristics of phosphoenolpyruvate phosphatase purified from
RT   Allium cepa.";
RL   Plant Sci. 161:861-869(2001).
CC   -!- FUNCTION: Phosphoenolpyruvate phosphatase that probably operates
CC       in the vacuole to release phosphate from phosphoenolpyruvate (PEP)
CC       under phosphorus starvation.
CC   -!- CATALYTIC ACTIVITY: Phosphoenolpyruvate + H(2)O = pyruvate +
CC       phosphate.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.44 mM for phosphoenolpyruvate;
CC         KM=3.72 mM for fructose 6-phosphate;
CC         KM=1.47 mM for glucose 6-phosphate;
CC         KM=1.60 mM for p-nitrophenylphosphate;
CC         KM=1.51 mM for ATP;
CC         KM=2.69 mM for ADP;
CC         KM=1.36 mM for phytic acid;
CC         Vmax=240 umol/min/mg enzyme toward phosphoenolpyruvate;
CC         Vmax=242 umol/min/mg enzyme toward fructose 6-phosphate;
CC         Vmax=374 umol/min/mg enzyme toward glucose 6-phosphate;
CC         Vmax=279 umol/min/mg enzyme toward p-nitrophenylphosphate;
CC         Vmax=349 umol/min/mg enzyme toward ATP;
CC         Vmax=510 umol/min/mg enzyme toward ADP;
CC         Vmax=178 umol/min/mg enzyme toward phytic acid;
CC       pH dependence:
CC         Optimum pH is 7;
CC   -!- SUBCELLULAR LOCATION: Vacuole lumen (Probable).
CC   -!- SIMILARITY: Belongs to the metallophosphoesterase superfamily.
CC       Purple acid phosphatase family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB052619; BAB60719.1; -; mRNA.
DR   ProteinModelPortal; Q93WP4; -.
DR   SMR; Q93WP4; 42-458.
DR   GO; GO:0005775; C:vacuolar lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0003993; F:acid phosphatase activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050189; F:phosphoenolpyruvate phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.380; -; 1.
DR   InterPro; IPR004843; Calcineurin-like_PHP_apaH.
DR   InterPro; IPR008963; Purple_acid_Pase-like_N.
DR   InterPro; IPR015914; Purple_acid_Pase_N.
DR   InterPro; IPR025733; Purple_acid_PPase_C_dom.
DR   Pfam; PF00149; Metallophos; 1.
DR   Pfam; PF14008; Metallophos_C; 1.
DR   SUPFAM; SSF49363; SSF49363; 1.
PE   1: Evidence at protein level;
KW   Glycoprotein; Hydrolase; Iron; Metal-binding; Protein phosphatase;
KW   Signal; Vacuole; Zinc.
FT   SIGNAL        1     36
FT   CHAIN        37    481       Phosphoenolpyruvate phosphatase.
FT                                /FTId=PRO_5000049662.
FT   REGION      354    356       Substrate binding (By similarity).
FT   ACT_SITE    327    327       Proton donor (By similarity).
FT   METAL       168    168       Iron (By similarity).
FT   METAL       195    195       Iron (By similarity).
FT   METAL       195    195       Zinc (By similarity).
FT   METAL       198    198       Iron (By similarity).
FT   METAL       232    232       Zinc (By similarity).
FT   METAL       317    317       Zinc (By similarity).
FT   METAL       354    354       Zinc (By similarity).
FT   METAL       356    356       Iron (By similarity).
FT   BINDING     232    232       Substrate (By similarity).
FT   CARBOHYD    109    109       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    206    206       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    370    370       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    427    427       N-linked (GlcNAc...) (Potential).
SQ   SEQUENCE   481 AA;  55970 MW;  6DA72EB851D7C8FD CRC64;
     MPIYTSRSCF YLLLFHIILL CSVDKTLCRQ TSSFVRSEFP AVDIPIDSKE FAVPKNQFSP
     QQVHITQGDY DGKAVIVSWV TFIDPGKSEV VYGTSPNSYD HSAQGKTTNY TYYDYTSGYI
     HHCLLDKLEY DTKYYYKIGK GDAAREFWFH TPPQIHPDAS YTFGIIGDLG QTYNSLSTLE
     HYMKSKGQTV LFVGDLSYAD RYSCNNGTRW DSWGRFVERS VAYQPWIWTV GNHEIEYRPD
     LGEVFPFRAY LNRYPTPHLA SASSSPLWYS IRRASAHIIV LSSYSPFVKY TPQWLWLSEE
     LTRVDREKTP WLIVLMHAPL YNSNEAHYME GESMRVAFES WFVQYKVDLV FAGHVHAYER
     SYRISNIVYN ITSGNRYPIP DKSAPVYITV GDGGNQEGLA ERFSESQPDY SAFRESSYGH
     STLELRNRTH AFYQWNRNDD GKHIPVDRII FRNQYWASNT RRRRLKKTRP SQAVERLISS
     Y
//
ID   PFI_PTIFI               Reviewed;         500 AA.
AC   Q8W257; Q8W256;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   16-APR-2014, entry version 45.
DE   RecName: Full=Polyenoic fatty acid isomerase;
DE            Short=PFI;
DE            EC=5.3.3.13;
DE   Flags: Precursor;
OS   Ptilota filicina (Red alga).
OC   Eukaryota; Rhodophyta; Florideophyceae; Ceramiales; Ceramiaceae;
OC   Ptilota.
OX   NCBI_TaxID=153248;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Zheng W., Wise M.L., Wyrick A., Metz J.G., Yuan L., Gerwick W.H.;
RT   "Polyenoic fatty acid isomerase from the marine alga Ptilota
RT   filicina.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 22-59, FUNCTION,
RP   SUBUNIT, GLYCOSYLATION, AND COFACTOR.
RX   PubMed=12054482; DOI=10.1016/S0003-9861(02)00002-4;
RA   Zheng W., Wise M.L., Wyrick A., Metz J.G., Yuan L., Gerwick W.H.;
RT   "Polyenoic fatty acid isomerase from the marine alga Ptilota filicina:
RT   protein characterization and functional expression of the cloned
RT   cDNA.";
RL   Arch. Biochem. Biophys. 401:11-20(2002).
RN   [3]
RP   CATALYTIC ACTIVITY.
RX   PubMed=7803384; DOI=10.1021/bi00255a002;
RA   Wise M.L., Hamberg M., Gerwick W.H.;
RT   "Biosynthesis of conjugated triene-containing fatty acids by a novel
RT   isomerase from the red marine alga Ptilota filicina.";
RL   Biochemistry 33:15223-15232(1994).
RN   [4]
RP   CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9062129; DOI=10.1021/bi962158v;
RA   Wise M.L., Rossi J., Gerwick W.H.;
RT   "Characterization of the substrate binding site of polyenoic fatty
RT   acid isomerase, a novel enzyme from the marine alga Ptilota
RT   filicina.";
RL   Biochemistry 36:2985-2992(1997).
CC   -!- FUNCTION: Involved in the biosynthesis of conjugated triene-
CC       containing fatty acids. Catalyzes the isomerization of a wide
CC       range of substrates containing three or more methylene interrupted
CC       olefins into a Z,E,E conjugated triene functionality. May be
CC       involved in a stress tolerance mechanism as response to intertidal
CC       habitats with direct sunlight, desiccation and high temperature.
CC       In vitro substrates include arachidonic acid ((5Z,8Z,11Z,14Z)-
CC       eicosatetraenoic acid), EPA ((5Z,8Z, 11Z,14Z,17Z)-eicosapentaenoic
CC       acid), DHA ((4Z,7Z,10Z,13Z,16Z,19Z)-docosahexenoic acid), adrenic
CC       acid ((7Z,10Z,13Z,16Z)-docosatetraenoic acid), anandamide
CC       (arachidonyl-N-ethanolamide) and eicosatrienoic acid ((5Z,8Z,11Z)-
CC       eicosatrienoic acid). Gamma-linolenic acid (18:3 6Z,9Z,12Z) and
CC       dihomo-gamma-linolenic acid (20:3 8Z,11Z,14Z) are transformed into
CC       mixtures of conjugated diene and triene fatty acids, linoleic acid
CC       is only transformed to a conjugated diene.
CC   -!- CATALYTIC ACTIVITY: (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate =
CC       (5Z,7E,9E,14Z,17Z)-icosapentaenoate.
CC   -!- COFACTOR: Flavin (Probable).
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.9 uM for (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexenoic acid;
CC         KM=17.0 uM for (7Z,10Z,13Z,16Z)-docosatetraenoic acid;
CC         KM=9.6 uM for (5Z,8Z, 11Z,14Z,17Z)-eicosapentaenoic acid;
CC         KM=25.5 uM for (5Z,8Z,11Z,14Z)-eicosatetraenoic acid;
CC         KM=52.8 uM for (5Z,8Z,11Z)-eicosatrienoic acid;
CC         KM=17.5 uM for arachidonyl-N-ethanolamide;
CC         Vmax=1.84 umol/min/mg enzyme with (4Z,7Z,10Z,13Z,16Z,19Z)-
CC         docosahexenoic acid as substrate;
CC         Vmax=1.1 umol/min/mg enzyme with (7Z,10Z,13Z,16Z)-
CC         docosatetraenoic acid as substrate;
CC         Vmax=6.0 umol/min/mg enzyme with (5Z,8Z, 11Z,14Z,17Z)-
CC         eicosapentaenoic acid as substrate;
CC         Vmax=2.78 umol/min/mg enzyme with (5Z,8Z,11Z,14Z)-
CC         eicosatetraenoic acid as substrate;
CC         Vmax=0.31 umol/min/mg enzyme with (5Z,8Z,11Z)-eicosatrienoic
CC         acid as substrate;
CC         Vmax=0.8 umol/min/mg enzyme with arachidonyl-N-ethanolamide as
CC         substrate;
CC       pH dependence:
CC         Optimum pH is below pH 6.0 with (5Z,8Z,11Z,14Z,17Z)-
CC         eicosapentaenoic acid as substrate;
CC   -!- SUBUNIT: Homodimer (Probable).
CC   -!- PTM: Glycosylated.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF354661; AAL57199.1; -; mRNA.
DR   EMBL; AF354662; AAL57200.1; -; mRNA.
DR   ProteinModelPortal; Q8W257; -.
DR   BRENDA; 5.3.3.13; 272033.
DR   GO; GO:0034016; F:polyenoic fatty acid isomerase activity; IEA:UniProtKB-EC.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Isomerase; Signal.
FT   SIGNAL        1     21
FT   CHAIN        22    500       Polyenoic fatty acid isomerase.
FT                                /FTId=PRO_0000418869.
FT   CONFLICT     56     57       ES -> SQ (in Ref. 2; AA sequence).
FT   CONFLICT     59     59       G -> Y (in Ref. 2; AA sequence).
FT   CONFLICT    327    328       AD -> TN (in Ref. 1; AAL57200).
FT   CONFLICT    367    367       N -> D (in Ref. 1; AAL57200).
FT   CONFLICT    477    477       S -> A (in Ref. 1; AAL57200).
SQ   SEQUENCE   500 AA;  55960 MW;  F2825B6F515DBD7D CRC64;
     MSLNRVLHIF LIAYLACTAL THDFDDTIAV VGAGYSGLSA AFTLVKKGYT NVEIYESQGE
     VGGYVYSVDY NNVAHDLATY ALTPAYWKFQ EAMKSIGVGF CELDVAIVQT NSTPVSVPFE
     KWMAAYWAAK VPNPLNLVRK VSTQVSTYVE VWKKLFNMDF IDTSTKRTNR LFPLKTNDVD
     VLAQFSMPMK DFVALHKLDL LEPLFIQATD SQAYGPYDTT PALYYMVWFP PNLFNGEENT
     VPCGTYNSMQ SMAEHMAEWL KSKGVTFHMN TKVTKISRAT DGSSPSLLEE GVATPKLFDT
     IISTNKLPSA NRAEVVTPLL PKEREAADTY EELQMFSALL ETNRSDAIPT TGFLMVDADA
     IIAHDPNTGF WGCLNAERRG GYSDENAILS SDTVTRVSAI YYYTERANNE RIDFSLDEKI
     QQVKTNLATW DSATWTNLTS RTFGGYFQRW RTPDVMGQKP WNLADIQGEG DVYYVNSAAC
     GFESVGHVFD CADNLIKDFF
//
ID   SAA1_HUMAN              Reviewed;         122 AA.
AC   P0DJI8; P02735; P02736; P02737; Q16730; Q16834; Q16835; Q16879;
AC   Q3KRB3; Q6FG67; Q96QN0; Q9UCK9; Q9UCL0;
DT   11-JUL-2012, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2012, sequence version 1.
DT   16-APR-2014, entry version 19.
DE   RecName: Full=Serum amyloid A-1 protein;
DE            Short=SAA;
DE   Contains:
DE     RecName: Full=Amyloid protein A;
DE     AltName: Full=Amyloid fibril protein AA;
DE   Contains:
DE     RecName: Full=Serum amyloid protein A(2-104);
DE   Contains:
DE     RecName: Full=Serum amyloid protein A(3-104);
DE   Contains:
DE     RecName: Full=Serum amyloid protein A(2-103);
DE   Contains:
DE     RecName: Full=Serum amyloid protein A(2-102);
DE   Contains:
DE     RecName: Full=Serum amyloid protein A(4-101);
DE   Flags: Precursor;
GN   Name=SAA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE SAA1.1).
RX   PubMed=3839415; DOI=10.1021/bi00333a018;
RA   Sipe J.D., Colten H.R., Goldberger G., Edge M.D., Tack B.F.,
RA   Cohen A.S., Whitehead A.S.;
RT   "Human serum amyloid A (SAA): biosynthesis and postsynthetic
RT   processing of preSAA and structural variants defined by complementary
RT   DNA.";
RL   Biochemistry 24:2931-2936(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE SAA1.1).
RC   TISSUE=Liver;
RX   PubMed=3183061; DOI=10.1172/JCI113779;
RA   Kluve-Beckerman B., Dwulet F.E., Benson M.D.;
RT   "Human serum amyloid A. Three hepatic mRNAs and the corresponding
RT   proteins in one person.";
RL   J. Clin. Invest. 82:1670-1675(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE SAA1.5).
RC   TISSUE=Liver;
RX   PubMed=1656519; DOI=10.1111/j.1365-3083.1991.tb01570.x;
RA   Betts J., Edbrooke M., Thakker R., Woo P.;
RT   "The human acute-phase serum amyloid A gene family: structure,
RT   evolution and expression in hepatoma cells.";
RL   Scand. J. Immunol. 34:471-482(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE SAA1.5).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELE SAA1.5).
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE SAA1.1).
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 73-122, AND VARIANTS VAL-75 AND ASN-78.
RC   TISSUE=Liver;
RX   PubMed=1971508;
RA   Steinkasserer A., Weiss E.H., Schwaeble W., Linke R.P.;
RT   "Heterogeneity of human serum amyloid A protein. Five different
RT   variants from one individual demonstrated by cDNA sequence analysis.";
RL   Biochem. J. 268:187-193(1990).
RN   [8]
RP   PROTEIN SEQUENCE OF 19-122.
RX   PubMed=7115671; DOI=10.1021/bi00257a008;
RA   Parmelee D.C., Titani K., Ericsson L.H., Eriksen N., Benditt E.P.,
RA   Walsh K.A.;
RT   "Amino acid sequence of amyloid-related apoprotein (apoSAA1) from
RT   human high-density lipoprotein.";
RL   Biochemistry 21:3298-3303(1982).
RN   [9]
RP   PROTEIN SEQUENCE OF 19-122 (ALLELE SAA1.2).
RX   PubMed=1546977;
RA   Beach C.M., de Beer M.C., Sipe J.D., Loose L.D., de Beer F.C.;
RT   "Human serum amyloid A protein. Complete amino acid sequence of a new
RT   variant.";
RL   Biochem. J. 282:615-620(1992).
RN   [10]
RP   PROTEIN SEQUENCE OF 19-101.
RX   PubMed=6155694; DOI=10.1111/j.1365-3083.1980.tb00023.x;
RA   Moyner K., Sletten K., Husby G., Natvig J.B.;
RT   "An unusually large (83 amino acid residues) amyloid fibril protein AA
RT   from a patient with Waldenstrom's macroglobulinaemia and
RT   amyloidosis.";
RL   Scand. J. Immunol. 11:549-554(1980).
RN   [11]
RP   PROTEIN SEQUENCE OF 19-94.
RX   PubMed=5055786;
RA   Ein D., Kimura S., Terry W.D., Magnotta J., Glenner G.G.;
RT   "Amino acid sequence of an amyloid fibril protein of unknown origin.";
RL   J. Biol. Chem. 247:5653-5655(1972).
RN   [12]
RP   PROTEIN SEQUENCE OF 19-94 (FAMILIAL MEDITERRANEAN FEVER PATIENT).
RX   PubMed=5056669; DOI=10.1172/JCI107098;
RA   Levin M., Franklin E.C., Frangione B., Pras M.;
RT   "The amino acid sequence of a major nonimmunoglobulin component of
RT   some amyloid fibrils.";
RL   J. Clin. Invest. 51:2773-2776(1972).
RN   [13]
RP   PROTEIN SEQUENCE OF 19-94.
RX   PubMed=4816450; DOI=10.1111/j.1432-1033.1974.tb03251.x;
RA   Sletten K., Husby G.;
RT   "The complete amino-acid sequence of non-immunoglobulin amyloid fibril
RT   protein AS in rheumatoid arthritis.";
RL   Eur. J. Biochem. 41:117-125(1974).
RN   [14]
RP   PROTEIN SEQUENCE OF 19-94, MASS SPECTROMETRY, DISEASE, VARIANTS
RP   ALA-70; VAL-75 AND ASN-78, AND ALLELE SAA1.3.
RC   TISSUE=Thyroid;
RX   PubMed=1463770; DOI=10.1016/0925-4439(92)90068-X;
RA   Baba S., Takahashi T., Kasama T., Shirasawa H.;
RT   "Identification of two novel amyloid A protein subsets coexisting in
RT   an individual patient of AA-amyloidosis.";
RL   Biochim. Biophys. Acta 1180:195-200(1992).
RN   [15]
RP   PROTEIN SEQUENCE OF 19-82.
RX   PubMed=1259755; DOI=10.1016/S0006-291X(76)80266-5;
RA   Sletten K., Husby G., Natvig J.B.;
RT   "The complete amino acid sequence of an amyloid fibril protein AA1 of
RT   unusual size (64 residues).";
RL   Biochem. Biophys. Res. Commun. 69:19-25(1976).
RN   [16]
RP   PROTEIN SEQUENCE OF 19-42.
RX   PubMed=11946204; DOI=10.1016/0014-5793(71)80506-9;
RA   Benditt E.P., Eriksen N., Hermodson M.A., Ericsson L.H.;
RT   "The major proteins of human and monkey amyloid substance: common
RT   properties including unusual N-terminal amino acid sequences.";
RL   FEBS Lett. 19:169-173(1971).
RN   [17]
RP   PROTEIN SEQUENCE OF 20-100.
RX   PubMed=3442653; DOI=10.1021/bi00399a035;
RA   Prelli F., Pras M., Frangione B.;
RT   "Degradation and deposition of amyloid AA fibrils are tissue
RT   specific.";
RL   Biochemistry 26:8251-8256(1987).
RN   [18]
RP   PROTEIN SEQUENCE OF 20-33; 44-57; 64-80 AND 86-122, TISSUE
RP   SPECIFICITY, AND MASS SPECTROMETRY.
RX   PubMed=12973732; DOI=10.1002/pmic.200300514;
RA   Howard B.A., Wang M.Z., Campa M.J., Corro C., Fitzgerald M.C.,
RA   Patz E.F. Jr.;
RT   "Identification and validation of a potential lung cancer serum
RT   biomarker detected by matrix-assisted laser desorption/ionization-time
RT   of flight spectra analysis.";
RL   Proteomics 3:1720-1724(2003).
RN   [19]
RP   PARTIAL PROTEIN SEQUENCE (VARIOUS FORMS), AND METHYLATION AT ASN-101.
RX   PubMed=8783012; DOI=10.1002/elps.1150170508;
RA   Ducret A., Bruun C.F., Bures E.J., Marhaug G., Husby G., Aebersold R.;
RT   "Characterization of human serum amyloid A protein isoforms separated
RT   by two-dimensional electrophoresis by liquid
RT   chromatography/electrospray ionization tandem mass spectrometry.";
RL   Electrophoresis 17:866-876(1996).
RN   [20]
RP   IDENTIFICATION OF ALLELE SAA1.4.
RX   PubMed=8670280; DOI=10.1006/bbrc.1996.0892;
RA   Westermark P., Sletten K., Westermark G.T., Raynes J., McAdam K.P.;
RT   "A protein AA-variant derived from a novel serum AA protein, SAA1
RT   delta, in an individual from Papua New Guinea.";
RL   Biochem. Biophys. Res. Commun. 223:320-323(1996).
RN   [21]
RP   POLYMORPHISM, AND NOMENCLATURE OF ALLELES.
RX   PubMed=10211414;
RA   Sipe J.;
RT   "Revised nomenclature for serum amyloid A (SAA). Nomenclature
RT   Committee of the International Society of Amyloidosis. Part 2.";
RL   Amyloid 6:67-70(1999).
RN   [22]
RP   MASS SPECTROMETRY.
RX   PubMed=12606051; DOI=10.1016/S0014-5793(03)00097-8;
RA   Kiernan U.A., Tubbs K.A., Nedelkov D., Niederkofler E.E., Nelson R.W.;
RT   "Detection of novel truncated forms of human serum amyloid A protein
RT   in human plasma.";
RL   FEBS Lett. 537:166-170(2003).
RN   [23]
RP   IDENTIFICATION OF ALLELE SAA1.3.
RX   PubMed=8512321; DOI=10.1006/abbi.1993.1296;
RA   Baba S., Takahashi T., Kasama T., Fujie M., Shirasawa H.;
RT   "A novel polymorphism of human serum amyloid A protein, SAA1 gamma, is
RT   characterized by alanines at both residues 52 and 57.";
RL   Arch. Biochem. Biophys. 303:361-366(1993).
CC   -!- FUNCTION: Major acute phase reactant. Apolipoprotein of the HDL
CC       complex.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the liver; secreted in plasma.
CC   -!- INDUCTION: Upon cytokine stimulation.
CC   -!- PTM: This protein is the precursor of amyloid protein A, which is
CC       formed by the removal of approximately 24 residues from the C-
CC       terminal end.
CC   -!- MASS SPECTROMETRY: Mass=11702; Mass_error=14; Method=MALDI;
CC       Range=19-122; Source=PubMed:12973732;
CC   -!- MASS SPECTROMETRY: Mass=11682.7; Method=MALDI; Range=19-122;
CC       Source=PubMed:12606051;
CC   -!- MASS SPECTROMETRY: Mass=11526.5; Method=MALDI; Range=20-122;
CC       Source=PubMed:12606051;
CC   -!- MASS SPECTROMETRY: Mass=11439.6; Method=MALDI; Range=21-122;
CC       Source=PubMed:12606051;
CC   -!- MASS SPECTROMETRY: Mass=11363.6; Method=MALDI; Range=20-121;
CC       Source=PubMed:12606051;
CC   -!- MASS SPECTROMETRY: Mass=11235.6; Method=MALDI; Range=20-120;
CC       Source=PubMed:12606051;
CC   -!- MASS SPECTROMETRY: Mass=10872.6; Method=MALDI; Range=22-119;
CC       Source=PubMed:12606051;
CC   -!- MASS SPECTROMETRY: Mass=8337.5; Mass_error=0.8;
CC       Method=Electrospray; Range=19-94; Note=With variants Ala-70, Val-
CC       75, Asn-78 and 86-Leu-Thr-87; Source=PubMed:1463770;
CC   -!- MASS SPECTROMETRY: Mass=8390.9; Mass_error=0.2;
CC       Method=Electrospray; Range=19-94; Note=With variant Ala-70;
CC       Source=PubMed:1463770;
CC   -!- POLYMORPHISM: At least 5 different SAA1 alleles have been
CC       described: SAA1.1 (SAA1alpha), SAA1.2 (SAA1beta), SAA1.3
CC       (SAA1gamma), SAA1.4 (SAA1delta), SAA1.5 (also named SAA1beta but
CC       which differs from SAA1.2). We use here the revised nomenclature
CC       described in PubMed:10211414. The sequence shown is that of
CC       SAA1.1.
CC   -!- DISEASE: Note=Reactive, secondary amyloidosis is characterized by
CC       the extracellular accumulation in various tissues of the SAA1
CC       protein. These deposits are highly insoluble and resistant to
CC       proteolysis; they disrupt tissue structure and compromise
CC       function.
CC   -!- DISEASE: Note=Elevated serum SAA1 protein levels may be associated
CC       with lung cancer.
CC   -!- SIMILARITY: Belongs to the SAA family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M10906; AAA60297.1; -; mRNA.
DR   EMBL; M23698; AAA64799.1; -; mRNA.
DR   EMBL; X56652; CAA39974.1; -; Genomic_DNA.
DR   EMBL; CR542241; CAG47037.1; -; mRNA.
DR   EMBL; AC107948; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007022; AAH07022.1; -; mRNA.
DR   EMBL; BC105796; AAI05797.1; -; mRNA.
DR   EMBL; X51439; CAA35804.1; -; mRNA.
DR   EMBL; X51441; CAA35806.1; -; mRNA.
DR   EMBL; X51442; CAA35807.1; -; mRNA.
DR   PIR; A22342; YLHUS.
DR   PIR; I39456; I39456.
DR   RefSeq; NP_000322.2; NM_000331.4.
DR   RefSeq; NP_001171477.1; NM_001178006.1.
DR   RefSeq; NP_954630.1; NM_199161.3.
DR   UniGene; Hs.632144; -.
DR   UniGene; Hs.731376; -.
DR   UniGene; Hs.734161; -.
DR   ProteinModelPortal; P0DJI8; -.
DR   DrugBank; DB00062; Human Serum Albumin.
DR   DrugBank; DB00064; Serum albumin iodonated.
DR   DMDM; 395406826; -.
DR   UCD-2DPAGE; P02735; -.
DR   PeptideAtlas; P02735; -.
DR   PRIDE; P0DJI8; -.
DR   DNASU; 6288; -.
DR   Ensembl; ENST00000356524; ENSP00000348918; ENSG00000173432.
DR   Ensembl; ENST00000405158; ENSP00000384906; ENSG00000173432.
DR   GeneID; 6288; -.
DR   KEGG; hsa:6288; -.
DR   CTD; 6288; -.
DR   GeneCards; GC11P018287; -.
DR   H-InvDB; HIX0009484; -.
DR   HGNC; HGNC:10513; SAA1.
DR   MIM; 104750; gene.
DR   neXtProt; NX_P0DJI8; -.
DR   Orphanet; 85445; Secondary amyloidosis.
DR   eggNOG; NOG26520; -.
DR   HOVERGEN; HBG016327; -.
DR   InParanoid; P02735; -.
DR   KO; K17310; -.
DR   OrthoDB; EOG7QVM4V; -.
DR   PhylomeDB; P0DJI8; -.
DR   TreeFam; TF332544; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_116125; Disease.
DR   Reactome; REACT_160300; Binding and Uptake of Ligands by Scavenger Receptors.
DR   Reactome; REACT_6900; Immune System.
DR   ChiTaRS; SAA1; human.
DR   GeneWiki; Serum_amyloid_A1; -.
DR   GenomeRNAi; 6288; -.
DR   NextBio; 24415; -.
DR   PMAP-CutDB; Q6FG67; -.
DR   PRO; PR:P0DJI8; -.
DR   Bgee; P0DJI8; -.
DR   CleanEx; HS_SAA1; -.
DR   Genevestigator; P02735; -.
DR   GO; GO:0071682; C:endocytic vesicle lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; NAS:UniProtKB.
DR   GO; GO:0070062; C:extracellular vesicular exosome; IDA:UniProt.
DR   GO; GO:0034364; C:high-density lipoprotein particle; IEA:UniProtKB-KW.
DR   GO; GO:0001664; F:G-protein coupled receptor binding; IDA:UniProtKB.
DR   GO; GO:0006953; P:acute-phase response; NAS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; TAS:Reactome.
DR   GO; GO:0048247; P:lymphocyte chemotaxis; IDA:UniProtKB.
DR   GO; GO:0048246; P:macrophage chemotaxis; IDA:UniProtKB.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; NAS:UniProtKB.
DR   GO; GO:0030593; P:neutrophil chemotaxis; NAS:UniProtKB.
DR   GO; GO:0030168; P:platelet activation; NAS:UniProtKB.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IDA:UniProtKB.
DR   GO; GO:0050715; P:positive regulation of cytokine secretion; IDA:UniProtKB.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB.
DR   GO; GO:0050716; P:positive regulation of interleukin-1 secretion; NAS:UniProtKB.
DR   GO; GO:0050708; P:regulation of protein secretion; NAS:UniProtKB.
DR   InterPro; IPR000096; Serum_amyloid_A.
DR   PANTHER; PTHR23424; PTHR23424; 1.
DR   Pfam; PF00277; SAA; 1.
DR   PIRSF; PIRSF002472; Serum_amyloid_A; 1.
DR   PRINTS; PR00306; SERUMAMYLOID.
DR   SMART; SM00197; SAA; 1.
DR   PROSITE; PS00992; SAA; 1.
PE   1: Evidence at protein level;
KW   Acute phase; Amyloid; Amyloidosis; Complete proteome;
KW   Direct protein sequencing; HDL; Methylation; Polymorphism;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     18
FT   CHAIN        19    122       Serum amyloid A-1 protein.
FT                                /FTId=PRO_0000031575.
FT   CHAIN        19     94       Amyloid protein A.
FT                                /FTId=PRO_0000031576.
FT   CHAIN        20    122       Serum amyloid protein A(2-104).
FT                                /FTId=PRO_0000031577.
FT   CHAIN        20    121       Serum amyloid protein A(2-103).
FT                                /FTId=PRO_0000031578.
FT   CHAIN        20    120       Serum amyloid protein A(2-102).
FT                                /FTId=PRO_0000031579.
FT   CHAIN        21    122       Serum amyloid protein A(3-104).
FT                                /FTId=PRO_0000031580.
FT   CHAIN        22    119       Serum amyloid protein A(4-101).
FT                                /FTId=PRO_0000031581.
FT   PROPEP       95    122       Often cleaved during amyloidogenesis.
FT                                /FTId=PRO_0000031582.
FT   MOD_RES     101    101       N4,N4-dimethylasparagine (Probable).
FT   VARIANT      15     15       G -> S (in dbSNP:rs712021).
FT                                /FTId=VAR_006925.
FT   VARIANT      70     70       V -> A (in allele SAA1.2, SAA1.3, SAA1.4
FT                                and SAA1.5).
FT                                /FTId=VAR_006926.
FT   VARIANT      75     75       A -> V (in allele SAA1.2, SAA1.4 and
FT                                SAA1.5).
FT                                /FTId=VAR_006927.
FT   VARIANT      78     78       D -> N (in allele SAA1.4).
FT                                /FTId=VAR_006928.
FT   VARIANT      86     86       F -> L (in dbSNP:rs1059559).
FT                                /FTId=VAR_057167.
FT   VARIANT      90     90       G -> D (in allele SAA1.2).
FT                                /FTId=VAR_006931.
FT   CONFLICT     71     71       W -> R (in Ref. 10; AA sequence and 11;
FT                                AA sequence).
FT   CONFLICT     77     77       S -> T (in Ref. 5; AC107948).
FT   CONFLICT     96    101       ADQAAN -> SEATVK (in Ref. 9; AA
FT                                sequence).
FT   CONFLICT    101    101       N -> D (in Ref. 6; AAH07022).
FT   CONFLICT    119    119       P -> S (in Ref. 1; AAA60297).
SQ   SEQUENCE   122 AA;  13532 MW;  43A57D56B37CB173 CRC64;
     MKLLTGLVFC SLVLGVSSRS FFSFLGEAFD GARDMWRAYS DMREANYIGS DKYFHARGNY
     DAAKRGPGGV WAAEAISDAR ENIQRFFGHG AEDSLADQAA NEWGRSGKDP NHFRPAGLPE
     KY
//
ID   SCA1_ANDAM              Reviewed;          74 AA.
AC   G8YYA5;
DT   11-JUL-2012, integrated into UniProtKB/Swiss-Prot.
DT   22-FEB-2012, sequence version 1.
DT   16-APR-2014, entry version 6.
DE   RecName: Full=Antimicrobial peptide 1;
DE            Short=AamAP1;
DE   Flags: Precursor;
OS   Androctonus amoreuxi (African fattail scorpion).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
OC   Scorpiones; Buthida; Buthoidea; Buthidae; Androctonus.
OX   NCBI_TaxID=112024;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 23-40, FUNCTION,
RP   AMIDATION AT LYS-40, SYNTHESIS OF 23-40, MUTAGENESIS OF HIS-30, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=22484288; DOI=10.1016/j.peptides.2012.03.016;
RA   Almaaytah A., Zhou M., Wang L., Chen T., Walker B., Shaw C.;
RT   "Antimicrobial/cytolytic peptides from the venom of the North African
RT   scorpion, Androctonus amoreuxi: biochemical and functional
RT   characterization of natural peptides and a single site-substituted
RT   analog.";
RL   Peptides 35:291-299(2012).
CC   -!- FUNCTION: Has antibacterial activity against the Gram-positive
CC       bacteria S.aureus (MIC=20 uM), the Gram-negative bacteria E.coli
CC       (MIC=150 uM), and the yeast C.albicans (MIC=64 uM). Causes
CC       hemolysis on horse erythrocytes.
CC   -!- SUBCELLULAR LOCATION: Secreted. Target cell membrane. Note=Forms a
CC       helical membrane channel in the prey.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=1931.94; Method=MALDI; Range=23-40;
CC       Source=PubMed:22484288;
CC   -!- SIMILARITY: Belongs to the short cationic antimicrobial peptide
CC       family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FR821613; CBZ41126.1; -; mRNA.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0044218; C:other organism cell membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR   GO; GO:0044179; P:hemolysis in other organism; IEA:UniProtKB-KW.
PE   1: Evidence at protein level;
KW   Amidation; Antibiotic; Antimicrobial;
KW   Cleavage on pair of basic residues; Cytolysis;
KW   Direct protein sequencing; Hemolysis; Membrane; Secreted; Signal;
KW   Target cell membrane; Target membrane; Transmembrane.
FT   SIGNAL        1     22
FT   PEPTIDE      23     40       Antimicrobial peptide 1.
FT                                /FTId=PRO_5000827072.
FT   PROPEP       46     74       By similarity.
FT                                /FTId=PRO_5000827071.
FT   MOD_RES      40     40       Lysine amide.
FT   MUTAGEN      30     30       H->K: Important increase in potency
FT                                against both bacteria and yeast (MIC=3-5
FT                                mM).
SQ   SEQUENCE   74 AA;  8573 MW;  2969EDF83D304638 CRC64;
     MEIKYLLTVF LVLLIGSDYC QAFLFSLIPH AIGGLISAFK GRRKRDLDGQ IDRSRNFRKR
     DAELEELLSK LPIY
//
ID   SCA2_ANDAM              Reviewed;          74 AA.
AC   G8YYA6;
DT   11-JUL-2012, integrated into UniProtKB/Swiss-Prot.
DT   22-FEB-2012, sequence version 1.
DT   16-APR-2014, entry version 6.
DE   RecName: Full=Antimicrobial peptide 2;
DE            Short=AamAP2;
DE   Flags: Precursor;
OS   Androctonus amoreuxi (African fattail scorpion).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
OC   Scorpiones; Buthida; Buthoidea; Buthidae; Androctonus.
OX   NCBI_TaxID=112024;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 23-40, FUNCTION,
RP   AMIDATION AT LYS-40, AND MASS SPECTROMETRY.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=22484288; DOI=10.1016/j.peptides.2012.03.016;
RA   Almaaytah A., Zhou M., Wang L., Chen T., Walker B., Shaw C.;
RT   "Antimicrobial/cytolytic peptides from the venom of the North African
RT   scorpion, Androctonus amoreuxi: biochemical and functional
RT   characterization of natural peptides and a single site-substituted
RT   analog.";
RL   Peptides 35:291-299(2012).
CC   -!- FUNCTION: Has antibacterial activity against the Gram-positive
CC       bacteria S.aureus (MIC=48 uM), the Gram-negative bacteria E.coli
CC       (MIC=120 uM), and the yeast C.albicans (MIC=64 uM). Causes
CC       hemolysis on horse erythrocytes.
CC   -!- SUBCELLULAR LOCATION: Secreted. Target cell membrane. Note=Forms a
CC       helical membrane channel in the prey.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC   -!- MASS SPECTROMETRY: Mass=1880.93; Method=MALDI; Range=23-40;
CC       Source=PubMed:22484288;
CC   -!- SIMILARITY: Belongs to the short cationic antimicrobial peptide
CC       family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FR821614; CBZ41127.1; -; mRNA.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0044218; C:other organism cell membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR   GO; GO:0044179; P:hemolysis in other organism; IEA:UniProtKB-KW.
PE   1: Evidence at protein level;
KW   Amidation; Antibiotic; Antimicrobial;
KW   Cleavage on pair of basic residues; Cytolysis;
KW   Direct protein sequencing; Hemolysis; Membrane; Secreted; Signal;
KW   Target cell membrane; Target membrane; Transmembrane.
FT   SIGNAL        1     22
FT   PEPTIDE      23     40       Antimicrobial peptide 2.
FT                                /FTId=PRO_5000827074.
FT   PROPEP       46     74       By similarity.
FT                                /FTId=PRO_5000827073.
FT   MOD_RES      40     40       Lysine amide.
SQ   SEQUENCE   74 AA;  8539 MW;  C869F8B134A48725 CRC64;
     MEIKYLLTVF LVLLIVSDHC QAFPFSLIPH AIGGLISAIK GRRKRDLDGQ IDRSRNFRKR
     DAELEELLSK LPIY
//
ID   SNO1_TYRJA              Reviewed;         456 AA.
AC   Q8MP06;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   16-APR-2014, entry version 55.
DE   RecName: Full=Senecionine N-oxygenase;
DE            Short=SNO;
DE            EC=1.14.13.101;
DE   Flags: Precursor;
GN   Name=sno1;
OS   Tyria jacobaeae (Cinnabar moth).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia;
OC   Noctuoidea; Arctiidae; Tyria.
OX   NCBI_TaxID=179666;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 23-60; 70-85 AND
RP   365-374, CATALYTIC ACTIVITY, AND COFACTOR.
RC   TISSUE=Larva;
RX   PubMed=11972041; DOI=10.1073/pnas.082674499;
RA   Naumann C., Hartmann T., Ober D.;
RT   "Evolutionary recruitment of a flavin-dependent monooxygenase for the
RT   detoxification of host plant-acquired pyrrolizidine alkaloids in the
RT   alkaloid-defended arctiid moth Tyria jacobaeae.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:6085-6090(2002).
RN   [2]
RP   CATALYTIC ACTIVITY, FUNCTION, COFACTOR, SUBUNIT, TISSUE SPECIFICITY,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9182998; DOI=10.1111/j.1432-1033.1997.00626.x;
RA   Lindigkeit R., Biller A., Buch M., Schiebel H.M., Boppre M.,
RA   Hartmann T.;
RT   "The two facies of pyrrolizidine alkaloids: the role of the tertiary
RT   amine and its N-oxide in chemical defense of insects with acquired
RT   plant alkaloids.";
RL   Eur. J. Biochem. 245:626-636(1997).
CC   -!- FUNCTION: NADPH-dependent monooxygenase that detoxifies
CC       senecionine and similar plant alkaloids that are ingested by the
CC       larvae. Is active towards a narrow range of related substrates
CC       with highest activity towards senecionine, followed by
CC       seneciphylline, retrorsine, monocrotaline, senecivernine,
CC       axillarine and axillaridine.
CC   -!- CATALYTIC ACTIVITY: Senecionine + NADPH + O(2) = senecionine N-
CC       oxide + NADP(+) + H(2)O.
CC   -!- COFACTOR: FAD.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Absorption:
CC         Abs(max)=456 nm;
CC       Kinetic parameters:
CC         KM=1.4 uM for senecionine;
CC         KM=1.3 uM for NADPH;
CC         KM=12.5 uM for monocrotaline;
CC       pH dependence:
CC         Optimum pH is 7.0;
CC       Temperature dependence:
CC         Optimum temperature is 40-45 degrees Celsius;
CC   -!- SUBUNIT: Homotetramer.
CC   -!- SUBCELLULAR LOCATION: Secreted (Potential).
CC   -!- TISSUE SPECIFICITY: Hemolymph.
CC   -!- MISCELLANEOUS: Larvae store pyrrolizidine alkaloids from their
CC       host plant S.jacobaeae as non-toxic N-oxides. This serves as
CC       protection against insectivores; after ingestion of the larvae,
CC       the N-oxides are reduced in the gut of the insectivores to form
CC       toxic alkaloids (PubMed:11972041).
CC   -!- SIMILARITY: Belongs to the FMO family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ420233; CAD12369.1; -; mRNA.
DR   ProteinModelPortal; Q8MP06; -.
DR   BioCyc; MetaCyc:MONOMER-16767; -.
DR   BRENDA; 1.14.13.101; 274510.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0004499; F:N,N-dimethylaniline monooxygenase activity; IEA:InterPro.
DR   GO; GO:0050661; F:NADP binding; IEA:InterPro.
DR   GO; GO:0033784; F:senecionine N-oxygenase activity; IDA:UniProtKB.
DR   GO; GO:0009820; P:alkaloid metabolic process; IDA:UniProtKB.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   InterPro; IPR000960; Flavin_mOase.
DR   InterPro; IPR020946; Flavin_mOase-like.
DR   Pfam; PF00743; FMO-like; 2.
DR   PRINTS; PR00370; FMOXYGENASE.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; FAD; Flavoprotein; Monooxygenase; NADP;
KW   Oxidoreductase; Secreted; Signal.
FT   SIGNAL        1     22
FT   CHAIN        23    456       Senecionine N-oxygenase.
FT                                /FTId=PRO_5000068127.
FT   NP_BIND      32     37       FAD (Potential).
FT   NP_BIND     215    220       NADP (Potential).
SQ   SEQUENCE   456 AA;  52232 MW;  3AE4ADD925D96932 CRC64;
     MFRKFVIMLV LSLLVAAGIS QASSASRVCI IGAGYSGLAT ARYLQDYGLN YTIFEATPNI
     GGTWRYDPRV GTDEDGIPIY SSNYKNLRVN SPVDLMTYHG YEFQEGTRSF ISGNCFYKYM
     KSFVRHFGLM ENIQVRSLVT WVQRTEDKWN LTYMKTDTRK NYTEECDFVV VASGEFSTPK
     IPHIKGQEEY KGKTMHSHDY KEAESFRGQR VLVIGAGPSG LDVVMQLSNI TSKLVHSQHI
     LKSWHIFNQP DFPGNFISKP NVKHFTANGA VFEDDTVEEF DMVIYCTGFY YNHPFLSTLS
     SGITATENYV MPLYQQVVNI NQPTMTFVGI CKPFFAKLLD QQAHYSAKLA AGHFKLPSQD
     KMLRHWLEHV QMLREAQFKI TDVNSVGPNV DEYFKALHKE AGVPLLPPVY ASVFVFSGKT
     LLEDLQNYRE YDYRIISDTQ FKKKYNPREE VCPYDD
//
ID   SOL5_ALTSO              Reviewed;         515 AA.
AC   D7UQ40;
DT   21-MAR-2012, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 1.
DT   22-JAN-2014, entry version 13.
DE   RecName: Full=Bifunctional solanapyrone synthase;
DE            EC=1.1.3.42;
DE            EC=5.5.1.20;
DE   AltName: Full=Prosolanapyrone-II oxidase;
DE   AltName: Full=Prosolanapyrone-III cycloisomerase;
DE   Flags: Precursor;
GN   Name=sol5;
OS   Alternaria solani.
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina;
OC   Dothideomycetes; Pleosporomycetidae; Pleosporales; Pleosporineae;
OC   Pleosporaceae; Alternaria.
OX   NCBI_TaxID=48100;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CATALYTIC ACTIVITY.
RX   PubMed=20486243; DOI=10.1002/cbic.201000173;
RA   Kasahara K., Miyamoto T., Fujimoto T., Oguri H., Tokiwano T.,
RA   Oikawa H., Ebizuka Y., Fujii I.;
RT   "Solanapyrone synthase, a possible Diels-Alderase and iterative type I
RT   polyketide synthase encoded in a biosynthetic gene cluster from
RT   Alternaria solani.";
RL   ChemBioChem 11:1245-1252(2010).
RN   [2]
RP   PROTEIN SEQUENCE OF 26-42, AND CATALYTIC ACTIVITY.
RX   PubMed=18256508; DOI=10.1271/bbb.70600;
RA   Katayama K., Kobayashi T., Chijimatsu M., Ichihara A., Oikawa H.;
RT   "Purification and N-terminal amino acid sequence of solanapyrone
RT   synthase, a natural Diels-Alderase from Alternaria solani.";
RL   Biosci. Biotechnol. Biochem. 72:604-607(2008).
RN   [3]
RP   CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9659400; DOI=10.1016/S0167-4838(98)00040-5;
RA   Katayama K., Kobayashi T., Oikawa H., Honma M., Ichihara A.;
RT   "Enzymatic activity and partial purification of solanapyrone synthase:
RT   first enzyme catalyzing Diels-Alder reaction.";
RL   Biochim. Biophys. Acta 1384:387-395(1998).
CC   -!- FUNCTION: Bifunctional enzyme involved in the biosynthesis of the
CC       phytotoxin solanapyrone, a causal agent of early blight disease of
CC       potato and tomato. Catalyzes the oxidation of prosolanapyrone II
CC       and the subsequent Diels Alder cycloisomerization of the product
CC       prosolanapyrone III to (-)-solanapyrone A.
CC   -!- CATALYTIC ACTIVITY: Prosolanapyrone II + O(2) = prosolanapyrone
CC       III + H(2)O(2).
CC   -!- CATALYTIC ACTIVITY: Prosolanapyrone III = (-)-solanapyrone A.
CC   -!- COFACTOR: FAD (By similarity).
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=16 uM for Prosolanapyrone II;
CC   -!- SIMILARITY: Contains 1 FAD-binding PCMH-type domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB514562; BAJ09785.1; -; Genomic_DNA.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0016853; F:isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008762; F:UDP-N-acetylmuramate dehydrogenase activity; IEA:InterPro.
DR   GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.465.10; -; 1.
DR   InterPro; IPR016169; CO_DH_flavot_FAD-bd_sub2.
DR   InterPro; IPR016166; FAD-bd_2.
DR   InterPro; IPR006094; Oxid_FAD_bind_N.
DR   Pfam; PF01565; FAD_binding_4; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; FAD; Flavoprotein; Glycoprotein; Isomerase;
KW   Oxidoreductase; Signal; Virulence.
FT   SIGNAL        1     25
FT   CHAIN        26    515       Bifunctional solanapyrone synthase.
FT                                /FTId=PRO_0000416192.
FT   DOMAIN       91    261       FAD-binding PCMH-type.
FT   CARBOHYD     66     66       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    274    274       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    355    355       N-linked (GlcNAc...) (Potential).
SQ   SEQUENCE   515 AA;  55994 MW;  7BCCBD564458484D CRC64;
     MRLIILNLLS LGITPSVVGH SGPHRQETQN LNNFLESNAI NPAAINGETR HTGGVHLACA
     ILEASNQTAV VFPSDGELYT QIDKAHASAT APKNPACIYT PNDVKGVSLG VKVATFVQAK
     FAIRSGGHSP MEYFANIDGG VLISLAGIKT LEYNADTQTQ RSGFGNLWQD VYRHVNAQGR
     TVVGGRTGSV GLALTLGGGL SHFSNAYGWA AQNVLSYEMV LADGSIVIAS EEENSDLYFA
     VKAGANNFGI VTHIVQRTYP LGKIWGGSMI FPGNASAQFM AALADYQAKG QLDKKSAILP
     YVGLIADAVV AQFSYLEPVE RPEAFEAFYD IPVIQDLTQV WDTFAAMVTA PIPYNMTRFS
     YATTDLLYDK EAYLEIERIC HKYIPRMRKL EGGDIMLMPQ PISVSMVGEA RARGSDPMGV
     ADQPQLWFVV SSGWNLAQDD AEAESIMLDA LAEVEEYTKS RALHLPFYFL NDAFSTQMPL
     QSYGAVTYGK LQAASRKYDP TRVFQELVPG GFKLV
//
